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Healthcare associated infections (HCAI) are a major concern due there their impact on morbidity and 
associated costs. To prevent subsequent infection, the use of an effective antiseptic agent is necessary 
before an incision is performed. However, there are two important issues that may restrict effective 
antisepsis; the first of these is that the penetration of most antimicrobial agents is very poor, and the 
antiseptic may not reach the deep layers of the skin; therefore microorganisms located in these layers 
are likely to survive. The second issue is the lack of miscibility between the antiseptic agent and the 
sebum which prevents the delivery to the target site within the hair follicle. Nanoemulsions are a 
promising drug delivery system which can potentially facilitate the penetration of an antiseptic agent 
to the deeper layers of the skin.  
 
In this thesis, the capability of nanoemulsion formulations in the delivery of antiseptic agents to target 
sites within the skin was assessed. Triclosan nanoemulsions were prepared using two different 
techniques, a high-pressure homogenisation and high-shear homogenisation followed by 
ultrasonication. The parameters of the triclosan nanoemulsion were evaluated; these include various 
types and concentrations of surfactants (Tween/Span) and various oil concentrations (eucalyptus oil). 
The detection of the amount of triclosan retained within the skin was also investigated both 
quantitatively and qualitatively using tape-stripping technique followed by hplc and micro CT scanning 
respectively. The lowest concentration of the surfactant mixture (0.34%W/W) (Tween 80 / Span 80) 
produced the highest skin retention of the antiseptic agent, this was detected quantitatively in the 
tape-stripping method and confirmed qualitatively in the novel approach using micro CT scans. 
 
Hansen solubility parameters (HSPs) were used to predict the miscibility of nano-formulations with 
artificial sebum, the HSP for artificial sebum was calculated using three different methods: 
contribution group method (Van Krevelen method), Y-MB method using HSPiP software and the third 
using the solubility and miscibility of known HSPs and regression statistics. HSPs were successfully 
used as a prediction tool in estimating the miscibility of nanoemulsion in artificial sebum using the 
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Chapter 1 - Introduction 
1.1 Healthcare-associated infections (HCAI) 
Healthcare-associated infections (HCAI) defined as infections which affect patients due to their 
medical treatment from healthcare providers. In UK affect around 300 thousand patients annually 
with a prevalence rate of 8.2%; these infections are a primary concern in National Health Service 
(NHS) hospitals, and HCAI is considered a major safety concern being associated with higher rates of 
morbidity and mortality, in addition, high healthcare costs of around £1 billion annually (Cole, 2011). 
1.1.1 Factors contributing to HCAI 
Various factors may be partially or fully responsible for the prevalence of HCAI including: 
environmental factors (in general)– such as air contamination due to air-conditioning systems and 
hospital beds being too close together, patient-related factors – such as severe hidden health 
conditions and lengthened stay in hospitals, and healthcare-associated factors – such as using 
invasive devices, selection pressure due to high use of antibiotics and surgical procedures. The 
interaction between the factors occurs in all healthcare systems and more than one factor combined 
may be the reason for the occurrence of infections such as high staff-to-patient ratios and the 
absence of adequate intervention programmes designed to minimise HCAI. (Al-Tawfiq and Tambyah, 
2014) 
1.1.2 Types of HCAI 
Urinary Tract Infections (UTIs) 
Catheter associated urinary tract infections are the most common type of infections that patients 
contract during their time under medical care and, more than 12% of reported infections are UTIs. 
Patients endogenous native microflora is what causes CAUTIs. When catheters are inserted, they act 






The occurrence of CAUTIs can lead to various complications in patients including meningitis and 
cystitis in addition to potential complications specific to male patients including; prostatitis, 
epididymitis and orchitis. (Khan, Baig and Mehboob, 2017) 
Lower respiratory tract infections  
These types of infections are accountable for approximately 20% of HCAI, and they are the 
infections which impact the respiratory routes, i.e., trachea, bronchi and the lungs and the most 
severe and fatal type of these infections is pneumonia which leads to mortality in almost 40% of 
cases. (Morse, 2009) 
Gastrointestinal  
Gastrointestinal infections account for around 22% of HCAI, they are mainly generated by 
Clostridium difficile (C. difficile) which is an organism that makes spores which are then released in 
faeces causing contamination to the environment. Spores can be transported to another patient by 
ingestion due to direct contact with an infected subject or through the environment. Another 
common organism that may lead to gastrointestinal infections is norovirus which is very contagious 
and leads to vomiting and diarrhoea. (Morse, 2009)  
Bloodstream infections 
Central line-associated bloodstream infections are a common type of infections contracted while 
under medical care, the mortality rate of these infections is 12%-25%.These can result from the 
prolonged use of catheters, which are inserted in the central line of patients to deliver fluids and 
drugs. This prolonged use and the infections that can be caused by this can have a determinantal 
effect on the health of patients and increase cost of care.  An annual rate of around 30 thousand 







Skin and soft tissue infections  
The severity of these type of infections is varied and usually controlled by the depth to which the 
skin or soft tissue is affected, with deeper infections requiring surgical intervention. These types of 
infections account for around 10% of HCAI. 
1.1.2.1 Surgical site infections (SSIs) 
Surgical site infections are the second most common type of infections affecting patients under 
medical care, they account for around 2%-5% of patients undergoing surgery. The main cause for 
SSIs is Staphylococcus aureus which can lead to a prolonged need of hospitalisation and a 
consequent risk of death to patients. Endogenous microflora lead to arising pathogens that 
subsequently lead to SSI in patients. The procedures taken and surveillance criteria for the surgery 
performed highly affects the incident rate of the SSIs occurring, which can be as high as 20% in some 
cases. (Khan, Baig and Mehboob, 2017) 
 
1.1.2.1.1 Microorganisms  
The patient’s flora is the most common source for the microorganisms causing SSIs, the main 
bacteria found due to SSIs are: Staphylococcus aureus, Escherichia coli and Enterococcus species 
(Schaberg, 1994). The escalation in the number of SSIs is due to antibiotic-resistant pathogens which 
lead to higher amounts of patients which are severely ill which generate a demand to use a broader 
variety of antimicrobial agents. Antibiotic-resistant pathogens include methicillin-resistant 
Staphylococcus aureus (MRSA) or Candida albicans. (Schaberg, 1994) Other factors such as 






microorganisms which can subsequently cause unexpected outbreaks in infections; these 
microorganisms include Clostridium perfringens, Rhodococcus bronchialis, Nocardia farcinica and 
Legionella pneumophila. (Mangram et al., 1999) 
1.1.2.1.2 Current prevention strategies for SSIs 
SSIs can be considered avoidable; guidelines were set and published by the National Institute for 
Health and Clinical Excellence (NICE) in 2008 to review management methods and strategies to 
prevent similar infections. these guidelines were published by and are currently adopted by health 
systems in the UK. These strategies are divided into three phases: the pre-operative phase, the 
intra-operative phase and the post-operative phase, where each phase has its specific set guidelines 
as follows:  
The pre-operative phase: Hair-removal is not to be routinely used to minimise the threat of SSI. 
Antibiotic prophylaxis to be given to patients before clean surgery which involves prosthetic or 
implant insertion, clean surgery and contaminated surgery, potential adverse effects to be taken 
into consideration when deciding on antibiotic prophylaxis.  
The intra-operative phase: Skin at the surgical site must be prepared using antiseptic instantly 
before the incision is made, and surgical incisions must be covered with relevant dressings when 
finishing the operation. 
The post-operative phase: Advice is to be sought on the correct dressing for surgical wound 
management for healing wounds by secondary intention, this advice must be given by a member of 






In the intra-operative phase, the use of skin antisepsis before the incision is made is mainly 
superficial, and the use of nanotechnology will improve the penetration of antisepsis in the layers of 
the skin.  
1.2 Skin structure 
 
Skin plays a number of important functions that help to maintain body homeostasis such as protection, 
temperature control, and sensation. It is considered as the first line of defence for the entire internal 
body from external threats such as sunlight, viruses, cold weather, dirt and dust, as well as playing a role 
in temperature regulation. For example, when the body is hot and needs to cool down, the blood vessels 
in skin swell and allow heat to be emitted; the sweat glands start secreting sweat and hairs lie flat to 
permit the heat to depart from the body. Also, the opposite is true in the case of the body needing to 
retain heat in cold conditions. 
The skin is one of the more popular routes for drug application, either for local or systematic effects. The 
route has been used to deliver active ingredients to targeted sites within the skin to treat many skin 
disorders such as alopecia (Gelfuso et al., 2013) or acne (Thiboutot, 2004) without exposing the whole 
body to the side effects of active pharmaceutical ingredients (APIs). 








Figure 0.1 Structure of the skin (Uchechi, Ogbonna and Attama, 2014) 
 
1.2.1 The subcutaneous layer 
The subcutaneous layer is also called the hypodermis or superficial fascia; it is considered to anchor the 
skin to underlying structures. It mainly contains adipose tissue and blood vessels. The thickness of this 
layer is usually several millimetres except for some areas such as the eyelids where it is mostly absent. It 
also functions as storage for high-energy molecules and carries the principal blood vessels and nerves to 
the skin (Williams, 2007). The subcutaneous layer is not considered an important layer in the study of 
transdermal and topical drug delivery as it is rarely considered as a barrier.  
1.2.2 The dermis 
The dermis is a layer between the epidermis and subcutaneous tissue, it has a thickness of around 3-5 
mm and contains connective tissue knitted with collagen, elastin and reticulin. The dermis plays an 
important role in transmitting nutrients, eliminating waste products, and control of pressure and 






arterial plexus that delivers blood to sweat glands, hair follicles, subcutaneous fat and the dermis itself 
(Williams, 2007).  
1.2.3 The epidermis 
The epidermis is the outermost layer of the skin, which overlies the dermis layer. It is composed of 
keratinised stratified squamous epithelium. Its most important functions are to control skin 
permeability, prevent the entry of biological pathogens, and synthesize vitamin D; the epidermis layer is 
also a self-regenerating layer.  
The specific layers of the epidermis are the stratum basal which is a mitotic layer, continuously replacing 
epidermal cells, at a turnover rate of between 25 to 50 days. The stratum spinosum has cells that push 
upward and flatten out while the stratum granulosum cells contain granules of keratin. The stratum 
lucidum is observed only in non-hairy or thick skin and contains several layers of dead cells with 
indistinct boundaries. The stratum corneum is composed of 25 or more layers of dead squamous cells 
still joined together by desmosomes.  Eventually, desmosomes break down, and cells flake off in a 







Figure 0.2 Structure of the epidermis (Tortora and Derrickson, 2014) 
1.2.4 The stratum corneum 
The major physical barrier of the skin is the stratum corneum (SC). Thus diffusion through the SC for a 
material permeating through the skin is often the rate-limiting step (Prow et al., 2011). Additionally, it is 
the essential barrier to the diffusion of water out of the skin (Bennett, 1975). Cells are arranged in the 
SC as bilayers, which forms a ‘bricks and mortar’ arrangement. These cells are flattened, anuclear, 
protein-rich corneocytes tightly crowded together and exist amongst an extracellular lipid matrix (Prow 
et al., 2011). The corneocytes are held together by corneodesmosomes, which help to form a tough 
outer layer by maintaining cellular shape and regular packing. Desquamation is the result of the break 
up the corneodesmosomes by proteolytic enzymes (Caubet et al., 2004). Transport via the SC happens in 






irregular and discontinuous layer that covers the corneocytes on the SC surface; this layer is thought to 
have a negligible effect as a permeation barrier through the SC. The layer consists of bacteria, sweat and 
dead skin cells in addition to sebum which is secreted by the sebaceous glands (Tregear, 1966). Solutes 
were previously considered to take separate routes to permeate through the stratum corneum 
depending on whether they are polar or non-polar, as more lipophilic solutes go through the 
intercellular lipids and polar solutes take a transcellular route (Scheuplein, 1965). However, in most 
cases, this pathway has been marked unlikely due to the difficulty of repeated separation of lipophilic 
and hydrophilic compartments in the SC. There has been both theoretical and histochemical evidence to 
support this; evidence demonstrated that diffusion through intercellular lipids was more likely for most 
solutes. For the transcellular route, it is still controversial even for lipophilic solutes in spite of 
reaffirmations of the importance of this route. With the majority of work centred on the hair follicles, 
the delivery of particles and drugs through the appendageal route is considered a sensible substitute to 
delivery across the SC (Prow et al., 2011) 
1.2.5  Hair follicles 
Hair follicles (HF) have recently been studied as a substitute pathway for dermal absorption. Regardless 
of their relatively low surface coverage of around 0.1%, they are frequently considered to enable 
permeation (Otberg et al., 2004).Hair follicles also provide considerable assistance to the absorption of 
(sub)micron particles and small molecules, particularly small molecules with octanol-water partition 
coefficients varying between low to intermediate (Frum, Eccleston and Meidan, 2008; Patzelt et al., 
2011). 
Furthermore, HFs are considered to serve as interesting target sites for drug delivery. For example, 






and sebum-flow and can provide protection against removal by washing or from contact with clothing 
(figure 1.3). 
 
Figure 0.3 structure of hair follicles (Fang et al., 2014) 
Moreover, in the lower third of the HF, the stratum corneum (SC) is not present, facilitating the 
penetration of substances (Raber et al., 2014). However, it has been shown by Otberg et al. (2004) that 
the follicle density varies in various body sites. For example, this is observed for the forehead and the 
calf regions;  a high density of small hair follicles is present on the forehead, whereas the follicles are 
larger with smaller density on the calf region (Otberg et al., 2004). 
Lademann et al. (2006) reported that time-dependent differences were displayed for the retention of 
nanoparticles in both the stratum corneum and the hair follicles. The nanoparticles remained in the 
stratum corneum for 24 hours, whereas in the hair follicle nanoparticles were observed even after the 






higher in the SC than within the hair follicle (Lademann et al., 2006). One important consideration is that 
an oily substance is secreted by sebaceous glands into the hair follicle making it very important to study 
the diffusion properties and drug partition in the sebum for the targeted delivery of therapeutic agents 
into the sebum-filled hair follicle (Valiveti and Lu, 2007). 
1.3 Wounds 
1.3.1 Wounds definition and classification 
A wound can be defined as destruction or disturbance to the skin in its functionality in providing 
protection; this occurs due to the epithelium losing its ability as a barrier as a result of one or more 
factor such as surgery, cuts, frictional forces, chemicals or even as a consequence of a disease. Wounds 
have been categorised into multiple types based on several factors including injury leading to wound, 
wound location and the healing time needed for the wounds. According to the healing time necessary 
for wounds, they can be categorised into acute or chronic wounds.  
1.3.1.1 Acute Wounds  
This type of wound is relatively common, and the healing time required is usually no more than 30 days 
as the tissue repair process begins instantly after the occurrence of the injury. The damage in acute 
wounds only affects the epidermis layer and the superficial dermis, and these types of wounds can be 
further classified in relation to the cause of the wound into many categories including surgical wounds, 
thermal burns, lacerations and abrasions. Another classification can be based on the type of the wound 






Surgical incision wounds 
This type of wound occurs through surgery, and the duration of damage is dependent on the surgery 
and some surgical incision wounds can cause pain to the patient and are life-threatening. This type of 
wound can be particularly harmful if made in the heart, lungs or blood vessels. 
Burns 
Burns can occur due to contact with heat, electricity, radiation or friction; this can lead to damage of 
skin tissue in its surface layer and deeper into other layers depending on the severity of the burn. Some 
burns can be treated by simple measures, whereas others must be treated in hospitals. These wounds 
may cause a large loss of skin functions and damage to the skin which may subsequently cause infection, 
and in some cases, they may cause the skin to lose its functionality including its normal 
thermoregulation and immunity (Li, Chen and Kirsner, 2007) 
Abrasion wounds 
These types of wounds lead to damage or removal of the epidermis due to contact with other surfaces 
in the form of friction or small cuts. Abrasion wounds are usually painless and do not generally cause 
bleeding (HC Korting & C Schollmann, 2011) 
Lacerations 
Lacerations lead to deeper cuts than those in abrasion wounds and this type of wound generally causes 
bleeding and severe pain. The cause of laceration wounds is normally due to a sudden accident or 
trauma (Monaco & W. Thomas Lawrence, 2003) 
1.3.1.2 Chronic Wounds 
Acute wounds will often develop into chronic wounds if they are subjected to one of the following 






is impaired, and this lead to the development of chronic wounds (Eming and Krieg, 2002) These wounds 
are also classified into various types including: ischemic wounds, infectious wounds and surgical 
wounds. (Degreef, 1998)(Robson, 2001)(Szycher and Lee, 1992) 
Ischemic wounds 
These chronic wounds can be identified by their appearance as they will usually be cold and pale. The 
reason behind the development of these wounds is a reduced blood supply reaching the tissue which 
delays the wound healing process due to undersupply of nutrients and oxygen to the tissue.  
Infected wounds 
Infected wounds can generally be identified by the encompassing of pus and debris and the release of 
bad odours, these wounds occur due to bacteria, fungi or viruses and result in symptoms of 
inflammation including redness, pain and high fever.  
Surgical wounds 
As mentioned in 1.2.1.1.1, surgical wounds are normally acute; however, they may transition into 
chronic wounds when necessary treatments are not followed. The most likely consequence of this lack 
of required treatment is an ulcer and ulcers can also be further divided into venous ulcers, diabetic and 
pressure ulcers. 
Various diabetes disorders, including vascular, metabolic and neurological, may lead to the development 
of ulcers. The way these disorders cause ulcers is that they first lead to damage in the nerves and a lack 
of adequate blood supply in addition to impairing immune functions which will all subsequently lead to 
damage of the skin and eventually ulceration. However, these chronic ulcers are painless. 
The main location for the development of pressure ulcers is the bony areas in the body that are near the 






soft tissue. This then causes an injury to the skin and/or tissue beneath the skin. Pressure ulcers can be 
identified by the redness and itching they cause in addition to the swelling and discolouration.  
Venous ulcerations are the most frequently developed type of vascular ulceration and are particularly 
common in lower limbs like deep vein thrombosis, venous hypertension and varicose veins. It is not 
unusual for patients who develop venous ulcers to have previously been subjected to lower limb 
oedema or damage and leaking in veins. 
 
1.3.2 Wound infection 
These are infections that occur in and/or surrounding the wound area, therefore, causing an 
interruption in the wound healing process, and the reason behind wound infections is due to the 
presence of microorganisms within the wound site or around it. Microorganisms most commonly 
present in the skin arise from external sources and are harmless if the skin is undamaged, however, 
when the skin is damaged, in the case of a wound, the skin loses its protective ability in that area, and 
the microorganisms gather and colonise the wound site, subsequently leading to a delay in the healing 
process of the wound.  
Various types of microorganisms lead to the infection of wounds and the most frequent bacteria causing 
these infections are Staphylococcus aureus in addition to different groups of Streptococci (Phillip M & 
Williford, 1999) Other well-known microorganisms which contribute in skin infections include 
Pseudomonas aeruginosa, Staphylococcus epidermis and Escherichia coli (Percival et al., 2012) 
Wound infection can cause the loss of soft tissue which may lead to the need for amputation and can 






reason behind the death of around 10 thousand wound patients in every million. (Edwards and Harding, 
2004)(Percival et al., 2012) 
  
1.3.3 Wound healing 
Wound healing is arranged into four continuous and overlapping phases,  haemostasis, inflammation, 
proliferation and finally, the remodelling phase (Diegelmann, 2004) (figure 1.4). 
 
Figure 0.4 Four phases of wound healing (Hemmila, M.R., Mattar, A., Taddonio, M.A., Arbabi, S., Hamouda, T., 
Ward, P.A., Wang, S.C., Baker, 2010) 
  
1.3.3.1 Haemostasis 
This is the first phase which takes place immediately after the occurrence of an injury and can simply be 
described as the phase in which the wound is closed through clotting. The aim of this phase is to stop 
more tissue from being lost from damaged blood vessels. This phase generates the supporting matrix 
needed for migrating cells which plays an important role in the upcoming healing phases. (Broughton, 






adhesion and accumulation of platelets; where adhesive molecules like fibronectin and vitronectin are 
stored on a fibrin mesh. The fibrin clots that are formed within the damaged blood vessels promote the 
termination of haemorrhage and the surrounding tissue with the blood vessels discharged into it form a 
provisional matrix used by migrating cells that are involved in the repair. The last stages of this phase are 
completed when inflammatory cells are activated by platelet-derived growth factors alongside fibrin 
degradation products.  
1.3.3.2 Inflammation 
This is the second phase of the healing process which immediately follows haemostasis. In this phase, an 
immune barrier for protection against microbial colonisation is created by cellular inflammation, and 
blood vessels release various leucocytes as a response to the cellular signals. This phase of wound 
healing can be divided into two stages based on the dominant type of leucocytes; these two phases are 
known as the early stage and the late stage (Hart, 2002). The early stage of the inflammation phase is 
dominated by neutrophils which facilitate phagocytosis and subsequent destruction of bacteria, 
therefore, leading to debridement of the wound. In the late stage, the predominant leucocytes are 
macrophages; the stage is completed when the lymphocytes infiltrate into the wound site. 
1.3.3.3 Proliferation 
The proliferation phase is characterised by the migration and growth of dermal and epidermal cells from 
neighbouring sites to the wound site, fibroblasts migrate, and new extracellular matrix (ECM) is 
deposited to replace the temporary network consisting of fibrin and fibronectin lasting around two 
weeks. The proliferation of the fibroblasts, in addition to the migration and the differentiation all take 
place due to the influence of growth factors. Other important characteristics of this phase are the 






differentiated myofibroblasts which originate from mesenchymal fibroblast cell lines. (Gilbane, Denton 
and Holmes, 2013) 
1.3.3.4 Remodelling 
The remodelling phase in wound healing is considered the last stage; therefore, in this phase, the new 
epithelium is formed in addition to final scar tissue. This is the longest phase of wound healing and can 
last for up to two years after the occurrence of the injury(Witte and Barbul, 1997 & Ramasastry, 2005). 
various actions take place during this phase such as the further organisation of collagen, and fibronectin 
is eliminated, glycosaminoglycans and hyaluronic acid are substituted with proteoglycans. Other factors 
occurring in this phase include: ECM is actively reorganised, new capillaries are formed, and 
proliferation and inflammation are reduced, these factors lead to a reduced need for nutrients in this 
phase. (Guo and Dipietro, 2010) 
1.3.4 Wound Dressings 
Traditionally, wound dressings were designed with the purpose of absorbing excretions from wounds in 
addition to maintaining a dry atmosphere. However, it is now recognised that it is important for the 
wound site to remain hydrated and moisturised to facilitate faster healing of wounds. To maintain 
hydration and retain moisture, new types of wound dressings were introduced which accomplished the 
necessary atmosphere through the occlusion. (Boateng et al., 2008) (Schultz et al., 2002) 
Wound dressings are used for various type of injuries ranging from minor superficial wounds to more 
complicated infected wounds and play multiple roles in stopping wound bleeding, preventing worsening 
of wounds by protecting them from bacteria in the surrounding environment in addition to expediting 
the healing of wounds through the prevention of excessive wound exudate being present. Any ideal 






forming a physical barrier from other infections and absorbing microorganisms and wound excretions. 
(Quinn et al., 1985)(Diegelmann, 2004) 
1.3.4.1 Wound dressing types 
Wound dressings are mainly split into two categories, the first category is the traditional dressings which 
include cotton wool, natural and synthetic bandages and gauzes. The second category, modern 
dressings, includes hydrogels, foam dressings, hydrocolloids, adhesive film dressings and alginates. 
These can be further subdivided into more categories regarding the dressing’s function and can be 
categorised into antimicrobial, absorbent, occlusive, adherence and debridement dressings. Another 
categorisation for dressings is based on the level of contact the dressing has with the wound where 
primary dressings are the first type, and these dressings have direct physical contact with the surface of 
the wound, whereas secondary dressings do not have direct physical contact with the wound and 
normally cover primary dressings(K and Babu, 2000 & A NNA F. F ALABELLA, 2006).  
1.3.4.1.1 Gauze Dressings 
Traditionally, gauze dressings were dry and did not maintain moisture which was proven to be 
inadequate for wounds which produce a small amount of exudate, in addition to causing discomfort and 
trauma during removal. Therefore, newer designs of gauze dressings aim to maintain a moist 
atmosphere for the wound leading to improved results and less discomfort when serving as a primary 
dressing, whereas, traditional designs can be used for secondary dressings  and they can also be used for 
wounds that are dry and clean. Gauze dressings comprise materials such as cotton fibres or rayon 






1.3.4.1.2 Foam Dressings 
Modern foam dressings are suitable for covering wounds which have little to moderate amounts of 
exudate as they can absorb moderate fluid levels. This absorbing ability is due to their porous 
polyurethane components which make these dressings adequate for treating granulating wounds. 
However, since foam dressings are dependent on exudates, they are unsuitable for the treatment of dry 
scars or wounds. (Ramos-e-silva, 2002) Branded foam dressings available include Lyofoam® (ConvaTec, 
UK) and Allevyn® (Smith and Nephew). 
1.3.4.1.3 Hydrocolloid Dressings 
Hydrocolloid dressings are usually made from pectin, gelatin and carboxymethylcellulose and are 
available in a range of forms such as films, sheets and gel forms where the gel form is an adhesive 
hydrocolloid gel. (Bethell, 2003) Hydrocolloid dressings are considered to be the most popular type of 
dressings; they are mostly suitable for wounds with little to moderate levels of exudate as the outer 
layer of the dressing is initially impermeable to oxygen, water vapour and bacteria when it is fully intact 
and gradually become more permeable as the gelling process occurs. (Barnea et al., 2004) There are 
various brands of hydrocolloid dressings which include Tegasorb® (3M Healthcare, UK), Aquacel® 
(ConvaTec, UK) and Comfeel® (Coloplast, UK)  
1.3.4.1.4 Hydrogel Dressings 
These dressings are hydrophilic materials which are insoluble and made from synthetic polymers such as 
polyvinylpyrrolidone and are capable of transferring vapour and water, while also providing required 
moisture to the wound. (Fan et al., 2011) The mechanism these hydrogel use is to rehydrate dead 
tissues and enhance the autolytic debridement for treating dry wounds, without causing irritation and 






1.3.4.1.5 Alginate Dressings 
Alginate dressings are made of sodium and calcium salts of alginic acid. Alginate dressings form a 
protective gel film by exchanging calcium ions in the alginate fibre with sodium ions in blood when 
treating wounds. Commercially available products of this dressing type include Kalostat® (ConvaTec, UK) 
and Sorbsan® (Maersk, UK) 
1.3.4.1.6 Biological Dressings 
Biological dressings, also referred to as bioactive dressings, are composed of biomaterials with 
important roles in the process of healing as they form sections of the natural tissue matrix and are made 
using various polymers including collagen, chitosan, hyaluronic acid and elastin. (Ishihara et al., 
2002)(Ueno et al., 1999) 
1.3.4.1.7 Antimicrobial Dressings 
The main role of antimicrobial dressings is to eliminate or limit microorganism growth within a wound. 
Using antimicrobial dressings for topical treatment will minimise wound infection risk, and this type of 
dressing can be used for various infected injuries ranging from acute wounds to chronic wounds. There 
are multiple characteristics that the optimal antimicrobial for local treatment should have which include 
being non-toxic and non-allergenic, having a wide range of activity in addition to being microbicidal. 
(Flores, 2007) Various antiseptics have been applied in antimicrobial dressings including chlorhexidine, 
silver, polyhexamethyl biguanide (PHMB) and iodine. (Gerald McDonnell, 1999) 
1.4 Antiseptics 
1.4.1 Alcohol 
Alcohols are considered effective antimicrobials with broad-spectrum against bacteria, viruses, and 






best option for sterilisation as they are not sporicidal but recommended for disinfection and skin 
antisepsis. Products with a combination of alcohol and a low concentration of another antiseptic (like 
chlorhexidine) increase the efficacy of antimicrobials since the other antiseptic agent remains in the skin 
after the alcohol evaporates (Small et al., 2013). At high concentrations of alcohol (60 to 90% v/v), an 
antimicrobial effect will be optimum, whereas below 50% will be considerably low (Mcdonnell & Russell, 
1999). Not much is clear about the mechanism of action of alcohol. However, it causes membrane 
damage, protein denaturation and cell lysis. (Fraise et al., 2013) 
1.4.2 Biguanides 
1.4.2.1 Chlorhexidine  
Chlorhexidine has a broad spectrum of uses, low irritation and high efficacy and does not cause high 
irritation to the skin and has high substantivity in the skin, due to these characteristics, it is the most 
commonly used antiseptic product as a biocide (Day and Russell, 1993). The interaction of chlorhexidine 
with bacteria was studied for the first time by Hugo et al. 2013 .  in which it was found that E. coli and S. 
aureus can take up chlorhexidine(Gerald McDonnell, 1999).  
 Since this antiseptic is not sporadical, the viability of Bacillus spores is not affected by chlorhexidine, 
even at its higher concentrations. The effect chlorhexidine has on the germination of bacterial spores is 
very small. However, it restricts outgrowth.  The reason behind this, although not known definitely, 
could theoretically be due to the relative uptake of chlorhexidine as germination of cells in comparison 






1.4.2.2 Alexidine  
This antiseptic has different Ethylhexyl end groups from chlorhexidine (figure 1.5), the bactericidal 
ability of alexidine is faster, and the alteration produced in bactericidal permeability is also significantly 
more rapid(Gerald McDonnell, 1999).  
 
Figure 0.5 structure of chlorhexidine(K.S. Lim & P.C.A. Kam, 2008) 
1.4.2.3 Polymeric biguanides 
These types of antiseptic have a wide range of applications including in the food industry as well as 
being very effective in disinfecting swimming pools. Polyhexamethylene biguanide (PHMB) is an agent 
that is membrane-active and causes impairment in the stability of the outer membrane of gram-
negative bacteria and can also operate as a barrier for permeability. The level of activity of PHMB rises 
with its weight which leads to higher polymerisation levels; this has been associated with improved 
perturbation of the inner membrane (Gilbert, Collier and Brown, 1990). 
1.4.3 Iodine-releasing agents 
Iodine has been used as an antiseptic for over a century in both its aqueous and alcoholic forms. Iodine 
has the advantages of being highly bactericidal, sporicidal and fungicidal. However, it has challenges 






unstable. Due to these downfalls, iodine-releasing agents were developed which are complexes of 
iodine in addition to a solubilising agent. The iodine-releasing agents maintain the germicidal ability but 
reduce the fungicidal activity. Although the exact mechanism is unknown, iodine has a fast antimicrobial 
ability even when it is at a low concentration, the microorganism can be quickly penetrated by iodine, 
and key groups of proteins are then attacked (Gottardi, 1991). 
1.4.4 Silver compounds 
Various forms of silver have been used for many years as an antimicrobial agent, The most popular in 
current use is silver sulfadiazine (AgSD), although other silver compounds are also still in use and have 
antimicrobial properties; these include silver nitrate, silver protein and silver metal. Silver antiseptics in 
their various forms have been used in many applications; recent applications include the prevention of 
burns infections, eye infections, and to overcome warts. Other medical functions include their use in 
dental applications and catheters (Klasen, 2000).  
1.4.5 Phenols 
Phenolic antimicrobials have been used in various applications including perseveration, antiseptic and 
disinfectant usages. The membrane-active properties of these compounds are large contributors to their 
general activity (Denyer, 1995). 
Phenol acts as a promoter for the gradual leaking of the constituents within a cell which includes the 
release of K+; this is thought to be the first sign of damage to the membrane. Low concentrations of 
phenol and different non-phenolic agents have been shown to cause break down of quickly growing 
cultures of various bacteria including E. coli, streptococci and staphylococci which led to the conclusion 






separation point of daughter cell pairs, therefore, leading to higher sensitivity to phenol in young 
bacteria cells than old cells. 
Phenols have antifungal and antiviral characteristics; the antifungal properties of phenol are believed to 
include destroying the plasma membrane which consequently leads to leaking in the intercellular 
constituents. Phenols, however, do not have any impact on phage DNA in the capsid, and only have a 
small impact on various phage band proteins, except for those who are treated for a minimum of 20 
minutes (Maillard et al., 1995). 
1.4.6 Bis-phenols 
These are hydroxy-halogenated products from two phenolic groups which are connected to one another 
through different bridges. They are generally known to have broad range efficacy. However, their 
activity towards P. aeruginosa and moulds is very limited in addition to only having a sporostatic effect 
on bacterial spores. The two main and most commonly used biocides within this group, particularly in 
antiseptic soaps and hand washes are triclosan and hexachlorophene. These two compounds have been 
proven to have a very high and persistent impact on the skin (Gerald Mcdonnell, 1999).  
1.4.6.1 Triclosan 
Triclosan (2,4,49-trichloro-29-hydroxy diphenyl ether) has specific activity towards gram-positive 
bacteria, and its efficacy towards bacteria, yeasts and gram-negative bacteria can be notably improved 
through formulation effects. This has been proven in various cases, one of these was the addition of 
EDTA to triclosan which led to higher permeability in the outer membrane. Suggestions have been made 
to triclosan may have anti-inflammatory activity in addition to its established antibacterial properties 






Although the exact action mechanism of triclosan remains unknown, suggestions have been made which 
state that its main effects are on the cytoplasmic membrane. Low concentrations of triclosan, when 
tested with E. coli, caused inhibition to the intake of required nutrients, and higher concentrations led to 




The main halophenol that is in use for antiseptic and disinfectant purposes is chloroxylenol (4-chloro-
3,5-dimethylphenol; p-chloro-m-xylenol). Although bactericidal, many moulds are resistant to its action, 
as is P. aeruginosa, and its mode of action is not yet fully understood, but since it is phenolic, it is 
expected that it affects microbial membranes (Mcdonnell and Russell, 1999). 
1.5 Nanotechnology 
Nanotechnology is an interesting development across  engineering, biology and pharmaceutical fields 
and is relatively considered a new Nano-scale was defined from 1 nm to 1000 nm(Forrest and Kwon, 
2008). One of the reasons behind applying nanotechnology in the pharmaceutical field is enhancing the 
bioavailability by improving the solubility and permeability of the API (Roduner, 2006). Moreover, at the 
same time nanotechnology reduced the side effects of an API by reducing the amount of drug as the 
surface area was increased (Agrawal et al., 2013). With the development of this technology, the skin has 
become a potential route for these nanoformulations. (Prow et al., 2011). Most of these 
nanoformulations are lipids carriers, or nanoemulsions with droplet size around 300 nm. And by using 
this nanoformulation, it is possible to increase the amount of drug that penetrates through the skin 






focuses on the developing formulations designed to deliver antiseptic agents to target sites within the 
skin to prevent the development of SSIs.  
1.5.1 Nanoemulsions 
A nanoemulsion is a system that consists of two immiscible liquids where one (the disperse phase) is 
dispersed in the other (the continuous phase) as a small droplet with a size ranging from 10-600 nm. In 
addition, a third component (emulsifying agent) is added which surrounds the droplets to prevent 
collapsing and segregation by reducing the interfacial tension between the two phases, therefore, 
choosing a suitable surfactant is a critical step in formulation and stability of the nanoemulsion (Solans 
et al., 2005). 
Nanoemulsions can be  oil in water (o\w) or water in oil (w\o) or can have multiple phases, depending 
on which is the disperse phase and which is the continuous phase (Mason et al., 2006). Unlike 
microemulsions which are thermodynamically stable, nanoemulsions are not spontaneously formed. 
However, they are kinetically stable, with no apparent flocculation or coalescence (Tadros et al., 2004). 
However, the main issue of stability of nanoemulsions is Ostwald ripening which happens when the 
disperse phase has some limited solubility in the continuous phase. It can be overcome by adding a 
second disperse phase which is totally insoluble in the continuous phase or by using a different 
surfactant or a mixture of surfactants which is strongly adsorbed on dispersing droplets (Tadros et al., 
2004). There are also other advantages other than stability: nanoemulsion production is easy to scale 
up, and are less likely to cause irritation than microemulsions due to requiring a lower amount of 







1.5.1.1 Role of surfactant 
As mentioned above, in addition to oil and water, surfactants are the third component in the 
formulation of a nanoemulsion. They play a vital role by preventing coalescence between droplets by 
forming an interfacial film around the new droplets. It is formed during the production process and  
prevents re-coalescence (Fletcher and Horsup, 1992).  For dermal formulations, non-ionic surfactants 
are preferred as they are less irritant to the skin than ionic surfactants. An example of non-ionic 
surfactant is Tween® 80, and Span® 80 and in addition to the role of improving the stability of 
nanoemulsion, the surfactant has a role in enhancing the penetration of the formula through the skin. 
According to Kushal and Zatz, (1991) when the role of cationic surfactant in the enhancement of water 
and lidocaine flux was explored, a high concentration of surfactant the flux of both water and lidocaine 
was found to be preferable. Therefore choosing the appropriate emulsifier is very important in the 
process of production of a nanoemulsion. 
1.5.1.2  Role of HLB 
The hydrophile-lipophile balance is a system designed to categorise emulsifying agents according to 
their polarity with hydrophilic surfactants favouring o\w emulsions and the lipophilic surfactant 








Figure 0.1 HLB scale for the classification of surfactant functions  (D.Attwood, 2013) 
 
There are various formulae for calculating the HLB value, one of which depends on the chemical 
structure of the surfactant and each group contribution has a specific value (Appendix 1). The HLB value 
for the determined surfactant can be obtained using equation 1.1. 
 
𝐻𝐿𝐵 = 7 + ∑(ℎ𝑦𝑑𝑟𝑜𝑝ℎ𝑖𝑙𝑖𝑐 𝑔𝑟𝑜𝑢𝑝 𝑛𝑢𝑚𝑏𝑒𝑟𝑠) − ∑(𝑙𝑖𝑝𝑜𝑝ℎ𝑖𝑙𝑖𝑐 𝑔𝑟𝑜𝑢𝑝 𝑛𝑢𝑚𝑏𝑒𝑟𝑠) equation 1.1 
 
It has been reported that some surfactants with given HLB values work best with specific oils, which led 
to the concept that all oils should have a specific required HLB value. So, to improve the stability of the 
emulsion, this value must be obtained. Therefore, the mixture of surfactant shows better stability than 
the singular as it easy to achieve the required HLB value for this oil by changing the percentage of 






1.5.1.3  Enhancement of skin penetration 
There are various strategies and materials which help with the enhancement of the penetration and 
absorption through, and within the skin, these are known as penetration enhancers. Two types of 
approaches can be used: physical approaches such as stratum corneum stripping, and stratum corneum 
hydration and chemical approaches such as synthesis of lipophilic analogue, delipidation of stratum 
corneum, and coadministration of penetration enhancers (Sapra, Jain and Tiwary, 2008). Examples of 
these enhancers are surfactant (Tween), fatty acids/esters (oleic acid), solvents (ethanol) and terpenes 
(eucalyptol).  
1.5.1.3.1 Eucalyptus oil  
Essential oils are aromatic oily liquids collected from several plants, most commonly by steam 
distillation.They have been used as a flavouring, antiseptic, and antibacterial agents (Burt, 2004). 
Eucalyptus oil is obtained from leaves of eucalyptus, a genus of the plant family Myrtaceae. The 
mechanism of antimicrobial activity of eucalyptus oil is not yet fully understood, but as reported by 
Cowan (1999) eucalyptus may act on the plasma membranes of microorganisms, and enhance the 
permeability of the cell membrane (Cowan, 1999). According to Cromwell et al. (1995) terpenes such as 
eucalyptol, the major component of eucalyptus oil, and d-limonene show significantly enhanced 
penetration within the skin for hydrophilic and hydrophobic compounds (Cornwell, 1996). In addition to 
enhancing penetration, a study by Hendry et al. (2009) reported a synergic antimicrobial effect between 
eucalyptol and chlorhexidine digluconate against some clinical isolates including S.aureus and E.coli 






1.5.2 Production of nanoemulsions 
Production methods for of nanoemulsions  may be classified into two groups: high energy methods and 
low energy methods and both can produce nanoemulsions with small droplets and uniform distribution 
(Campos, Ricci-júnior and Mansur, 2012). Examples of high energy methods include: 
Microfluidisation- the droplet size in this technique can be modified by changing the pump pressure or 
by altering the number of times it passes through the chamber (Seid Mahdi Jafari & Yinghe He, 2007),  
Ultrasonication- although this technique can produce very small droplets, to produce a nanoemulsion 
with a good Polydispersity index (PDI), the run must be repeated multiple times because the samples 
close to the vibrating probe are often smaller (Fraise et al., 2013).  
High-pressure homogeniser- this method was used in this thesis (section 3.1.4.1). The advantages of this 
method are that is it easily scaled up, and it is a continuous process. 
 Low energy methods  include phase inversion temperature; this is a preferred method in the industry as 
it does not require high energy levels. However, all the compounds must be able to withstand high 
temperatures (Hessien et al., 2011).  
1.5.3 Analysis methods for detection of retained drug in the skin  
Various experimental techniques are used to study absorption from different formulations into skin; 
these techniques allow measuring of in vivo penetration or ex vivo penetration or permeation 
characteristics of elements penetrating through the SC barrier. 
1.5.3.1 Tape stripping technique 
This famous technique was first proposed by Pinkus in 1951, it is commonly used to study and evaluate 
the localisation of various elements within the SC and their distribution and is a minimally-invasive 






tape-stripping and superglue stripping and was known as differential stripping; this facilitated evaluating 
the process of hair follicle penetration quantitatively (Teichmann et al., 2005).  
The differential stripping method is performed by applying the substance to the skin then performing 
the tape-stripping method to extract the substance portion that is within the SC; this is followed by the 
superglue stripping technique to remove the remaining substance with is located within the orifices of 
the hair follicle. This, therefore, enables the quantitative evaluation by region of substances within 
multiple pathways, intercellular, transcellular and transfollicular (Teichmann et al., 2006) 
For ex-vivo evaluations, the skin fixed onto Franz diffusion cells is exposed to the drug for set times 
before it is removed and studied and the penetration of the drug is quantified; this evaluation can be for 
full-thickness skin or defined thicknesses of skin as horizontal sections. HPLC is usually used after this to 
analyse the amount of drug in the receiver fluid. Other methods such as infrared imaging, Raman 
spectroscopy and confocal laser scanning microscopy are other forms of quantification methods which 
can be used(Anja Gysler, 1999, Naik et al., 2004).  
However, it is important to note that at the subcellular level, spatial resolution is not achieved by most 
of these approaches; therefore, some studies for skin absorption replace the drug with dyes to visualise 
the substance within the skin and the transport of the substances using fluorescence microscopy 
(Küchler et al., 2009). High sensitivity is achieved with confocal laser scanning, and two-photon 
microscopy as single-molecule detection is possible, however, since fluorescence microscopy requires 
drugs to show fluorescence, this method cannot usually be used to examine the uptake of drugs in the 






1.5.3.2 X-ray microtomography (Micro CT scan) 
In the field of materials science, the understanding of a material’s microstructure provides an in-depth 
understanding of its mechanical and physical properties. The characterisation of these properties is 
usually shown using two-dimensional images through optical or electronic microscopy, resulting in a 
limitation of the measurable parameters and may require destruction of specimens.  These two 
difficulties can be overcome using three-dimensional imaging with x-ray microtomography which 
facilitates more measurable parameters of the internal microstructure without requiring destruction of 
the samples (Salvo et al., 2010). 
X-ray microtomography can be defined as “A radiographic imaging technique that can produce 3D 
images of a material's internal structure at a spatial resolution better than 1 micrometre” (Govender et 
al., 2003). This is also commonly referred to as micro-CT and has been used in various medical 
applications for over 40 years (Hsieh, 2009). 
The principle of micro CT requires the specimen to be fixed on an x-ray beam trajectory, a section of the 
x-rays is transmitted and converted to visible light with the use of a scintillator, whereas, the rest is 
absorbed. The light corresponding to sample projections is recorded using optics such as CCD (charge-
coupled device) and CMOS (complementary metal-oxide-semiconductor) cameras, this is followed by a 
180° or 360° rotation of the sample during which several hundreds of projections are recorded. This 
series of projections is usually known as a scan; this scan is used for reconstruction of a sample 3D image 









Figure 0.2 - Stages of micro CT principle(Kinney and Nichols, 1992) 
  
The coefficient of absorption varies depending on a few factors such as material density, X-ray energy 
and atomic number. This variation is reflected by a contrast in the image due to the various 
characteristics of the microstructure in the material (Salvo et al., 2010). 
X-ray microtomography has multiple applications including the analysis of phases; this is used to find the 
different phases within a material and their distribution within it. Micromechanical measurements; this 
is the study of a sample subjected to mechanical loading, using micro CT, the relationship can be found 
between the sample, the load it is subjected to, the external deformation and the internal damaged 
caused. This technique is an ideal choice for these measurements as it does not cause destruction of the 
samples (Govender et al., 2003).  
In conclusion, the advantages of micro CT are the facilitation of high spatial resolution 3D images of the 






exploited in this thesis, as micro CT was used to qualitatively study the distribution of nanoemulsion 






Aims of the thesis 
The aim of this thesis is to develop and characterize relevant pharmaceutical formulations designed to 
deliver antiseptic agents to target sites within the skin.  
Many infections of wounds and surgical sites arise due to contamination of the site by the patient’s 
bacterial flora. This project will explore the ability of nanoparticles containing antiseptics to effectively 
penetrate the skin more than current skin disinfection methods. 
 
• To develop and characterise an optimum Nanoemulation NE by using two techniques: a high-
pressure homogeniser technique and a high-shear homogeniser followed by ultrasonication. 
 
• To study the effect of changing parameters in both techniques such as the number of cycles in 
HPH and the sonication time in HSH on NE formulation. 
 
• Find and explore novel analysis methods for detection of the retained drug in the skin   
 
• To predict the miscibility of the antiseptic nanoemulsion formulations with artificial sebum by 








2 Chapter 2 -Methodology and Materials 
2.1 Instruments and Apparatus  
2.1.1 High-pressure homogeniser 
 
The high-pressure homogeniser which was used in this work is an EmulsiFlex-C5 from Avestin. (Figure 
2.1). Samples are introduced to the cylinder body (1) then pushed to the motor pump (2). Subsequently, 
the high-pressure pump pushes the sample through an adjustable homogenising value(3) which is 
connected to the homogenising pressure gauge.  Finally, it is collected in a beaker and completion of all 
these steps is considered as one cycle. 
The minimum sample volume for the apparatus is 7 ml, and maximum pressure is 30000 Psi/207 MPa, 
the flow rate is changed according to pressure (1 -5 L/h), and it is possible to regulate the pressure by 
increasing or decreasing the homogeniser pressure (Avestin, 2010) 
 
 









2.1.2 High shear homogeniser 
The high shear homogeniser used was the Silverson L5M-A. In this method, a strong suction is exerted 
by the rotor with high-speed rotation which moves the liquid into the rotor-head. The material is then 
driven to a puncture of the rotor-head by a centrifuge force and mixed at a high speed between the 
blade and stator. Intense hydraulic shear then forces the material out as it returns to the mix. A 
circulatory mixing pattern is formed as fresh material is constantly driven to the rotor-head. 
 
2.1.3 Ultrasound 
A  3000MP Ultrasonic Homogenizer was used, and the chosen settings were amplitude of 25% and the 
pulse timer alternated between 5 seconds on and off. The mechanism of this device is that line voltage 
is converted to high-frequency electrical energy at 20kHz using ultrasonic power. The electrical energy is 
then converted to mechanical energy after being transmitted to the probe. The probe vibrations are 
strengthened through a titanium tip which also causes coupling of the vibrations, this is then followed 
by the vibrations being passed on to the tip which is fully in solution. Cavitation then occurs which leads 
to instant formation and collapsing of vapour bubbles which in turn lead to strong shock waves radiating 
through solution closely to radiating tip face (BioLogics, no date). 
2.1.4 Zetasizer 
 
Malvern Zetasizer Nano –ZS is claimed to deliver accurate, reliable and repeatable size analysis of 
particles and molecules in solution. Size measurement can be undertaken from 0.3 nm (diameter) to 10 






2.1.4.1 Particle size analysis and PDI 
The Zetasizer Nano-ZS measures droplet sizes using a dynamic light scattering (DLS) technique, 
performed by measuring Brownian motion corresponding to particle size through particle illumination 
with a laser then analysing intensity fluctuations in scattered light. 
Particles within a liquid are never static, and their constant motion is due to Brownian motion, which 
can be defined as the motion of particles because of collisions between random molecules surrounding 
the particle in the liquid.  An essential characteristic of Brownian motion for Dynamic Light Scattering 
DLS is the faster movement of small particles in relation to larger particles which are slower. The Stokes-
Einstein equation (equation 2.1) can be used to define the relationship between the particle size and its 




  equation 2.1 
Where D is the diffusion coefficient of a spherical particle of radius r in a fluid of dynamic viscosity 𝜂 at 
absolute temperature T ,and  where K is the gas constant and n is Avogadro's Number. 
The size of particles is calculated through the Zetasizer Nano system which determines the intensity rate 
of fluctuations which were formed due to light scattering, therefore, particle size can be found.  
 To determine PDI, the decay rates for various size classes can be extracted through algorithms by the 
Zetasizer software which in turn produce a distribution of sizes.    
2.1.4.2 Zeta potential measurements 
The electrophoretic mobility of the particles was measured using the Zetasizer and was then converted 
using the Helmholtz-Smoluchowski equation into the value of ZP. This equation is built into the Malvern 
Zetasizer software, and version 7.11 of this software was used. This measurement was repeated three 






addition to the equipment used and operating conditions, were kept constant for every batch, and an 
average of the three independent results were calculated and stated as the final measurement.  
Each sample was diluted using ultrapure water at a concentration of 10 µm/ml before the measurement 
was accomplished and 1ml of the sample after diluting was injected using a syringe in the disposable 
capillary cell; the cell was cleaned using deionised water at the end of every measurement in addition to 
between runs. 
 
2.1.5 Franz diffusion cell 
In vitro diffusion models either consist of “static” diffusion cells made up of two compartments or “flow-
through” cells which are multi-jacketed. Inert materials are most widely used as the construction 
materials, and they are usually made of glass. The membrane is fixed as an obstruction in the diffusion 
cell between the donor compartment and the receptor compartment. In this incidence, the membrane 
is excised skin (figure 2.2). The amount of drug that diffuses from the donor cell to the receptor cell can 
be examined as a function of time.  
Buffer solution or physiological saline is used to fill the receiver compartment; this can facilitate drug 
diffusion from the donor compartment by providing the needed ions and pH.  The circulating water 
temperature is usually maintained at 37ºC to maintain a temperature of 32ºC at the surface of the skin. 
Continuous stirring is applied to the receiver compartment, to maintain sink conditions and prevent 
saturation of the receiver conditions. In this study, a PermeGear system (V6-CA-02) vertical glass 







Figure 2.2 Standard Franz cells(Sonam Vats & Charu Saxena, 2014) 
2.1.5.1 Membrane selection 
The ideal and most suitable model for the evaluation and examination of drug delivery of different 
formulations is undoubtedly human skin which has commonly been used in ex vivo examination of drug 
penetration. It can be taken from multiple sources such as plastic surgery, cadavers and  amputations, 
and from various sites within the human body and can vary in thickness. The most common sites include 
the abdomen and back in addition to the breast or leg. (Godin & Touitou, 2007)  
Another essential factor that widely varies between samples is the permeability of the skin, which not 
only varies between samples taken from different subjects and age groups but also greatly varies 
between multiple anatomical locations within the same subject (Haigh and Smith, 1994). The different 
anatomical locations in addition to health conditions, gender, race and age of donor are all factors that 
play a role in determining the lipid composition, hydration of the skin and the skin thickness which, 
therefore, lead to the differences in skin permeability (Gomes and Martins, 2014). After excising human 






disadvantage with using human skin samples. These factors combined have led many in vitro studies on 
the permeation of skin using animal skin as an alternative to human skin anda wide variety of animals 
have been used for similar studies including rat, pig, rabbit and skin shed snake (Gomes and Martins, 
2014)(Ngawhirunpat et al., 2008).  
Domestic porcine skin has a number of similarities with human skin including anatomical, histological 
and physiological resemblances, and it is therefore believed to be the most relevant animal model. The 
epidermal thickness of porcine skin is similar to that of human in addition to having a similar dermal-
epidermal thickness ratio (Godin and Touitou, 2007). Another likeness is found in the density of both the 
hair follicles and blood vessels within the skin of pigs and humans, another important resemblance 
between the human model and the porcine model is in the content of SC glycosphingolipids, elastin, 
dermal collagen and ceramides(Dick & Scott, 1992; Godin and Touitou, 2007). 
Another advantage of using porcine skin is its accessibility being readily available as a waste material 
from animals slaughtered for food. The drug permeability of human and porcine skin samples has been 
compared, and a good correlation has been found between the models specifically for lipophilic 
substances, with porcine skin found to have less donor variability than that found in human skin. The 
permeability of skin obtained from rodents was less representative being notably higher than the 
permeability of human skin (Barbero and Frasch, 2009).  
2.1.6 Inverse gas chromatography (IGC) 
IGC measurements were conducted using IGC Surface Measurement System (SMS), London, UK coupled 
with a flame ionization detector (FID). Methanol was used as an inert probe for the correction of 
deadtime retention. The selected carrier gas was helium with a flow rate of 10 ml/min. The columns 






to interaction type and listed in Table 2.1. Target fractional surface coverage was selected at 0.05 n/nm 
at 20 °C and 0 RH% 
 
Table 2.1 List of test probes used in the determination of HSPs using IGC 















2.1.7 High-performance liquid Chromatography 
2.1.7.1 HPLC system 
A Shimadzu HPLC System was used, with an LC-20 AT pump which works on a series –type double 
plunger. The capacity to evacuate bubbles had been enhanced by changing the pump-head structure 
and the flow line. Maximum discharge pressure was 40 MPa, and the flow rate range was 0.001 – 10 
ml/min,  and the temperature range for the column oven was 4 – 80 °C. Injection volume of the 
autosampler (SIL-20A HT ) was 0.1 – 100 µl (High-per and Chromatograph, no date) 
The SPD-M20A photo-diode array detector used has a high-resolution mode and high-sensitivity mode. 






ranged from 190 to 800nm.Workstation software is LC solution software was used – Version/ Release 
Number: 1.25 
The columns which were used for detection triclosan and para-chloro-meta-xylenol (PCMX) were:  
• Phenomenex – pentafluorophenyl PFP, P/No. AJ0-8773. Size 250 X 4.60 mm, 5 µm which was 
used for triclosan. 
• Phenomenex – C18, P/No. 00F-4361-E0. Size 150 X 4.60 mm, 5 µm which was used for PCMX 
2.1.7.2 Preparation of HPLC system 
2.1.7.2.1 Triclosan  
The HPLC method used comprised an isocratic mobile phase of acetonitrile (ACN): water (65: 35) (v/v), a 
flow rate of 1.0 ml/min, and the wavelength of photo-diode array detector at 287 nm. The injection 
volume was 20 µl, and the run time was 10 min. the column used PFP (pentafluorophenyl) (250 mm x 
4.6 mm ID, 5μm) from Phenomenex, UK  
2.1.7.2.2 Chloroxylenol 
• The HPLC method used comprised an isocratic mobile phase of acetonitrile (ACN): water (60: 40) 
(v/v), a flow rate of 1.0 ml/min, the wavelength of photo-diode array detector at 288 nm. The 
injection volume was 20 µl, and the runtime was 6 min. the column used C18 (150 mm x 4.6 mm 
ID, 5μm) from Phenomenex, UK 
2.1.8 UV Spectrometers 
The UV spectrophotometer which used in this work was Agilent Cary 60 UV-Vis.  
The wavelength range is 190 – 1100 nm  






2.1.9 Micro CT scan 
After applying the formulation to the skin samples, the samples were removed and mounted onto a 
sample holder using double-adhesive tape. Imaging was recorded using X-ray microtomography (Nikon 
XT H 225, Nikon Corp. Tokyo, Japan) with the following specifications: tungsten targets, accelerating 
voltage of 75kV, current of gun of 250µA, copper filter thickness of 0.125 mm. Projections were then 
recorded for approximately two hours and CT-pro, and VG Studio 2.1 software were used to reconstruct 







2.2.1 Analytes and general chemicals 
 
• Tween 80 (POE (20) sorbitan monooleate), Span 80 (sorbitan monooleate), eucalyptol 99%, 
squalene, cottonseed oil, coconut oil, olive oil, paraffin wax (Sigma Aldrich, United Kingdom). 
• Triclosan 96.0%, chloroxylenol, Tween 20, Span 20, Tween 40, Span 40, Tween 60, and Span 60 
(TCI America, USA). 
• Ultra-pure water from Milli-Q Direct 8 water purification system.  
• Palmitoleic acid (Acros, United Kingdom). 
• Cholesteryl oleate, Oleic acid, 99%, palmitic acid  (Alfa Aesar, United Kingdom). 
• Spermaceti wax (Croda Europe limited) 
 
2.3 Methodology 
2.3.1 Preparation of nanoemulsions 
 
For triclosan/PCMX nanoemulsions, the hydrophilic and lipophilic phases were prepared independently. 
The hydrophilic phase was prepared by adding tween 80 (T80) and deionised water in a beaker, then 
stirring them for a 5 min on hot plate stirrer at 60 °C/ 500 RPM (to avoid the cloud point of T80 at65ºC). 
The same conditions were used for the lipophilic phase, containing S80 and triclosan/PCMX (lipophilic 
antiseptic) and eucalyptol oil in another beaker. After heating, the lipophilic phase was added to the 
hydrophilic phase slowly and stirred for a further 5 min on a hot plate at 60 °C/ 800 RPM. Then this milky 
emulsion was passed through the HPH- EmulsiFlex-C5/HSH followed by ultrasound for several cycles 







2.3.2 Preparation of Artificial Sebum 
 
All components of artificial sebum were weighed in a glass beaker (w/w %) and heated to 60 °C for 18 
min with stirring until the liquid became clear.  
  
2.3.3 Preparation the skin  
Full-thickness porcine ear skin from freshly-slaughtered animals was isolated and stored frozen at -20°C 
a maximum of one week. Before using the skin, it was placed in PBS solution for one hour to defrost and 
hydrate, before being cut to size and left on Franz cells for one hour to equilibrate. The formulation was 
then applied onto the skin and left for 24 hours, the skin was then removed and shaken to remove 
excess formulation and left to dry for 10 minutes. Either the tape-stripping method was then applied to 
the skin to find the quantitative amount of antiseptic within the skin, or a CT scan was used to 






3 Chapter 3 - Design and Development of Triclosan Nanoemulsion for 
Dermal Delivery 
3.1 Introduction 
Although the dermal drug delivery route is appealing, this route faces certain challenges in delivering 
the required amount of drug to the target site and overcoming skin barrier properties. Another 
challenge in utilizing this route is the difficulty in predicting the amount of drug delivered to the target 
site; this is even more of a challenge for drugs with poor solubility.  
The focus of this chapter will be to examine the impact of preparation method on the properties of a 
nanoemulsion formulation. Triclosan was incorporated into a nanoemulsion using two methods: high-
pressure homogenisation and high shear homogenisation followed by ultrasonication. The ideal ratio of 
different surfactant mixtures; T80/S80, T60/S60, T40/S40 and T20/S20 was obtained based on the 
required hydrophilic-lipophilic balance of eucalyptol oil, which was calculated and will be discussed. The 
critical parameters of nanoemulsion formulation (discussed in section 3.3.1), i.e., the effect of the 
amount and type of surfactant, the effect of the amount of oil and the sonication duration effect on 
MDS, and PDI of formulations were studied. Viscosity, pH and ZP were determined for each formulation.  
An HPLC method to determine the triclosan in NE formulation was developed and validated according to 
ICH guidelines and will also be reviewed in this chapter.     
The stability of the NE formulation was monitored over three months at two different temperatures (4°C 
and 25°C). This chapter also includes determination of the amount of triclosan within the skin 
quantitatively by tape stripping method and qualitatively through CT scans.  
Finally, all determined data in this chapter is used to find an optimised formulation with the highest 







3.1.1 Nanoemulsion and nanoemulsion formation 
 
NEs are isotropic, unstable, thermodynamically dispersed systems of two non-miscible liquids, but are 
not formed spontaneously like microemulsions. Hence NEs need high energy input in order to form. The 
size of the dispersed droplets is in nanoscale dimensions (100 -600 nm). To prevent Ostwald ripening, 
which leads to creaming and flocculation of NEs, it is normal to add a surfactant to stabilise the 
formation of NEs. Figure 3.1 shows the steps of NE formation (Uchechi, Ogbonna and Attama, 2014). 
Unlike microemulsions, NE requires lower amounts of surfactant for successful formation, which gives 
NEs a commercial advantage with a reduced requirement for excipients (Mason et al., 2006). 
Furthermore, high concentrations of surfactant (ionic) may cause skin irritation, and consequently may 
not be acceptable in dermal formulations (Uchechi, Ogbonna and Attama, 2014). 
Primarily, there are three methods to formulate NEs, high-pressure homogenization, microfluidization, 
and phase-inversion temperature methods (Mason et al., 2006). As mentioned above, to form a NE, 
energy (pressure or shear) must be applied. When sufficient pressure is applied, large droplets are 
broken into small droplets in nanosize ranges, and the role of the surfactant is to coat these 
nanodroplets with a very thin film and prevent coalescence due to interfacial repulsion between the 
surfactant films (Mason et al., 2006) (Figure 3.1). 
Each spherical droplet is exposed to Laplace pressure (Lp),  “the pressure difference between the inside 
and the outside of a curved surface” (Butt, Graf and Kappl, 2003). This is the pressure proportional to 











     Equation 3.1 
From Equation 3.1, it can be deduced that small droplets require higher pressure to form than larger 
ones. 
 
Figure 3.1 Steps for the formation of a NE (Mason et al., 2006) 
 
As mentioned above, to stabilise the NE for an extended period, a  surfactant is required, and surfactant 
selection must take into account the Hydrophile-Lipophile balance (HLB), i.e., a “system of classification 








3.1.2 Hydrophile –Lipophile balance 
 
In 1949, Griffin proposed a system able to identify the tendencies of non-ionic surfactants between oil 
and water, according to different regions in the molecule (functional groups); this system is called the 
Hydrophile-Lipophile balance (HLB) (Guo, Rong and Ying, 2006). Lipophilic surfactants are considered to 
have low HLB values, while hydrophilic surfactants have high HLB values. According to theory, o/w NEs 
generally require the use of surfactants with high HLB, and in contrast, a low value of HLB should be 
used in w/o NEs (Schmidts et al., 2010). For a stable NE, it was found that a combination of low HLB and 
high HLB surfactants like Span 80 (HLB=4.3) and T80 (HLB=15) were more effective in stabilising a NE 
than a single surfactant (Croda Europe Ltd, 2009); (Orafidiya and Oladimeji, 2002).  
Equations 3.2 is used to calculate the percentage of each surfactant according to the required HLB value 




 Equation 3.2 
%(𝐵) = 100 − %(𝐴) 
Where (A) is the first surfactant, and (B) is the second surfactant. 
 
3.1.3 Physicochemical characterisation of nanoemulsion formulations 
3.1.3.1 Droplet size and PDI measurement 
The size and PDI for NE formulations were measured using Zetasizer Nano Zs (Malvern Instruments Ltd, 
UK). The polydispersity of the NE describes the distribution of the droplets in the continuous phase. The 






unstable due to the variability in size of droplets which leads to coalescence and cracking (separation of 
emulation into its constituent phases)(Laouini, Fessi and Charcosset, 2012).  
 
3.1.3.2 Zeta potential measurement: 
The ZP of NE formulations was measured using Zetasizer Nano Zs (Malvern Instruments Ltd, UK). ZP 
measurement is a critical parameter in disperse systems which measures the electrostatic charges of 
repulsion and attraction between dispersed droplets to predict whether the droplet will cause 
coalescence or whether it will be dispersed in the continuous phase. Araujo et al. found that if the value 
of ZP is greater than ±30 mV, then generally, the emulsion can be considered stable (Araújo et al., 2011). 
Each sample (100 µl) was diluted with 10 ml of deionised water, and all analyses carried out in triplicate 
to determine the mean value. 
 
3.1.3.3 Stability studies 
All NE formulations were stored in sealed glass vials at two different temperatures (25°C and 4°C) for 
three months to study the stability. Samples were taken every month to check MDS, PDI and ZP. All 
measurements were carried out in triplicate.  
 
3.1.3.4 pH determination 
The pH of the NEs formulations was measured by using a pH meter at 25°C. All measurements were 






3.1.3.5 Determination of viscosity 
The viscosity of NEs was measured in triplicate using a Bohlin cone and plate rheometer at 25°C and 
shear ramp between 0.1 and 100 s-1. Methods of production of nanoemulsions 
 
There are three methods to produce nanoparticles and NEs, such as high shear homogenization and 
ultrasound, high-pressure homogenization, and solvent emulsification/evaporation. Each of these 
methods has relative advantages and disadvantages (Mehnert and Mäder, 2001).    
 
3.1.3.6 The principle of high-pressure homogenization 
High-pressure homogenization (HPH) is a technique involving application of high pressure (100 – 2000 
bar) on a liquid to push it through a very narrow gap (in the micron range) in a homogeniser, and as a 
result, the fluid crosses this distance at a very high speed (1000 km/h). This cycle is repeated several 
times. Due to this process, high shear stress and cavitation forces arise, and consequently, the macro 
droplets rupture to form nanodroplets (Lippacher & Muller, 2000). In practice, the pressure must be 
gradually increased to prevent clogging of the narrow homogeneity gap (Kipp, 2004).  Particle size and 
particle size distributions are mainly affected by the number of cycles through the homogeniser, and the 









Figure 3.2 Schematic diagram of high-pressure homogenization (Fontes et al., 2015) 
 
 
3.1.3.7 The principle of high-shear homogenization and 
ultrasound 
This technique of nanoemulsion preparation needs two steps; the first step is homogenising a NE by HSH 
and second step is sonicating it to minimise the size distribution and improve the stability.  
A high shear mixer can reduce mixing time by 90% when compared with a conventional method. High-
speed rotation of the rotor exerts a powerful suction driving the liquid upward into the rotor head. Then 
a centrifugal force drives the material towards a perforation in the rotor head where it is rapidly mixed 
between the rotor blade and stator (a stationary component around the rotor). This is followed by 
intense hydraulic shear as the material is forced out through the perforation and back into the bulk mix. 






Figure 3.3 shows a schematic diagram of the high-shear homogenization and ultrasound technical steps.   
 
Figure 3.3 Schematic diagram of high-shear homogenization and ultrasounds technique 
3.1.4 Triclosan and mechanisms of action 
 
Antiseptics and disinfectants are utilised widely in hospitals and are found in many examples of topical 
formulations. Since 1999, antisepsis is considered a crucial part of infection control practices and can 
help in the avoidance of nosocomial infections (McDonnell & Russell, 1999). 
Triclosan (2, 4, 49-trichloro-29-hydroxy diphenyl ether; Irgasan DP 300), as shown in Figure 3.4, is a 
broad-spectrum antimicrobial agent, with activity against both gram-positive and gram-negative 
bacteria (Waaler, 1993). 
Triclosan is insoluble in water but soluble in most organic solvents; (pKa = 7.9), log P =4.76 and molecular 







Figure 3.4 Chemical structure of triclosan (Ramos, 2009)  
 
Triclosan mainly exerts its effects on the cytoplasmic membrane of bacteria in which it inhibits the 
uptake of essential nutrients, which occurs at low concentrations. It plays a bacteriostatic role, while at 
high concentrations it is considered bactericidal causing a rapid release of cellular components and cell 
death (McDonnell & Russell, 1999) 
 
3.1.5 Analysis and characterisation of nanoemulsions 
 
3.1.5.1 HPLC - method validation 
In accordance to the ICH (International Committee on Harmonization, 1996); the process through which 
it is established that performance characteristics of methods meet requirements for the envisioned 
analytical application using laboratory studies is known as the validation. There are multiple parameters 








The linearity parameter is a representation of the directly proportional relationship between the known 
concentration of analytes and the instrumental response. Linearity is indicated by the correlation 
coefficient (R2) of the curve, when the correlation coefficient is equal to one this means the curve is 
completely linear, the linearity also decreases with the decrease in value of the correlation coefficient.  
For a linearity test to be completed, this requires a minimum of five concentrations of analytes, it is 
preferable that one of these is the limit of quantitation, the test must also be repeated five times.  
 
3.1.5.1.2 Sensitivity 
There are two factors that represent the sensitivity parameter, the first of these factors is the limit of 
quantification (LOQ); the lowest analyte concertation within a sample which can be determined with an 
adequate level of accuracy and precision. The second factor is the limit of detection (LOD); The lowest 
detectable concentration within a sample, this does not necessarily mean it is quantifiable.  
These two factors LOD and LOQ can be calculated according to ICH using equations 3.3 and 3.4 
respectively.  
 
𝐿𝑂𝐷 =  
3.3 𝜎
𝑆
  Equation 3.3 
Where (σ) standard deviation of the intercept 







𝐿𝑂𝑄 =  
10  𝜎
𝑆
 Equation 3.4 
Where (σ) standard deviation of the intercept 
 And   (S) mean of the slope 
 
3.1.5.1.3 Precision 
When an analytical method is applied to various sampling of a homogenous sample, the degree of 
agreement obtained amongst individual test results is known as the precision of the method (Rockvilie 
1985). For this precision test to be completed, a minimum of five various analyte concentrations are 
required, a minimum of five replications of the test must also be performed on the same day for the 
determination of intra-day precision. As for inter-day precision, this is determined by repeating the test 
for five days.  To express precision, the Relative Standard Deviation (RSD) is then calculated, RSD 
percentage is given by equation 3.5 
 
%𝑅𝑆𝐷 =  
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑋 100
𝑚𝑒𝑎𝑛 𝑜𝑓 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
  Equation 3.5 
 
3.1.5.1.4 Accuracy 
The degree of closeness of a measurement to the true or actual value is referred to as the accuracy, the 
accuracy increases with the closeness to the true value and decreases as it grows further away, 










 𝑋 100 Equation 3.6 
 
3.1.6 Determination of triclosan in skin quantitively and qualitatively 
3.1.6.1 In vitro skin diffusion study 
Even though human skin is the best model to study the penetration through/in the skin, pig ear skin 
according to many authors shows a high similarity with human skin in histological, physiological and 
permeation characteristics compared with other aminal models (DICK & SCOTT, 1992; Flaten et al., 
2015). In the present study, fresh, full-thickness porcine skin was obtained from a local abattoir (J.& E 
Medcalf Ltd, Huddersfield) and used immediately or frozen at -20°C  and used within one week. The 
standard 15 mm jacketed Franz cell vertical glass diffusion cell with an orifice area of 1.77 cm2, and 12 ml 
receptor volume (PermeGear, USA) was used for diffusion studies. Skin samples were examined for any 
punctures or defects before use, and all skin samples were immersed in PBS (pH 7.4) for an hour. Then 
the hydrated skin was put into Franz cell for 30 min to equilibrate before applying 1 ml of triclosan NE 
formulation (equivalent to 10mg/g) in the donor chamber. The donor chamber was covered with 
parafilm to prevent evaporation. The receiver chamber was filled in PBS solution with 1% w/v of SLS to 
improve the solubility of triclosan. The water bath of jacketed Franz cell was maintained at 37°C, so the 
surface of the skin sample was kept 32°C, to mimic the human skin temperature. Each experiment was 
run for 24 hours, and then triclosan was determined quantitively by using an adhesive tape stripping 
method and qualitatively by using CT scan. 
3.1.6.2 Quantitively by using an adhesive tape stripping method 
There is a consensus among many authors that the differential tape stripping method is a successful 






2001; Wosicka & Cal, 2010). In this method, the tape isolates the stratum corneum layer by layer to 
determine the amount of the drug in stratum corneum and is followed by cyanoacrylate adhesive step 
to determine the amount of drug in hair follicles. Subsequently, the skin sample is cut into small pieces 
to determine the amount of drug in the entire sample (Ossadnik et al., 2007). In the current study after 
24 hours of diffusion in the Franz cell, skin samples were removed and shaken to remove the excess 
triclosan NE which had not been absorbed, then skin samples were left for 20 min to dry and after that a 
2X2 cm2 pieces of tape (3M Transpore®) were used to strip the layers of stratum corneum following 
application of an even pressure. This process was repeated 15 times, and then tapes were placed in 5 ml 
methanol according to the following distribution tape 1, tapes 2-5, tapes 6-10, tapes 11-15. 
Subsequently, a cyanoacrylate adhesive step w,as applied to determine the amount of triclosan in hair 
follicles. A small amount of cyanoacrylate was placed on the stripped skin and the cyanoacrylate was 
covered by a 2X2 cm2 of tape and was left for 10 min then removed quickly. This step was repeated 
twice, and these two tapes were put in 5 ml methanol. The final step involved cutting the skin to small 
pieces and placing them in 5 ml of methanol. All these tubes were sonicated for 30 min and then were 
centrifuged at 400 rpm for 20 min. Then the supernatant was analysed by HPLC to determine the 
amount of triclosan in each tube.     
3.1.6.3 Qualitatively by using CT Scan 
After leaving the samples in Franz cells for 24 hours, they were removed and left to dry for 1 hour; the 
samples were then placed on the CT scan to obtain 3D images of each sample. The density of triclosan 
and the skin was determined and used to find the distribution of triclosan within the skin, which 






Various formulations were examined using this method, and these results were found to agree with 
results from the previous tape stripping method, where formulations that showed high amounts of 
triclosan in the skin quantitatively also qualitatively showed a high density of triclosan using 3D imaging. 
3.2 Aim and Objectives 
 
The aim of this chapter was to develop and characterise relevant pharmaceutical formulations designed 
to deliver antiseptic agents, in this case, triclosan, to target sites within the skin.  
Many infections of wounds and surgical sites arise due to contamination of the site by the patient’s own 
bacterial flora. This chapter explores the ability of nanoparticles containing triclosan to effectively 
penetrate the skin compared to solution formulations.  
 
• To develop and character an optimum triclosan NE using two techniques: a high-pressure 
homogeniser technique and a high-shear homogeniser followed by ultrasonication. 
 
• To study the effect of processing parameters such as the number of cycles in HPH and the 
sonication time in HSH on NE formulation on the formulation 
 
• To determine the relative stability of triclosan NEs 
 
• To determine the amount of triclosan in the skin quantitatively using tape stripping and 







• To compare both techniques and find the optimum one by the amount of triclosan determined 
in the skin.  






3.3 Results and Discussion 
3.3.1 Formulation study of triclosan nanoemulsion 
3.3.1.1 Development of triclosan nanoemulsion 
 
As outlined previously, NEs are thermodynamically unstable, so to extend stability for long periods (up 
to years), the optimum type and concentration of surfactants should be used. It is, therefore, useful to 
determine the required HLB value for eucalyptol and the solubility of triclosan in it. 
A triclosan NE was prepared by two different methods , HPH as a continuous processing method, and 
HSH followed by ultrasound as an alternative.  
3.3.1.2 Determining the required HLB value for eucalyptol 
 
To formulate stable emulsions, it is recommended that the HLB value of surfactants or combinations of 
surfactants should be close to the HLB value of the oil phase (Orafidiya and Oladimeji, 2002). To 
determine the required HLB value of eucalyptol, a matched pair of Tween and Span, such as T80 with 
S80 was used.   Seven batches of emulsifier combinations with different HLB values according to 
Equation 3.7, ranging from HLB =4.3 (S80) to HLB = 15 (tween 80) were prepared. Table 3.1 shows the 




    Equation 3.7 
%(𝐵) = 100 − %(𝐴) 
 










Emulsifier Blend Calculated 
HLB Span 80 Tween 80 
1 100% --- 4.3 
2 85% 15% 6 
3 65% 35% 8 
4 46% 53% 10 
5 28% 72% 12 
6 9% 91% 14 
7 --- 100% 15 
 
All vails was stirred by using a magnetic stirrer for 30 min at 25°C. 
The most stable one is that which does not cause separation of the oil and water phases, it is considered 
as the primary optimum one, and as shown in Figure 3.5 is sample 5 (HLB=12). Once this was 
determined, values in a closer range to this were then studied to produce a more accurate value. Table 








Figure 3.5 Proposed emulsion formulations using a wide range of HLB mixtures to determine the most stable 
(sample 5=12 HLB) 
 
Table 3.2 The HLB values of different percentages of emulsifier blend range 11-13  




Span 80 Tween 80 
8 37% 63% 11 
9 33% 67% 11.5 
10 28% 72% 12 
11 23% 77% 12.5 
12 19% 81% 13 
 
As shown in Figure 3.6, the most stable emulsion was sample 11, with an HLB value of 12.5. Thus the 








Figure 3.6 Proposed NEs formulation using a narrow range from 11 to 13 of HLB mixtures to determine the most 
stable (sample 11=12.5 HLB) 
  
 
Using Equation 3.8 and the determined HLB value for eucalyptol, the ratio of surfactant mixture is 
determined as 3:1 T80: S80.    
       % (𝑇𝑤𝑒𝑒𝑛 80) =
(12.5−4.3) × 100
15−4.3
 = 76.63 %      Equation 3.8 
%(𝑠𝑝𝑎𝑛 80) = 100 − 76.63 = 23.37 % 
3.3.1.3 The solubility of triclosan in eucalyptol 
Determination of the solubility of triclosan (drug) in eucalyptol (oil phase) is an important factor in 
developing a triclosan NE formulation (Zhao, 2013). To determine the solubility of triclosan, three vials 








Table 3.3 The amount of triclosan in each vial 
 Eucalyptol (g) Triclosan(g) Span 80(g) Tween 80(g) Water (g) 
Vial 1 1.80 0.33 ----- ----- ----- 
Vial 2 1.78 0.32 0.07 0.05 ----- 
Vial 3  0.09   5 
 
The three vials were mixed using a vortex mixer at speed 1500 rpm and then were maintained in an 
isothermal shaker at 25 ±1˚C for 72 h to equilibrate.  Following centrifugation at 3000 rpm for 15 min,  
the supernatant was removed, filtered using a 0.45µm filter and analysed by HLPC, after dilution by 
methanol (Shafiq et al., 2007). The solubility of triclosan is shown in Table 3.4 
 
Table 3.4 The solubility of triclosan after 72 h equilibration at 25 ±1˚C. 
 Solubility of triclosan (mg/ml) 
Triclosan in eucalyptol only 122.85 
Triclosan in eucalyptol + T80 + S80 141.29 
Triclosan in water 0.35 
 
3.3.1.4 Determination of minimal surfactant concentration 
If it is assumed that T80 and S80 form a thin film around each droplet in a monolayer, so according to 
geometric calculations, it possible to estimate sufficient amounts of these surfactants to stabilise any 
emulsion. 
For example, for 2.5g of eucalyptus oil (density is 0.912 g/ml)(Silva et al., 2011).  
Volume = mass / density 
            = 2.5 g / 0.912 g/ml 







For a droplet diameter of 33 nm (section 3.3.1), thus: 
 
Droplet diameter=33 nm= 3.3 x 10-6 cm, and if assumed that the droplet is spherical, so 
Volume of droplet = 
4
3
π 𝑟3 = 
π𝑑3
6
 = 1.882 x10-17 cm3 
 
where r: radius  
         d: diameter 
 
Total number of drops in 2.5 g = volume of eucalyptus oil/volume of the droplet                                                                                                                             
                                             = 2.7412 / 1.882 x10-17 
                                             = 1.457 x 1017 
 
Surface area of each droplet = πd2 
                                          = 3.422 x 10-11 cm2 
 
Total surface area of droplets = Surface area of each particle x Total number of drops 
                                           = 3.422 x 10-11 x 1.457 x 1017  
                                           = 4.984051 x 106 cm2 
 
The molecular weight of T80 = 604.41 g/mol  






Molecular weight of S80 = 428.31 g/mol  
Surface area = 96.2 Å =9.62 x 10-15 cm2   (Pub chem, no date a) 
 
Number of required molecules of T80 = Total surface area of droplets/surface area of T80 
                                                               = 4.984051 x 106 / 1.33 x 10-14 
                                                               = 3.7474 x 1020                                                                                     
Number of required molecules of S80 = Total surface area of droplets/surface area of S80 
                                                              = 4.984051 x 106 / 9.62 x 10-15 
                                                              = 5.18093 x 1020 
                                                                               
Amount of required surfactant (g) =
(Number of required molecules x molecular weight)
𝐴𝑣𝑜𝑔𝑎𝑑𝑟𝑜′𝑠 𝑛𝑢𝑚𝑏𝑒𝑟
 
Amount of required tween 80 (g) =
(3.7474 x 1020 x 604.41)
6.0221415 x 1023 
= 0.376107 𝑔 
 
Amount of required span 80 (g) =
(5.18093 x 1020 x 428.31)
6.0221415 x 1023 
= 0.368481𝑔 
 
So according to the formula and using a ratio of surfactant mixture (T80: S80) (3:1), 0.28208 g of T80 and 
0.09212 g of S80 would be the minimum needed to emulsify 2.5 g of eucalyptol oil in water.  
3.3.1.5 Physicochemical characterisation of the nanoemulsion 
formulations 
Physicochemical characterisation was carried out( zeta potential, pH, and viscosity) for all  NE 






potential is an important parameter for stability, and as the charge increases the repulsion between 
droplets increases and decreases the chance of coalescence. In the present study, the values of zeta 
potential for the HPH technique and HSH technique range between -23.4 ± 2.5 mV to -37.5 ± 3.5mV and 
-20.3 ± 3.4mV to -41.2 ± 3.4 mV, respectively.  So in both  techniques, the values of zeta potential were 
high, and according to different studies  (Yang and Benita, 2000; Zhao et al., 2010; Laouini, Fessi and 
Charcosset, 2012) with a high value of zeta potential the charged droplets will repel one another more 
than droplets with a low value of zeta potential and thus prevent coalescence. The negative charge in 
triclosan arises from the chlorinated polyaromatic phenol groups, and thus the droplets acquire a 
negative overall charge.  
Since all NEs formulations in this study are O/W, they have low viscosity water forms the continuous 
phase and is in a higher ratio than the oil.  However, formulations which have a higher percentage of oil 
have a slight increase in viscosity, as shown in Table 3.5 (Solans et al., 2005). The increased viscosity of 
the continuous phase decreases the movement of the droplets, consequently reducing the chance of 
coalescence between droplets (Jafari et al., 2008).  
According to Schmid et al., a change in skin pH plays a role in the pathogenesis of skin conditions like 
irritant contact dermatitis, to avoid that, the pH of detergents and antiseptics formulations should be 
around 5.5 (Schmid-Wendtner and Korting, 2006) as the pH of healthy human skin ranges between (5.4 
– 5.9) (Braun-Falco and Korting, 1986) In the present study, all NE formulations in both techniques HPH 








Table 3.5 Physicochemical characterisation of the NE formations for both technique HPH & HSH (n=3; mean±sd) 
NE 
High Shear Homogenizer High-pressure Homogenizer 
Surfactant Oil 










0 0.34% 5% 5.32 ±0.2 -37.57 ±3.5 20.05 ± 1.25 5.21 ±0.3 -38.01±5.6 19.67 ± 0.98 
2% 5% 5.78 ±0.3 -23.45±2.5 21.36 ± 0.63 5.47 ±0.1 -26.62±2.6 20.58± 1.11 
5% 5% 5.63 ±0.1 -27.95±4.5 19.85 ± 0.87 5.60 ±0.3 -28.63±4.7 19.08 ± 1.85 










0 0.34% 5% 5.38 ±0.2 -32.71±3.4 20.25 ± 1.12 5.39 ±0.2 -36.64±5.9 20.85 ± 1.62 
2% 5% 5.95 ±0.1 -28.32±4.7 22.22 ± 1.01 5.34 ±0.1 -23.38±3.4 21.69 ± 1.24 
5% 5% 5.49 ±0.1 -31.75±8.6 22.07 ± 0.87 5.12 ±0.1 -28.49±3.7 20.58 ± 0.95 










0 0.34% 5% 5.67 ±0.2 -24.83±1.8 20.30 ± 1.52 5.34 ±0.3 -32.76±3.7 21.58 ± 1.26 
2% 5% 5.24 ±0.3 -28.44±6.2 20.29 ± 1.43 5.87±0.3 -25.42±5.6 19.98 ± 1.43 
5% 5% 5.39 ±0.3 -29.27±1.2 19.58 ± 1.58 5.49 ±0.3 -27.38±4.6 23.25 ± 1.21 










0 0.34% 5% 5.67 ±0.3 -37.19±1.8 21.58 ± 1.13 5.29 ±0.5 -41.29±3.4 20.29 ± 1.65 
2% 5% 5.34 ±0.2 -27.82±4.7 21.36 ± 1.29 5.75 ±0.2 -20.38±3.4 21.69 ± 1.01 
5% 5% 5.97 ±0.1 -28.83±3.9 23.02 ± 0.90 5.64 ±0.1 -27.45±5.8 19.20 ± 1.20 










0 2% 2.5% 5.36 ±0.1 -28.30±1.9 19.85 ±0.67 5.99 ±0.3 -34.16±1.5 18.65 ±0.97 
2% 5% 5.34 ±0.3 -32.74±6.7 21.47 ± 1.19 5.37 ±0.0 -32.69±6.3 20.42 ± 0.58 
2% 7.5% 5.76 ±0.3 -30.33±4.5 22.87 ± 1.49 5.54 ±0.7 -34.34±6.4 21.99± 1.85 






3.3.1.6 Effect of concentration of oil on triclosan nanoemulsions 
3.3.1.6.1 High-pressure Homogenizer technique 
Formulations were prepared with different concentrations of oil (2.5%, 5%, 7.5% and 10% (%w/w). All 
other variables were fixed to examine the effect of varying concentrations of oil on particle size, i.e. 2% 
mixture of surfactant T80: S80 (3:1), 0.5% triclosan and deionised water and at a homogeniser pressure 
of 20K psi. Table 3.6 shows the impact of the concentration of oil on particle size and size distribution 
following 3 and 5 cycles. 
 
Table 3.6 Size and PDI of NEs prepared with different oil concentrations following 3 and 5 cycles using HPH 
No of cycles Property 
concentration of oil (% w/w) 
2.50 5 7.5 10 
After 3 Cycles 
Size (nm) 113.90 70.02 62.15 101.38 
PDI 0.27 0.26 0.33 0.27 
After 5 Cycles 
Size (nm) 83.28 69.59 58.92 80.96 
PDI 0.25 0.26 0.20 0.24 
 
From the results in Table 3.6, it can be seen the smallest particles with a relatively narrow PDI were 
produced at a concentration of 7.5% oil. The increase in size at 10% w/w oil can be explained by the 
reduced efficacy of surfactant at this concentration, due to the amount of surfactant  not being enough 
to cover this amount of oil, or the increased the oil in formulation obstructed the movement of 
surfactants. However, in order to choose the best concentration, the stability of formulations must also 







3.3.1.6.2 High Shear Homogenizer followed by ultrasound technique 
As outlined in paragraph 3.3.1.6.1, four formulations were prepared to study the effect of the amount of 
oil on MDS and PDI. Results in Table 3.7 and Figure 3.7 show that the MDS increases with the amount of 
oil, indicating that the amount of surfactant is not enough to prevent the coalescence between droplets 
in emulsification zone resulting in an increase in the MDS beyond a concentration of 10% w/v. This is as 
expected as the amount of surfactant used was optimised to stabilise 7.5%.    
Table 3.7 Size and PDI of NEs prepared with different oil concentrations (n=3; mean±sd) 
Amount of oil (w/w%) 
Tween 80/span 80 
Size ±SD PDI±SD 
2.5 34.87±0.76 0.25±0.01 
5 76.60±1.76 0.18±0.02 
7.5 99.04±2.15 0.15±0.01 































































3.3.1.7 Effect of type and concentration of surfactant on triclosan 
nanoemulsions  
3.3.1.7.1 High-pressure Homogenizer technique 
To study the effect of type of surfactant on triclosan NEs, formulations using a blend of emulsifiers were 
prepared as detailed in Table 3.8. As mentioned above the required HLB value of eucalyptol was 
calculated to be 12.5, to get that the ratio of surfactants in the emulsifier blend was varied to match this 
using a range of Tween and Span (Table 3.8).  
 
 
Table 3.8 Ratio of blend emulsifier at HLB = 12.5 using a range of Tween and Span 
 T20 : S20 T40 : S40 T60 : S60 T80 : S80 
HLB =12.5 50% : 50% 33.5% : 66.5% 22.5% : 77.5% 22.5% : 77.5 % 
Ratio 1 : 1 1 : 2 1 : 3 1 : 3 
 
For each formulation, a range of surfactant concentrations (0.34 %, 2%, 5% and 10% w/w) was prepared. 
All other variables were kept constant: 5% w/w oil (eucalyptol), 0.5% w/v triclosan and deionised water 
at a homogeniser pressure of 20Ksi. Samples were taken after 3 and 5 cycles to check the size, PDI, and 
ZP. Tables 3.9 and 3.10 and figures 3.8, 3.9, 3.10, and 3.11 show the size and PDI of NEs prepared with 








Table 3.9 Size and PDI of NEs prepared by HPH with different emulsifiers at 3 cycles 
After 3 cycles 
Surfactant mixture Property 
Concentrations of surfactant % w/w 
0.34 2 5 10 
Tween 80/ Span 80 
Size (nm) 105.47 62.37 70.02 94.93 
PDI 0.12 0.19 0.26 0.26 
Tween 60/ Span 60 
Size (nm) 71.06 76.43 127.00 142.39 
PDI 0.19 0.27 0.37 0.43 
Tween 40/ Span 40 
Size (nm) 98.04 60.67 68.59 80.19 
PDI 0.19 0.26 0.39 0.46 
Tween 20/ Span 20 
Size (nm) 121.97 66.75 87.87 83.75 
PDI 0.17 0.19 0.23 0.29 
   
 
Table 3.10 Size and PDI of NE prepared with different emulsifiers at 5 cycles 
 
At 5 cycles 
Surfactant mixture Property 
Concentrations of surfactants % w/w 
0.34 2 5 10 
Tween 80/ Span 80 
Size (nm) 104.94 53.51 69.59 74.57 
PDI 0.09 0.12 0.26 0.267 
Tween 60/ Span 60 
Size (nm) 73.58 60.92 85.25 73.19 
PDI 0.14 0.25 0.29 0.45 
Tween 40/ Span 40 
Size (nm) 81.34 48.84 43.21 52.87 
PDI 0.12 0.22 0.37 0.42 
Tween 20/ Span 20 
Size (nm) 87.55 55.35 71.38 61.27 







For all emulsifiers, the smallest sizes were produced at 2% surfactant, which indicates that there is 
enough surfactant at this concentration to cover all oil droplets and prevent collapsing of droplets. The 
increase in size after 2% indicates that this exceeded the critical micelle concentration (CMC) and the 
emulsifier itself may form a micelle, or aggregates may form. This hypothesis is supported by the 
increase in PDI in all formulations with increasing concentration. The T40/S40 combination produced the 
smallest size at all concentrations but not the lowest PDI, whereas the T20/S20 and T80/S80 produced 
small sizes and narrow PDI profiles. This variation between the emulsifier pattern is due to differences in 
the hydrophilicity and chemical structure of each one (Yuan and Gao, 2008). When the HPH breaks large 
droplets of oil into smaller ones, the role of the surfactant is to prevent the cohesion of droplets again. 
The more effective the surfactant is, the smaller the particle size. In order to choose the best emulsifier, 








Figure 3.8 Size of NE with different emulsifiers at 3 cycles 
 
 
Figure 3.9 Size of NE with different emulsifiers at 5 cycles 
  
Figure 3.10 Size distribution of NE with different emulsifiers at 3 cycles 
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3.3.1.7.2 High Shear Homogenizer followed by Ultrasound Technique 
As mentioned above, different formulations were prepared to study the effect of type and amount of 
surfactant harmonised with the required HLB value for each surfactant. Table 3.11 and Figure 3.12 show 
that the MDS decreases as the concentration of surfactant increases which corresponds with previous 
reports (Jafari et al., 2008) as more surfactant is adsorbed onto the surface of the new disrupted 
droplets and prevents coalescence. Increasing the amount of surfactant can increase the cost and 
potential toxicity, albeit that nonionic surfactants are considered safer than ionic one(D.Attwood, 2013) 
,and smaller MDS will be more susceptible to stability issues like Ostwald’s ripening (Klang and Valenta, 
2011).   
 
Table 3.11 Size and PDI of NE prepared with different amounts of emulsifiers(n=3; mean±sd) 
Amount of surfactant(w/w%) 
tween 80/span 80 
Size ± SD (nm) PDI ± SD 
0.3 163.56 ± 4.38 0.14+ 0.01 
2 76.67 ±1.76 0.17 ± 0.02 
5.0 32.65 ±0.73 0.22 ±0.00 








Figure 3.12 size (A) and PDI (B) of NE prepared with different amounts of emulsifiers 
 
In addition to the concentration of surfactant, the MDS is also affected by the rate of adsorption of 
surfactant on the interfacial surface of the droplet which depends on the viscosity of the continuous 
phase and how the surfactant moves within the continuous phase to cover the droplet. So a different 
type of surfactant has a different pattern and movement, and therefore, a different effect on MDS. 
Table 3.12 and Figure 3.13 show the effect of different types of surfactant on the MDS. 






















































type of surfactant size ± SD (nm) PDI± SD 
Tween 80/Span 80 76.61±1.76 0.17± 0.01 
Tween 60/ Span 60 82.42 ± 1.3 0.25± 0.00 
Tween 40/ Span 40 109.43 ± 2.87 0.20± 0.02 







Figure 3.13 Size and PDI of NE prepared with different types of emulsifiers 
In comparison with the NE prepared by HPH, the MDS was smaller for most formulations due to the 
residence time in dispersing zone (when the droplets break-up) being shorter for HPH than HSH, which 
reduces the probability of coalescence. (Jafari et al., 2008).  
 
3.3.2  Parameters used for High-Pressure Homogenisation 
3.3.2.1 Effect of the number of cycles of HPH 
According to Müller & Peters (1998), increasing the number of cycles (passing of a NE through an HPH) 
will reduce both mean particle size and the polydispersity index of NEs. Thus, the effect of the number 
of cycles on the size of droplets using a homogeniser pressure of 20 ksi, was studied and PSD and PDI 
determined after 3, 5, 7 and 9 cycles. 
Table 3.13 shows the effect of the number of cycles on size and PDI. To measure the effect of the 
number of cycles on size, OLS (ordinary least square) single regression was carried out using EViews 
software. There is a negative association between size and number of cycles increased by 1 unit, and 































of 1% (P-value < 0.001). And the P-value of F-statistics is less than 1%, so our model is overall significant. 
The explanatory power of this model is high (R2=79% of the variation in size can be attributed to the 
variation in a number of the cycle). 
 The average size decreased sharply as the number of cycles increased from 3 to 7 and it decreased 
slightly from 7 till 9. A T-test was conducted to compare the average size along 5 cycles with the average 
size of 7 cycles and another T-test to compare the average size along 7 cycles with the average size of 9 
cycles. The null hypothesis of the T-tests proposes that the difference between the two groups is not 
significant. If the P-value < 5%, we reject the null hypothesis and therefore, the difference is statistically 
significant. The P-value for 5 till 7 cycles are 0.036, which means the decrease was significant, whereas 
the P-value for 7 to 9 cycles is 0.281, which means the impact on particle size was not significant. 
Therefore, 7 cycles were used for standard formulations.  
 




No. of cycles Average size (nm) PDI 
3 cycles 100.44 0.135 
5 cycles 99.43 0.099 
7 cycles 94.45 0.065 






3.3.3 Parameters for High Shear Homogenisation followed by 
Ultrasound 
In this research, three parameters were varied: homogenization time, the speed of mixer and sonication 
time to determine the impact on NE properties.  
3.3.3.1 Impact of homogenization time 
To check the optimum homogenization time, MDS and PDI were used as indicators of formulation 
success. Both are considered as the main parameters in NE formulation due to their effect on delivery 
through skin and stability. Figure 3.14 shows that as duration increased, the MDS decreased. A  
significant decrease was found between 5 and 15 minutes, after which time there was no further 
significant impact. The same trend was found for PDI but with no impact after 10 minutes. Therefore a 
















































3.3.3.2 Impact of mixing speed 
Mixer speed was varied from 3000 -10000 RPM. Results (Figure 3.15) showed that there is no significant 
change in the MDS of resultant NEs above 5000 rpm, whereas PDI was similar for all speeds. According 
to that, the optimum speed was 5000 rpm. The formulation used to study the speed was 5% w/w of oil 
and 2% w/v of a mixture of T80/ S80 and 0.5% w/v of triclosan.   
 
Figure 3.15 Effect of Speed of mixer on mean droplets size (A) and PDI (B) 
  
3.3.3.3 Impact of ultrasonication time 
To determine the effect of ultrasonication time on the MDS and PDI of triclosan NE an amplitude of 50% 
was used and the duration varied from 2 to 10 minutes, with a formulation of 5% w/v of oil and 2% w/v 
of a mixture of T80/ S80 and 0.5% w/v of triclosan PSD and PDI decreased with increasing sonication 
time (Figure 3.16). This is expected with an increase in shear force on droplet size, which causing 
deformation of the droplet and reduction in size. These results are comparable to Shahavi et al., which 









































Figure 3.16 Effect of sonication time on mean droplets size (A) and PDI (B) 
3.3.4 Long-term stability of triclosan nanoemulsion 
3.3.4.1 High-pressure Homogenizer technique 
NEs, in general, have better stability than emulsions, as flocculation and coalescence decrease with 
decreasing the particle size (Qian and Mcclements, 2011). In this thesis, the stability of samples was 
studied at two different temperatures, 4ºC and 25ºCover three months. For samples having a different 
type and concentration of surfactant, Figure 3.17 and Figure 3.18 show the effect of storage on particle 
size. These figures show that formulation containing surfactants at 2% w/w is generally stable except the 









































Figure 3.17 The effect of surfactant on triclosan NE during storage at 4 and 25ºC for 3 months (A)effect of surfactant (T20/S20)at 5 cycles/4°C (B) effect of 







Figure 3.18 The effect of surfactant on triclosan NE during storage at 4 and 25ºC for 3 months (A)effect of surfactant (T60/S60)at 5 cycles/4°C (B) effect of 






3.3.4.2 High shear homogenisation followed by ultrasound 
technique 
The stability of all formulations was studied over a 3 month period. When assessed visually only samples 
prepared at low mixing speeds (3000 and  5000 rpm) and without sonication appeared to exhibit some 
cracking behaviour. This implies that sonication aids stabilisation of batches prepared at slower mixing 
speeds., This was also reported by Baspinar et al. who found that the effect of the number of cycles on 
particle size is greater at lower pressures is greater than the effect on high pressure (Baspinar, Keck and 
Borchert, 2010). Figure 3.20 shows the stability results for different concentrations and types of 
surfactant. These graphs show that the MDS and PDI were more stable compared with the formulation 
prepared by HPH technique. Nevertheless, the optimum formulation is not only determined by the 
smallest droplet size or highest stability; the determining parameters for the optimised formulation will 








Figure 3.19 PDI result for the stability study of different type and amount of surfactant for triclosan NE storage at 4 and 25ºC for 3 months (A) Different 






















































































Figure 3.20 MDS result for stability study of different type and amount of surfactant for triclosan NE storage at 4 and 25ºC for 3 months (A)  Different 









































































































3.3.5 Development and validation method of HPLC determination of 
triclosan in nanoemulsion 
 
3.3.5.1 Development method 
In order to obtain the optimum separation and resolution, various ratios of solvents in the mobile phase 
acetonitrile (ACN) and water were considered, the optimum ratio was found to be 60:40 ACN:water. 
There were two different columns that were also studied, these are; C18 and pentafluorophenyl (PFP), 
the peaks formed by the PFP column had a higher intensity that the C18, this is because of the fluorine 
atoms in the PFP which cause a unique aromatic selectivity. The maximum wavelength (λ max) for 
triclosan was determined using a UV-visible spectrophotometer, this was found to be 287 nm and is 












3.3.5.2 Validation method 
Validation of each method is required, the process to achieve this throughout this study was performed 
in accordance to the ICH 1996 guidelines 
3.3.5.2.1 Linearity 
Six different concentrations of triclosan were prepared in order to establish linearity, these 
concentrations were; (1, 5, 10, 20, 50, 100 µg/ml), covering the expected range and including the limit of 
quantification. This test was performed five times, the ratio of peak area of triclosan concentration was 
then plotted. Figure 3.22 shows linearity in one of the five tests performed (group A, B, C, D and E), 
whereas other graphs can be found in Appendix A. The correlation coefficient (R2) in the five groups was 
studied and the average R2 was 0.9996; this was found using statistical methods along with visual 
examination and is an indication of a very high linearity relationship, suggesting that all triclosan 
concentration alterations will lead to a corresponding change in peak area.  
 
Figure 3.22 Linearity curve of group A for triclosan (n=3; mean±sd) 
  
























The limit of detection (LOD) and the limit of quantification (LOQ) are the two factors used to determine 
sensitivity, the equations for these are expressed in Equation 3.3 and 3.4. The LOD and LOQ were 
calculated in this study.  
Table 3.14 shows the mean of slopes in the linearity curves in the five groups as well as the standard 
deviation of the intercept of these groups.  
 
Table 3.14 Standard deviation of intercept and slopes mean 
 Intercept Slope 
Group A 8039.85 14398 
Group B 3114.45 16477 
Group C 3154.36 16463 
Group D 14324 15625 
Group E 14611 15601 
Standard Deviation 5677.71  
Mean  15712.88 
  
The limit of detection and limit of quantification were subsequently calculated and found to be 1.192 







As shown in Figure 3.24, this method leads to good selectivity for triclosan and has good separation for 
triclosan as it was eluted at 6.737 min.  
 
 
Figure 3.23 Peak of triclosan at 6.737 min 
 
3.3.5.2.4 Accuracy 
Low, medium and high concentrations were prepared for this accuracy test, different to the 





performed five times and the average was calculated. The final found concentration was then calculated 
by a calibration curve and plotting peak area on the curve. Equation 3.6 was the equation used to 
calculate the accuracy.  
The range of accuracy was from 99.25 to 102.58%, according to the ICH guidelines (1996), this is an 
acceptable accuracy range, these results are shown in Table 3.15 
 
Table 3.15 Range of accuracy for HPLC method for triclosan 
Actual concentration (µg/ml) Observed concentration (µg/ml) % Accuracy 
10 10.25 102.58 
40 40.17 100.44 
80 79.40 99.25 
 
3.3.5.2.5 Precision 
Three varying triclosan concentrations were needed for the calculation of precision. Low, medium and 
high concentrations were used these were; (4, 40, 80) µg/ml. The relative standard deviation (RSD) must 
be calculated for the determination of precision, If the RSD is equal to or less than 2% this is a 
confirmation of the precision of the method. There are two parts to the precision test; the first is the 
intra-day precision that is replicated five times within the same day to find the RSD between every two 
injections, the second is the inter-day precision in which the process is performed and repeated over 
five days to find the RSD between the days. (All precision data is found in Appendix B) Table 3.16 shows 
the RSD range of the inter-day precision as well as the intra-day precision. Inter-day precision was found 
to be between 0.06% and 0.18%, as for the intra-day precision this was between 0.83 and 1.47%. Since 
both the inter-day precision and intra-day precision were both found to be lower than 2%, this confirms 






Table 3.16 Range of RSD for both intra-day and inter-day precision 
Nominal concentration (µg/ml) 
% Relative Standard Deviation (RSD) 
Intra-day Inter-day 
low =4 0.18 1.46 
medium = 40 0.12 1.13 
high = 80 0.06 0.82 
 
3.3.6 In vitro skin permeation study 
 
3.3.6.1 Quantitative determination using an adhesive tape 
stripping method 
As mentioned in section 3.1.7.2, an adhesive tape stripping method is a successful method to determine 
triclosan within the skin. Permeation of a number of triclosan formulations into the skin was studied.   
3.3.6.1.1 Effect of amount of surfactant 
To study the effect of the amount of surfactant used in NE formation on skin permeation, four different 
formulations were prepared using HSH technique as shown in table 3.17, and a control (triclosan in oil) 
to compare with these formulations. Figure 3.25 shows that the four formulations have better release 
and penetration in the skin compared with the control. Therefore, it can be concluded that the triclosan 
NE was successful in improving the penetration of triclosan (increasing overall amount, and reaching 
deeper layers) into the skin. On the other hand, there are significant differences between these 
formulations (P<0.05), the formula (H1-P031) which has the lowest amount of surfactant showed the 
best release (increasing overall amount) and retention (deeper layers) of triclosan within the skin. This 
result could be due to a monolayer surfactant film around an oil droplet, which made the release of 






Table 3.17 parameters of different triclosan NE to study the effect of the amount of surfactant 
High shear homogeniser - the effect of the amount of surfactant 





control 5 ---- ---- 0.5 ---- 
H3-P031 5 T80/S80 10.00 0.5 84.5 
H2-P031 5 T80/S80 5 0.5 89.5 
H1-P028 5 T80/S80 2 0.5 92.5 
H1-P031 5 T80/S80 0.34 0.5 94.15 
 
 
Figure 3.24 Effect of the different amount of surfactant on skin permeation (mean ±SD n=3) 
 
3.3.6.1.2 Effect of type of surfactant 
As mentioned above, four different mixtures of surfactants were tested to study the effect of type of 
surfactant on skin permeation, as shown in Table 3.18. The better release (increasing overall amount) 
was in formulation with a mixture of T20/S20, that could be explained by two reasons; firstly, to get the 
required HLB of eucalyptol 12.5 which was determined in section 3.3.1.2 the ratio of T20/ S20 should be 
1:1 (section 3.3.1.7.1). So, the lipophilic surfactant in this formulation is higher than the rest of the 
















































monolaurate) the alkyl group of the fatty acid in it is shorter than S40, S60, S80 (sorbitan monoplmitate, 
sorbitan monostearate, sorbitan monooleate respectively) and that will reduce the hindering of the 
movement of molecules.so as shown in figure 3.26 the formulation with T20/S20 shows the best 






   
Table 3.18 Parameters of different NE to study the effect of the type of surfactant 
High-pressure homogeniser - the effect of type of surfactant 




(w/w%) Type Amount(w/w%) 
Control 5 ---- ---- 0.5 ---- 
F3-P032 5 T80/S80 2 0.5 92.5 
F1-40/P024 5 T40/S40 0.34 0.5 94.15 
F2-40/P024 5 T40/S40 2 0.5 92.5 
F2-20/P024 5 T20/S20 2 0.5 92.5 




Figure 3.25 Effect of the different type of surfactant on skin permeation (mean ±SD n=3) 
 
3.3.6.1.3 Effect of amount of oil 
To study the effect of the amount of oil on skin permeation, three formulations were prepared, as 
shown in table 3.19. All formulations had the same parameter except the H1-P030 the amount of 
















































shows the there is no significant difference in permeation at all levels between formulations (P>0.05). 
For that, a 5% w/w consider an optimum amount for this formulation.  
Table 3.19 Parameters of different NE to study the effect of the type of surfactant 
 
High-shear homogeniser - the effect of the amount of oil 




(w/w%) Type Amount(w/w%) 
control 5 ---- ---- 0.5 ---- 
H1-P030 2.5 T80/S80 2 0.25 95.25 
H1-P028 5 T80/S80 2 0.5 92.5 
H2-P030 7.5 T80/S80 2 0.5 90 
 
 
Figure 3.26 Effect of the different amount of oil on skin permeation (mean ±SD n=3) 
 
3.3.6.2 Qualitative determination using CT Scan 
After quantitatively determining the amount of triclosan within the skin using the tape stripping 
method, the triclosan was also tested qualitatively using CT scans to find the distribution of triclosan 
















































As explained in section 3.1.7.3, the skin sample was left on Franz cells for 24 hours then removed and 
left to dry for 1 hour, then placed on the CT scan. False-colouring was applied to the samples based on 
the various densities within each sample. A video and 3D images were recorded for the samples; the 
video records the 3D movement across the skin samples and screenshots were taken every three 
seconds in the sagittal plane video. The sagittal plane was chosen since it views the triclosan penetration 
from the surface to the bottom of the samples, making it the clearest view out of the three possible 
planes. Three samples were tested using this method; skin without formulation (Figure 3.28 a and b), 
and skin with H1-P031 formulation (Figure 3.29a and Figure 3.29b) and F3-P032 formulation (Figure 30a 
and Figure 3.30b).  
As seen in Figure 3.28, only one colour appeared when applying false-colouring on skin samples without 
formulation, indicating that only one density was found. Whereas in Figure 3.29 and Figure 3.30. Two 
colours appeared on the skin sample, indicating the presence of triclosan within the skin. Figure 3.29 
showed a larger red area than Figure 3.30, which indicates a greater amount of triclosan in this sample. 
This result correlates with the result found in the quantitative tape stripping method where the H1-P031 






Figure 3.27(a) 3D image of the skin sample without formulation (b) screenshots from video every 10 seconds of 
skin sample without formulation (blue; skin, green; plate) 
 
 
Figure 3.28 3D image of the skin sample with H1-P031 formulation (b) screenshots from video every 3 seconds of 







Figure 3.29 3D image of the skin sample with F3-P032 formulation (b) screenshots from video every 3 seconds of 
skin sample with F3-P032 formulation (blue; skin, red; triclosan, green; plate) 
 
3.3.6.3 Impact of preparation method on skin permeation 
To study the effect of preparation technique on penetration and retention of triclosan in the skin, three 
formulations prepared using an HPH technique (F3-P032, F2-40/P024, F1-40/P024) were compared with 
two formulations made using an HSH technique (H1- were prepared as shown in table 3.20). All 
formulations which were prepared by HSH show better release and retain within the skin than the 
formulations were prepared by HPH as shown in figure 3.31, despite smaller size and PDI. The MDS and 
PDI of NE which prepared by HPH lesser than HSH. In view of that, there are other parameters must be 







Table 3.20 Parameters of different NE to compare between two techniques 
Comparison of two techniques   




(w/w%) type amount(w/w%) 
control ---- ---- ---- 0.5 99.5 
F3-P032 5 T80/S80 2 0.5 92.5 
F2-40/P024 5 T40/S40 2 0.5 92.5 
H1-P028 5 T80/S80 2 0.5 92.5 
F1-40/P024  5 T40/S40 0.34 0.5 94.15 
H1-P031 5 T80/S80 0.34 0.5 94.15 
 
 
Figure 3.30 Comparison between two techniques (mean ±SD n=3) 
3.3.6.4 The optimum formulation 
From studying the effect of the amount of surfactant in the penetration of triclosan into the skin 
(section 3.3.6.1.1), it was concluded that the lowest amount of surfactant showed the highest level of 
penetration and retention of triclosan within the skin, which was 0.34% w/w. From studying the type of 
surfactant (section 3.3.6.1.2), the best was found to be T20/S20, which resulted in the highest 

















































significant differences. Therefore, 5% was chosen to minimise the amount of surfactant needed to cover 
the oil. By comparing both techniques (section 3.3.6.3), high-shear homogenisation was found to 
produce NE with better penetration than the high-pressure technique.  
From the mentioned studies, it was concluded that the F1-20/P024 formulation is the optimum 
formulation which resulted in the highest level of penetration and retention of triclosan within the skin, 
this formulation was prepared by high-shear homogeniser and has surfactant mixture 0.34% w/w 
T20/S20, 5% oil and 0.5% triclosan and is shown in Figure 3.32. 
 
Table 3.21 Variables Summary of all formulations used in skin  
 
All formulations 




(w/w%) type amount(w/w%) 
control ---- ---- ---- 0.5 99.5 
H2-P031 5.0 T80/S80 5.00 0.5 89.5 
F3-P032 5.0 T80/S80 2.00 0.5 92.5 
H1-P028 5.0 T80/S80 2.00 0.5 92.5 
F1-40/P024  5.0 T40/S40 0.34 0.5 94.15 
H1-P030 2.5 T80/S80 2.00 0.25 95.25 
F2-40/P024 5.0 T40/S40 2.00 0.5 92.5 
H1-P031 5.0 T80/S80 0.34 0.5 94.15 
F1-20/P024  5.0 T20/S20 0.34 0.5 94.15 
F2-20/P024  5.0 T20/S20 2.00 0.5 92.5 
H2-P030 7.5 T80/S80 2.00 0.5 90 
F2-60/P024 5.0 T60/S60 2.00 0.5 92.5 







Figure 3.31 graph of all formulations (mean ±SD n=3) 
3.4 Conclusion  
In conclusion, triclosan NE was successfully designed and developed using two techniques; a high-
pressure homogeniser and a high-shear homogeniser followed by ultrasonication. The physicochemical 
characterisation of the formulations was studied, which includes; MDS, PDI, ZP, PH and viscosity. The 
amount and type of surfactant in addition to the amount of oil were explored to determine the 
optimum formulation, specific parameters for each technique were also considered including; the effect 
of the number of cycles for the high-pressure homogeniser and the sonication time for the high-shear 
homogeniser. A stability study was carried out for all formulations in both techniques over three 
months. 
The HLB for the eucalyptol was calculated and found to be 12.5. The formulation with the lowest 






















































The number of cycles for HPH did have not a significant effect on MDS and PDI after seven cycles, 
according to t-test (P-value < 0.05). In the HSH technique, the sonication had an important role in 
minimizing the PDI and improving stability. 
The use of the tape-stripping method was successful in quantitatively determining the triclosan within 
the skin, and the micro CT scan was successful in the qualitative determination and correlation was 











4 Chapter 4- Design and Development of Chloroxylenol Nanoemulsion 
for Dermal Delivery 
4.1 Introduction 
Microbes are frequently able to access the preferred environment for infections, which is a moist, 
nutritious and warm environment, due to a rupture in the skin, more commonly known as a wound 
which can subsequently lead to infection due to the presence of bacteria, fungi, etc. MRSA, for example, 
is generally found in open wounds and abrasions to the skin and is frequently the result of infections 
within hospitals. These types of infections lead to complications and result in a lengthened illness, which 
subsequently leads to the requirement for prolonged treatment and higher treatment costs. To limit 
wound infection, it is therefore essential in wound management to generate an ideal environment for 
the regeneration of the epidermal layer of the skin while considering the avoidance of possible further 
injury to the skin throughout the renewal period of the epidermis. This leads to the requirement and 
importance of antimicrobial dressings in wound treatment; the current most commonly used topical 
antimicrobial dressings are iodine and silver sulfadiazine (Shupp et al., 2010). However, there are 
challenges with the design of antimicrobial dressings which include the possibility of toxicity to host 
cells, low adherence to skin and low duration of activity against both gram-positive and gram-negative 
bacteria (Hemmila et al., 2010).  
These disadvantages have led to the drive for development of improved and enhanced delivery systems 
that can control drug release over a prolonged period and penetrate the antimicrobial agent further into 
the skin than current solutions.  
Nanoemulsions can generally be defined as the liquid dispersion of both an oil phase and a water phase 
combined with a surfactant; this liquid dispersion is thermodynamically stable or kinetically stable. 





preferred system for delivery for hydrophobic substances. The favourable delivery system for 
hydrophilic substances, however, is W/O NEs.   
In this thesis, various NE formulations with varying types of surfactant mixtures and different amounts 
of the mixtures and eucalyptol oil were studied. Eucalyptol oil was chosen for two reasons; it is 
considered an antimicrobial agent and it has a role in enhancing the permeability of formulation within 
the skin.  
Therefore, these studies were performed to achieve the optimum formulation to find the highest 
amount of antiseptic which can penetrate the skin. 
4.1.1 . Physicochemical characterisation of the nanoemulsion 
formations: 
The following tests were mentioned in Chapter 3 and thoroughly explained. 
4.1.1.1 Accelerated stability studies 
Three steps were used for the accelerated stability study which are; heating-cooling cycle followed by 
centrifugation and finally the freeze-thaw cycle.  
1- Heating-cooling cycle: The samples were placed in the refrigerator at 4°C for 48 hours then 
heated at 45°C for another 48 hours. Six cycles were performed, and the samples that remained 
stable throughout this step moved onto to the next step.  
2- Centrifugation: The samples which remained stable were then centrifuged at 3500rpm for half 
an hour, the samples which showed no segregation between phases or creaming were then 
tested in the final step.  
3- Freeze-thaw cycle: The samples which passed the centrifugation step were then frozen at -21°C 






The samples which passed all three stages were considered to pass the accelerated stability study(Shafiq 
et al., 2007).  
4.1.1.2 Droplet size and PDI measurement: 
Zetasizer Nano ZS (Malvern Instruments Ltd, UK) was used to find the size and PDI of NE formulations 
and the measurements were carried out in triplicate to find the mean value and sd.  
4.1.1.3 Zeta potential measurement:  
Zetasizer Nano ZS (Malvern Instruments Ltd, UK) was used to find the ZP to find the droplet’s 
electrostatic charge, and this was repeated three times to find the mean value and sd. 
4.1.1.4 Stability studies: 
All formulations were placed at two temperatures of 4°C and 25°C for three months to study their 
stability, a sample was taken each month and repeated three times to measure the size and PDI and find 
the mean value and sd.  
4.1.1.5 pH determination: 
pH was found using pH meter at 25°C; this was carried out in triplicate to find the mean pH value and 
the sd. 
4.1.1.6 Determination of viscosity: 
The viscosity was measured using Bohlin cone and plate rheometer at 25°C and shear ramp between 0.1 
and 100 s-1. The mean value and sd of three of these measurements were found.  
 
4.1.2 Chloroxylenol and mechanisms of action 
Chloroxylenol is a disinfectant and antiseptic, first used in the 1920s.  It is also known as para-chloro-





Its main use is in skin disinfection, disinfection of surgical instruments and wounds and as a household 
cleaning product. PCMX is mainly active against gram-positive bacteria and functions by disrupting the 
cell wall and suspending the functionality of enzymes (Fraise et al., 2013).  
Chloroxylenol is relatively cheap and accessible; it is available as a liquid and, the most common brand 
name for this antiseptic is Dettol®.  
 
Figure 4.1 Chemical structure of PCMX 
 
4.1.3 Analysis and characterisation of PCMX nanoemulsions 
4.1.3.1 HPLC - method validation 
In this study, the guidelines adopted in the validation process were those, according to ICH 
(International Committee on Harmonization, 1996). The analytical parameters used are linearity, 
sensitivity, precision, accuracy, and stability outlined in section 3.1.6.1.  
4.1.4 Physicochemical characterisation of nanoemulsion formulations 






4.1.5 Determination of PCMX in skin quantitively and qualitatively 
4.1.5.1 In vitro skin diffusion study 
The in-vitro diffusion studies for PCMX NE formulations were performed using Franz cells to find the 
optimum formulation for skin retention, as outlined in section 3.1.7.1.  
4.1.5.2 Quantitively by using an adhesive tape stripping method 
To quantitatively determine the PCMX within the skin, an adhesive tape stripping method was used, as 
described in section 3.1.7.2 
4.1.5.3 Qualitatively by using CT Scan 






4.2 Aim and Objectives 
The aim of this chapter was to develop appropriate pharmaceutical formulations designed for the 
delivery of PCMX to target sites, i.e. hair follicle in the skin in addition to characterising the formulations.  
 
• To develop and characterise an optimum PCMX NE using a high-shear homogeniser followed by 
ultrasonication and to determine the relative stability of PCMX NEs 
 
• To study the effect of processing parameters such as the sonication time during HSH on NE 
formulation on the formulation 
 
• To determine the amount of PCMX in the skin using an in vitro Franz cell method following 
topical application quantitatively using tape stripping and qualitatively using CT. 
 
• To compare the penetration of PCMX NE in human skin and porcine skin.  
  





4.3 Results and Discussion 
4.3.1 Formulation study of PCMX nanoemulsion 
4.3.1.1 Development of PCMX nanoemulsion 
As nanoemulsions stability is affected by many parameters, including the type and amount of surfactant, 
it was necessary to design a system to investigate the relative stability of emulsion formulations (see 
section 3.3.1.2). 
A PCMX NE was prepared by using an HSH method followed by ultrasound as described in section 3.3.3 
4.3.1.2 Solubility of PCMX in eucalyptol 
The solubility of PCMX in eucalyptol, water and PBS with 1% SLS was determined by adding an excess of 
PCMX to the solutions which were mixed using a vortex mixer at 1500 rpm. Then these were maintained 
in an isothermal shaker at 25 ±1˚C for 72 h to equilibrate.  Following centrifugation at 3000 rpm for 15 
min,  the supernatant was removed, filtered using a 0.45 µm filter and analysed by HLPC, after dilution 
by methanol (Shafiq et al., 2007). The solubility of PCMX is shown in Table 4.1. 
  
Table 4.1 The solubility of PCMX in eucalyptol, water, and PBS 
 Solubility of PCMX (mg/ml) 
PCMX in eucalyptol only 510.19 
PCMX in BPS+1% of SLS 320.04 
PCMX in water 0.53 
 
4.3.1.3 Determination of minimal surfactant concentration 
If it is assumed that T80 and S80 form a thin film around each droplet in a monolayer, so according to 
geometric calculations, it possible to estimate sufficient amounts of these surfactants to stabilise any 
emulsion. 
For example, for 2.5g of eucalyptol oil (density is 0.912 g/ml)(Silva et al., 2011).  





            = 2.5 g / 0.912 g/ml 
            = 2.7412 ml (cm3) 
 
For a droplet diameter of 30 nm (section 4.3.1), thus: 
 
Droplet diameter=30 nm= 3 x 10-6 cm, and if assumed that the droplet is spherical, so 
Volume of droplet = 
4
3
π 𝑟3 = 
π𝑑3
6
 = 1.439 x10-17 cm3 
 
where r: radius  
         d: diameter 
 
Total number of drops in 2.5 g = volume of eucalyptus oil/volume of the droplet                                                                                                                             
                                             = 2.7412 / 1.882 x10-17 
                                             = 1.457 x 1017 
 
Surface area of each droplet = πd2 
                                          = 2.828 x 10-11 cm2 
 
The total surface area of droplets = Surface area of each particle x Total number of drops 
                                           = 3.422 x 10-11 x 1.457 x 1017  
                                           = 5.482456 x 106 cm2 
 





Surface area = 133 Å =1.33 x 10-14 cm2  (PubChem, n.d.-b) 
Molecular weight of S80 = 428.31 g/mol  
Surface area = 96.2 Å =9.62 x 10-15 cm2   (Pub chem, no date a) 
 
Number of required molecules of T80 = Total surface area of droplets/surface area of T80 
                                                               = 5.482456 x 106 / 1.33 x 10-14 
                                                               = 4.122 x 1020                                                                                     
Number of required molecules of S80 = Total surface area of droplets/surface area of S80 
                                                              = 5.482456 x 106 / 9.62 x 10-15 
                                                              = 5.699 x 1020 
                                                                               
Amount of required surfactant (g) =
(Number of required molecules x molecular weight)
𝐴𝑣𝑜𝑔𝑎𝑑𝑟𝑜′𝑠 𝑛𝑢𝑚𝑏𝑒𝑟
 
Amount of required tween 80 (g) =
(3.7474 x 1020 x 604.41)
6.0221415 x 1023 
= 0.41371 𝑔 
 
Amount of required span 80 (g) =
(5.18093 x 1020 x 428.31)
6.0221415 x 1023 
= 0.32786𝑔 
 
So according to the formula and using a ratio of surfactant mixture (T80: S80) (3:1), 0.311 g of T80 and 
0.082 g of S80 would be the minimum needed to emulsify 2.5 g of eucalyptol oil in water.  
4.3.1.4 Physicochemical characterisation of the nanoemulsion 
formulations 
A range of formulations was prepared as detailed in Table 4.2 and zeta potential, pH and viscosity were 





ZP value ranged between -14 ± 5.9 mV to -28.5 ± 3.5mV. Various studies (Yang and Benita, 2000; Zhao et 
al., 2010; Laouini, Fessi and Charcosset, 2012) have confirmed that higher values of ZP cause more 
repulsion for charged droplets than lower values, therefore stopping coalescence between the droplets.  
The negative charge in the ZP values of PCMX shows the chlorinated polyaromatic phenol groups. 
The NE formulations in this study are all O/W; therefore, are of low viscosity as the continuous phase is 
formed by water. The results shown in Table 4.3 show the viscosity ranges between 19.08  ± 1.25 cP to 
23.74 ± 1.63 cP. The high viscosity in the continuous phase in these results leads to a decrease in the 
droplet motion, which subsequently leads to increased stability (Jafari et al., 2008).  
As mentioned in section 3.3.1.5, an alteration in pH of skin contributes to the pathogenesis of skin 
diseases such as irritant contact dermatitis. Therefore it is reported that the pH of formulations should 
be around 5.5 to minimise irritation  (Schmid-Wendtner and Korting, 2006).  In this study, the pH results 
range between 5.34 ± 0.3 to 6.92 ± 0.3; these results are close to the recommended value of 5.5 without 








Table 4.2 Physicochemical characterisation of PCMX NE formulations (n=3; mean±sd) 
Surfactant Oil 
pH ±SD ZP (mV) ±SD Viscosity (cP) ±SD 
Type  Amount (%w/w) Amount (%w/w) 
T80/S80 0.34 5 6.87 ±0.2 -28.5 ±3.5 19.58 ± 1.25 
T80/S80 2 5 6.69 ±0.3 -16.4±2.5 21.36 ± 0.63 
T80/S80 5 5 5.63 ±0.1 -27.9±4.5 22.81 ± 0.89 
T80/S80 10 5 6.92 ±0.3 -24.7±3.8 23.65 ± 1.09 
T60/S60 2 5 6.52 ±0.3 -28.1±1.8 20.54 ± 1.23 
T40/S40 2 5 6.52 ±0.2 -22.8±4.7 22.36 ± 1.29 
T20/S20 2 5 5.88 ±0.1 -22.8±3.9 21.02 ± 0.80 
T80/S80 2 2.5 5.74 ±0.3 -14±5.9 19.08 ± 1.25 
T80/S80 2 7.5 5.36 ±0.1 -25.3±1.9 23.85 ±0.87 





4.3.1.5 Effect of concentration of oil on PCMX nanoemulsions 
Formulations were prepared with different concentrations of oil (2.5%, 5%, 7.5% and 10% (%w/w). All 
other variables were fixed to examine the effect of varying concentrations of oil on particle size, i.e. 2% 
mixture of surfactant T80: S80 (3:1), 0.24% PCMX and deionised water. The mixer speed was set at 7000 
rpm for 10 min and then 8 mins sonication. 
 
Table 4.3 Size and PDI of PCMX NEs prepared with different oil concentrations 
amount of oil (% w/w) Size ±SD PDI±SD 
2.5 39.89±0.17 0.43±0.01 
5 62.58±1.31 0.36±0.03 
7.5 89.17±0.55 0.28±0.01 
10 99.02 ±0.56 0.28±0.00 
 
From Table 4.3, it can be inferred that as oil concentration increased, the size of the droplet increased, 
and the PDI decreased. The increase in size can be explained by way of the measurement method of 
zatesizer. Since the zetasizer determines the average volumes of the droplets, it is possible that there 
are micelles of surfactant with a very small range (20-30 nm) that are causing a reduction in the average 
sample size. That is confirmed by the high value of PDI with a low value of MDS as shown in the sample 
with 2.5% oil, which means there is a wide range in the droplet sizes. As the concentration of oil is 
increased, more surfactant is needed to cover each droplet, and fewer micelles are formed, which 
reduces the PDI, which is shown in the sample with 10% oil. However, in order to choose the best 
concentration the stability of formulations must also be considered (section 3.3.4) 
4.3.1.6 Effect of type and concentration of surfactant on PCMX 
nanoemulsions  
As surfactants alter the interface between the oil phase and the aqueous phase, therefore controlling 
the adsorption and coalescence rate, they are essential components in the formation of NEs (Qian and 





technique as they adsorb onto the oil droplets that are newly formed, subsequently preventing 
coalescence and aggregation of the droplets and lowering the surface tension (Guzey and McClements, 
2006).  
 In this study, the effect of the type and concentration of surfactant on PCMX NEs was investigated. To 
study the effect of type of surfactant on PCMX NEs, formulations using a blend of emulsifiers were 
prepared as detailed in Table 4.4. As mentioned in Chapter 3 section 3.3.1.2, the HLB value of eucalyptol 
was calculated to be 12.5, and a range of ratios of Tween and Span were used to match that HLB (Table 
4.4).  
 
Table 4.4 Ratio of blend emulsifier at HLB = 12.5 
 T20: S20 T40: S40 T60: S60 T80: S80 
HLB =12.5 50%: 50% 66.5% : 33.5% 77.5% : 22.5% 77.5% : 22.5% 
Ratio 1: 1 2: 1 3: 1 3: 1 
 
All other variables were kept constant: 5% w/w oil (eucalyptol), mixture of surfactant 2% w/w, 0.24% 
w/w PCMX and 92.76% w/w deionized water.  A blend of T80/S80 produced the smallest droplet size 
(62.58 nm) in relation to the other surfactant types, whereas T40/S40 resulted in the largest size (142.94 
nm) (Figure 4.2). This could be due to the surfactant nature and solubility in water, as T80/S80 has the 
highest ratio of hydrophilic to hydrophobic characteristics at 3:1, whereas, T40/S40 has a lower ratio 
which could facilitate faster motion of surfactant (T80/S80 blend) in the aqueous phase which could 
allow the surfactant to adsorb onto the newly formed oil droplets preventing aggregation. This fits with 
the smaller droplet size in T80/S80 blend in comparison with other surfactants and has also been 
observed in other studies (Jafari et al., 2008; Ziani et al., 2011).  







Figure 4.2 Effect of type of surfactant on mean droplet size (A) and PDI (B) 
 
 
 To study the effect of the amount of surfactant on particle size, a range of surfactant concentrations 
(0.4 %, 2%, 5% and 10% w/w) was prepared. The size of droplets decreased as the amount of surfactant 
is increased between 0.4% to 5%, then the droplet size slightly increased until 10% (Table 4.5) which is 
likely to be due to the increase in amount of surfactant leading to formation of micelles and this can be 
confirmed through the high value of PDI (0.53±0.01) at this percentage of surfactant. Although the 5% 
amount of surfactant resulted in the smallest droplet size, it is important to note that using a minimal 
amount of surfactant is preferable for cost and reduction of any potential toxicity or irritant risks of 
surfactant. Another essential factor to consider is the optimum surfactant amount to enable permeation 
into the skin which is shown in section 4.3.5.1.1 
 
Table 4.5 Size and PDI of NEs prepared with different surfactant concentrations 
Amount of surfactant w/w% Size (nm) ±SD PDI±SD 
0.4 98.97±1.96 0.32±0.02 
2 62.58±1.31 0.36±0.03 
5 30.72±0.35 0.38±0.01 

















































4.3.2 Optimisation of homogenization and sonication parameters 
To study the impact of homogenization time, the speed of mixer and impact of sonication a prepared 
nanoemulsion containing 5% w/w eucalyptol as oil, 2% w/w of mixture surfactant 3:1 T80: S80, 0.24% 
w/w PCMX and 92.76% w/w water was used. 
4.3.2.1 Impact of homogenization time 
To check the impact of homogenization time on formulation characteristics, MDS and PDI were used as 
indicators of formulation success. Both are considered as important parameters in NE formulation due 
to their effect on delivery through skin, appearance and stability of the formulation. Results, 
summarized in Table 4.6, show a significant decrease in both MDS and PDI  from 5 min to 10 min; this 
was followed a by a plateau until 15 min and then an increase from 15 to 20 min. The increase can be 
explained by the additional energy which caused droplets to collapse. A study by Shahavi et al. also 
shows similar results when preparing a NE using clove oil as during the sonication time increase from 1 
to 10 min, a droplet size decreased from 160 nm to 40 nm. This was then followed by a stage when 
there was no further reduction in the droplet size until after 15 min (Shahavi et al., 2015). Therefore, the 
chosen homogenization time in this study was 10 min. 
 
Table 4.6 Effect of homogenization time on mean droplet size and PDI 
Homogenization duration (min) 
tween 80/span 80 
Size-Ave (nm) standard error PDI standard error 
5 26.96 0.39 0.34 0.01 
10 21.47 0.09 0.28 0.01 
15 22.57 0.18 0.27 0.01 







4.3.2.2 Impact of Mixing Speed 
 
Mixing speeds were varied between 3000 – 10000 RPM and results are shown in Figure 4.3. A speed of 
7000 RPM was chosen since it resulted in the smallest droplet size while maintaining acceptable PDI 
results of less than 0.5.  
   
Figure 4.3 Effect of speed of mixer on mean droplet size (A) and PDI (B) for PCMX NE 
 
4.3.2.3 Impact of sonication 
Sonication has a significant effect on MDS and PDI, which can be seen in Figure 4.4. The samples were 
sonicated using a sonication probe for 8 minutes after homogenisation with the mixer. A sonication 
stage was introduced to minimise droplet size and reduce the PDI, which should ultimately lead to 
improved stability as similar droplet sizes eliminate the collapsing of larger droplets to smaller droplets. 



























































Figure 4.4 Effect of sonication on mean droplet size (A) and PDI (B) for PCMX NE 
 
4.3.3 Stability of PCMX nanoemulsion 
Two stability studies were performed, one long-term study and an accelerated stability study. The long-
term stability study was performed at two temperatures for 3 months; the two temperatures were 25°C 
and 4°C. 
4.3.3.1 Accelerated stability studies 
To consider the NE formula stable, it should pass all three stages in the accelerated stability study; these 
are a heat-cooling cycle, centrifugation and a freeze-thaw cycle (Hung et al., 2011). The heat-cooling 
cycle stage was performed to accelerate the motion and increase collisions between the oil droplets as 
higher temperatures lead to higher kinetic energy in the Brownian motion of oil droplets. All prepared 
formulations were stable under these conditions (Table 4.7) as no creaming or sedimentation was 
observed, and all formulations were progressed onto the centrifugation stage of the study. Again, there 
was no evidence of phase separation (Figure 4.5). Gravitational forces may be the cause of emulsion 
instability during centrifugation as the centrifugation phase has been found to accelerate creaming and 
sedimentation rate s(Hung et al., 2011). In this study, since the NE is O/W, creaming is expected to occur 















































Formulation C3/P061, with a high percentage of surfactant (10%w/w), separated into two layers on 
centrifugation, and formulations C2/P064 and C3/P064 with high percentages of oil (7.5% and 10% 
respectively) resulted in a small amount of creaming. When separation occurred, the reason could be 
due to the amount of surfactant used being too high, and when creaming occurred, this could be due to 
the amount of surfactant being insufficient for covering the oil droplets.     
In the final stage of the freeze-thaw cycle, during freezing, segregation of the oil droplets occurs due to 
the formation of a crystalline ice particle which leads to breaking of the surfactant film. During thawing, 
the droplets melt and can collide with other droplets.  Formulations C2/P061, C3/061, C2/P063, C1/P064 
and C3/P064 did not pass this stage as creaming or separation occurred (Table 4.7 and Figure 4.6), and 





















Table 4.7 Effect of type and concentration of surfactant and oil in accelerated stability study for NE 
Formula code 










C1/P061 T80/S80  0.4 5 7000  stable stable stable 
C2/P061 T80/S80  5 5 7000  stable stable creaming 
C3/P061 T80/S80  10 5 7000  stable two layers two layers 
C1/P062 T60/S60 2 5 7000  stable stable stable 
C2/P062 T40/S40 2 5 7000  stable stable stable 
C3/P062 T20/S20 2 5 7000  stable stable stable 
C1/P063 3000 rpm 2 5 3000  stable stable stable 
C2/P063 5000 rpm 2 5 5000  stable stable creaming 
C3/P063 10000 rpm 2 5 10000  stable stable stable 
C1/P064 T80/S80  2 2.5 7000  stable stable creaming 
C2/P064 T80/S80  2 7.5 7000  stable Little creaming stable 
C3/P064 T80/S80  2 10 7000  stable Little creaming creaming 





4.3.3.2 Long-term stability 
The long-term stability of NE was studied for 3 months at two different temperatures for formulations of 
NE with varying types and amounts of surfactant. Samples were observed for a separation every month 
and size, and PDI determined.  
There was no change in droplet size or PDI on storage for 3 months (Figures 4.7 and 4.8). The reason 
behind these results can be due to one of two reasons at 25°C; either the NE was highly stable or the 
25°C was not high enough to increase the movement of the droplets, therefore, no collapsing occurred.  
As for the 4°C temperature, the reason could be that the low temperature caused a reduction in 
movement of the droplets, therefore, reducing the risk of collapsing between droplets and subsequently 
maintaining stability.    






Figure 4.7 The effect of surfactant on size of PCMX NE during storage at 4 and 25ºC for 3 months (A)effect of surfactant concentration at 4°C (B) effect of 







Figure 4.8  The effect of surfactant on PDI of PCMX NE during storage at 4 and 25ºC for 3 months (A)effect of surfactant concentration at 4°C (B) effect of 





4.3.4 Development and validation method of HPLC for the 
measurement of PCMX 
4.3.4.1 Development method 
A 60: 40 ratio of ACN: water was found to be the optimum ratio. The C18 column was the first to be 
tested, followed by a pentafluorophenyl (PFP) column, the peaks of the two columns were compared 
and the C18 column was found to produce peaks with higher intensity than the PFP column as well as 
having better resolution. There is a highly hydrophobic stationary phase for C18, which shows great 
methylene selectivity. For the determination of PCMX’s maximum wavelength (λ max) UV-visible 
spectrophotometry was the method used, λ max was found to be 288 nm, this is shown in Figure 4.9. 
 
 
Figure 4.9 UV spectrum for PCMX, showing the λ max at 288nm 
 
4.3.4.2 Validation method 
It is a requirement that each method developed should be validated, in this study, the validation 







Six various concentrations of PCMX were used to find linearity, all of which were within the expected 
range in addition to including the limit of quantification, the six concentrations used were (2, 5, 10, 20, 
50, 100 µg/ml). Measurements were performed and replicated five times, after which a plot was made 
of the ratio of peak area with PCMX concentration. The results of one of the five repetitions of the 
linearity test (group A, B, C, D and E) is shown in Figure 4.10, (all remaining graphs can be seen in 
Appendix A). The correlation coefficient (R2) average between the five groups was calculated and found 
to indicate a high linearity relationship through visual inspection as well as the use of statistical methods 




Figure 4.10 Linearity curve of group A (one graph of the five graphs of linearity) For PCMX 
 



















Concentration of PCMX( µm\ml)
ratio of peak area








There are two different factors that can be used for expressing sensitivity, the first of these is the limit of 
detection (LOD) whereas the second is the limit of quantification (LOQ), to calculate these two factors 
equations 3.3 and 3.4 were used.  
The mean of the slopes in the linearity curves as well as the standard deviation of the intercept in the 
five groups are shown in Table 4.8  
 
 
Table 4.8 Standard deviation of intercept and slopes mean of the five group of linearity for PCMX 
 Intercept Slope 
Group A 2984.75 7448.95 
Group B 3151.16 7446.96 
Group C 3136.87 7509.37 
Group D 13.37 7988.79 
Group E 190.84 7984.64 
Standard Deviation 1639.51  
Mean  7675.68 
  
The limit of detection was therefore found to be 0.71 µg/ml whereas the limit of quantification was 
calculated to be 2.14 µg/ml. 
 
4.3.4.2.3 Selectivity 
From Figure 4.11 it is concluded that this method proves good selectivity for PCMX as well as having 







Figure 4.11 Selectivity test shows the resolution of the method - Peak of PCMX at 3.29 min 
 
4.3.4.2.4 Accuracy 
To establish the accuracy, three various PCMX concentrations were prepped, these were; 10, 40 and 80 
µg/ml taken from the concentration used in the linearity test. Five repetitions of this test were 





concentration through a plot of the peak area on a calibration curve and accuracy was calculated with 
Equation 3.6. 
The range of accuracy was found to be between 97.35% and 98.48% as shown in table 4.9   which is an 
acceptable accuracy range in accordance to the ICH guidelines (1996). 
 
 
Table 4.9 Range of accuracy for HPLC method for PCMX 
Actual concentration (µg/ml) Observed concentration (µg/ml) % Accuracy 
10 9.73 97.35 
40 39.39 98.48 
80 78.57 98.22 
 
4.3.4.2.5 Precision 
As for the precision test, PCMX concentrations of 4, 40 and 80 g/ml were used and the test was split 
into two parts; the first of these is the intra-day precision test which is performed five times within one 
day and the RSD is then calculated between every two injections. The second part of the precision test is 
the inter-day precision, in which the process performed for the intra-day test is repeated over five days 
and the RSD is then calculated between the days. (see appendix B to show all the dates the precision 
test was performed on). For a method to be considered of satisfactory precision, the PSD must be lower 
than or equal to 2%. The range for the RSD in the intra-day tests was found to be between 0.02– 0.19%, 
as for the RSD range for the inter-day precision test, this was between 0.29 -0.58% as shown in table 
4.10. Since all values in both the tests were between 2%, this is a confirmation that the precision of the 







Table 4.10 Precision test - Range of RSD for both intra-day and inter-day precision 
Nominal concentration (µg/ml) 
% Relative Standard Deviation (RSD) 
Intra-day Inter-day 
low =4 0.19 0.29 
medium = 40 0.09 0.41 
high = 80 0.02 0.58 
 
4.3.5 In vitro skin permeation study 
As previously mentioned, the amount of drug retained within the skin was determined quantitatively 
using the tape-stripping method and qualitatively using a micro CT scan.  
4.3.5.1 Quantitative determination by using an adhesive tape 
stripping method 
4.3.5.1.1 Effect of amount of surfactant 
To quantify the amount of drug retained within the skin following application of PCMX 
nanoformulations, a tape-stripping method was used. The superficial layer of SC was removed using 
adhesive tape; the drug was quantified using HPLC as described in section 3.3.6.1 (Lademann et al., 
2009) 
Formulations, as detailed in Table 4.11, were used, and Dettol® was used as the control (Figure 4.12).  
Tape 1 contains an excess formulation that did not penetrate the skin. As for Tape 2-5 and Tape 6-10 
and Tape 11-15 were performed to ensure that no excess formulation remained on the surface of the 
skin. Whereas the super-glue step was performed to study the amount of drug in the hair follicle, as for 
the full skin (homo) was performed to study the amount of drug penetrated deeper into the skin. 
Formulation C1-P061, which contained the lowest amount of surfactant, had the highest amount of drug 
in Homo level (full thickness skin), even exceeding the amount of PCMX in the control (Dettol®). This 





to penetrate further into the skin. This could be because eucalyptol modifies the barrier properties of 
SC, therefore facilitating the penetration process (Femenía-Font, 2005). A second reason is that as the 
formulation is NE, which has a large surface area that enhances the penetration and NE also helps 
hydrate the skin, therefore, improving the delivery. (Tadros et al., 2004) 
For the remaining formulations with higher amounts of surfactant than the C1-P061 formula, the 
amount of PCMX NE was lower which may be due to the higher amount of surfactant which could 
possibly reduce the role the eucalyptol plays in improving penetration, another possible reason could be 
due to the multi-layer of surfactant surrounding the oil droplet which could obstruct the penetration 
within the skin.      
 
Table 4.11 Parameters of different NE to study the effect of the amount of surfactant 







type Amount (w/w%) 
Dettol® ---- ---- ---- 0.50 99.50 
C1-P061 5 T80/S80 0.4 0.24 94.56 
C1-P060 5 T80/S80 2.0 0.24 92.76 
C2-P061 5 T80/S80 5.0 0.24 89.76 







Figure 4.12 Effect of the different amount of surfactant on skin permeation of PCMX NE (mean ±SD n=3)  
 
 
4.3.5.1.2 Effect of type of surfactant 
To study the type of surfactant, four formulations with varying types of surfactants were prepared, as 
shown in Table 4.12. Figure 4.13, it shows formulations containing T80/S80 showed the highest amount 
of drug retainment (permeation uptake through the skin) into the skin on both the hair follicle level and 
in full skin (homo). This may be due to compatibility between the PCMX and T80/S80, and as mentioned 
in section 4.3.1.6, the smallest droplet size was in this mixture., This is similar to the findings of Shafat et 
al., (2013) which states that the formulations with smaller droplet size and low viscosity have higher 
















































Table 4.12 Parameters of different NE to study the effect of the type of surfactant 








C1-P060 5 T80/S80 2 0.24 92.76 
C1-P062 5 T60/S60 2 0.24 92.76 
C2-P062 5 T40/S40 2 0.24 92.76 
C3-P062 5 T20/S20 2 0.24 92.76 
 
 
Figure 4.13 Effect of the different type of surfactant on skin permeation (mean ±SD n=3) 
4.3.5.2 Qualitative determination by using Micro CT  
Qualitative determination of the distribution of PCMX in the skin was performed using micro CT 
according to the method detailed in section 3.1.7.3. 
3D images in addition to a video were recorded, and the video shows 3D motion for PCMX NE through 
the skin samples and screenshots were captured in the sagittal plane video with 3-second intervals. The 














































Two formulations were studied, C1-P061 and C2-P062 and results are shown in figures 4.15 and 4.16, 
respectively. 
As mentioned in section 3.2.6.2 and seen in Figure 3.28, when the skin sample did not have any 
formulation and using the false-colouring technique, only one colour appeared, therefore, indicating a 
similar density throughout the sample. In Figure 4.14 and Figure 4.15, two colours are present in the 
sample after using false-colouring, this indicates the presence of PCMX within the skin.  
Figure 4.14 with the C1-P061 formulation showed a larger area of red than in Figure 4.15 with the C2-
P061 formulation meaning a higher amount of PCMX in the C1-P061 sample. Therefore, this sample is 
thought to have higher levels of penetration through the skin; the same conclusion was found in the 
quantitative evaluation using the tape-stripping method.  
 
Figure 4.14 screenshots from video every 3 seconds of skin sample with C1-P061 formulation (blue; skin, red; 






Figure 4.15 screenshots from video every 3 seconds of skin sample with C2-P061 formulation (blue; skin, red; 






4.3.5.3 Comparison of penetration of PCMX nanoemulsion in 
human and porcine skin 
As mentioned in section 2.1.5.1, porcine skin is considered a suitable model for human skin but selected 
studies were repeated using human skin (Table 4.13 and Figure 4.16) From Figure 4.16, the high 
similarity between both skin samples was shown, however, the permeation of the drug in the porcine 
sample was slightly higher than that in the human sample. This could be due to a slightly higher density 
of pores in the porcine sample. 











C1-P061/human skin 5 T80/S80 0.4 0.24 94.56 
C1-P061/Pig skin 5 T80/S80 0.4 0.24 94.56 
 
 












































4.3.5.4 The optimum formulation 
Through the studies for finding the effect the amount and type of surfactants have on the penetration of 
PCMX through the skin, the lowest amount of surfactant was found to have the highest penetration 
levels. This is similar to the results found when studying the effect of the amount of surfactant on the 
penetration of triclosan through the skin where the highest penetration was also found with the lowest 
amount of surfactant. Therefore both results support the suggested hypothesis claiming that the lowest 
amount of surfactant results in the highest penetration level.  For PCMX nanoemulsion, the 
concentration and combinations of surfactants resulting in highest penetration were 0.4% surfactant 
and T80/S80; C1/P061 formulation. These results are shown in Figure 4.17, and Table 4.14 shows the 
variables for the formulations tested.  
 









Dettol® ---- ---- ---- 0.24 99.50 
C1-P060 5 T80/S80 2.0 0.24 92.76 
C1-P062 5 T60/S60 2.0 0.24 92.76 
C2-P062 5 T40/S40 2.0 0.24 92.76 
C3-P062 5 T20/S20 2.0 0.24 92.76 
C2-P061 5 T80/S80 5.0 0.24 89.76 
C1-P061 5 T80/S80 0.4 0.24 94.56 







Figure 4.17 Graph of all PCMX formulations (mean ±SD n=3) 
 
4.4 Conclusion  
In conclusion, high-shear homogenisation followed by ultrasonication was a successful method for the 
design and development of a PCMX NE. Various parameters and variables were studied for this NE, 
including MDS, PDI, ZP, pH and viscosity. Several types and amount of surfactant were investigated to 
find the optimum formulation, the effect of the amount of oil was also explored and other factors that 
were tested include the sonication time, mixing time and mixer speed of the high-shear homogeniser. 
An accelerated and long-term stability study was carried out for all formulations over three months. 
The results showed that the formulation with the lowest amount of surfactant was found to be 



















































The use of the tape-stripping method was successful in quantitatively determining the PCMX within the 
skin, and the micro CT scan was successful in the qualitative determination, which confirmed what tape 










5 Chapter 5-Hansen solubility parameters (HSPs) as a tool to predict 
miscibility of nanoemulsion formulations with artificial sebum  
5.1 Introduction 
The hair follicle is considered an important route for delivering drugs into and through the skin. 
However, there are some difficulties associated with this route such as the presence of sebum which 
prevents the formulation from reaching the target site. It is therefore important to study the miscibility 
of the formulation with the sebum. 
In this chapter, HSPs are used to predict the miscibility of nano-formulations with artificial sebum, and 
for this to be achieved the HSP for artificial sebum was calculated using three different methods: 
contribution group method (Van Krevelen method), Y-MB method using HSPiP software and the third 
method using the solubility and miscibility of known HSPs and regression statistics.  
The miscibility of nano-formulations with artificial sebum was then studied using their HSPs values using 
a miscibility equation according to Greenhalgh approaches. 
5.2 The composition of artificial sebum and similarity with human 
sebum 
The composition of triglycerides and fatty acids in sebum varies from one human to another and varies 
over time due to triglyceride degradation and these changes lead to differences in the exact human 
sebum composition from site to site, person to person as well as temporally. Thus, the average human 
sebum composition as obtained by Valiveti (2008) was used to formulate artificial sebum as shown in 
Figure 5.1. In artificial sebum, the wax esters in the human sebum were replaced by a paraffin wax and 
spermaceti wax. Triglycerides in the human sebum were substituted with olive oil, cottonseed oil and 
coconut oil, having carbon chain lengths of fatty esters similar to components in serum(Valiveti, Wesley 





The extent of triglyceride degradation which takes place during the secretion of sebum from the 
sebaceous glands up towards the surface of the skin is the reason for the variation in the percentage of 
fatty acids in human sebum. There are no fatty acids in the sebum that is secreted from the glands while 
levels can reach up to 45% fatty acids content when the sebum reaches the surface of the skin. Since the 
sebum of most relevance in this study is in the upper duct of the hair follicle, a 11% of fatty acid was 
incorporated into the artificial sebum. 
Valiveti (2008) tested this artificial sebum in comparison with human sebum using DSC and NMR 
methods and established the similarity between the two. A high correlation was also found in the 
diffusion and partition property between the human sebum and the artificial sebum; this was achieved 
through the execution of partition and diffusion studies. In this study, this composition of artificial 
sebum was adopted to study the miscibility of nanoemulsion with it. 
 
Figure 5.1 The composition of artificial sebum (Valiveti, Wesley and Lu, 2008) 
5.3 Overview of chemical bonds 
The calculation of HSPs is highly dependent on the energy of chemical bonds, therefore, to reach an 
understanding of HSPs a short summary of the various chemical bonds and interactions between atoms 





5.3.1 Intra-molecular bonds 
5.3.1.1 Covalent bonds 
When two atoms with equal electronegativity share one or more electrons, a pure covalent bond is 
formed between them. An example of this is the hydrogen molecule which has two atoms of hydrogen 
sharing an electron, and since both have the same electronegativity, it is shared equally between them. 
Whereas if the two atoms have differing electronegativity and the difference in electronegativity is less 
than 1.7, the covalent bond will be a polar covalent bond. In this case, the shared electron will be closer 
to the atom with higher electronegativity and give the atom a small negative charge, whereas the other 
atom is given a small positive charge, this is known as the electric dipole. An example of this is the water 
molecule in which the oxygen atom has a higher electronegativity than the hydrogen atom and the bond 
between them is a polar covalent bond (Manning, 2009). 
5.3.1.2 Ionic bonds 
This type of bond is formed between two atoms with large and clear differences in electronegativity 
between both atoms. An example of this difference is found between alkali metals of Group 1 of the 
periodic table which easily lose electrons and halogens of Group 17 which are likely to gain electrons, 
and a strong ionic bond is usually formed as a result, and an example of this bond is sodium chloride 
(NaCl). The ionic bond is considered the strongest bond and a very large amount of energy is needed to 
break this bond; this explains the reason behind the very high melting point for materials with this bond. 
The strength of the bond is variable based on the difference in electronegativity between the two atoms 
(Manning, 2009).  
5.3.2 Inter-molecular bonds 
5.3.2.1 Van der Waals interactions 
This type of bond connects between two dipole molecules, where the small positive charge of the first 





interactions have a clear effect on liquids, but also affect solids and gases, although the effect is much 
reduced. An example of this is the bond that connects hydrogen chloride, the HCl molecules align 
themselves in a way that the positive end of one molecule is close to the negative end of the other 
molecule, and this configuration, known as a Van der Waals interaction, results in an intermolecular 
force which holds two molecules together. 
Van der Waals interactions are weak interactions where HCl is a gas at room temperature and changes 
to liquid at -85°C and freezes at -114°C (Manning, 2009). 
 
Figure 5.2 Molecules held together by dipoles (Manning, 2009) 
 
5.3.2.2 Hydrogen bonds 
The energy required to dissociate the polar covalent bond of H-Cl is 431 kJ/mol, whereas only 3.3 kJ/mol 
is needed to break a dipole-dipole bond of the same compound (HCl – HCl) which is 130 times less than 
the energy required in a polar covalent bond, thus exemplifying the variation between the strength of 
bonds. However, the dipole bond between water molecules is stronger than that in hydrogen chloride 
molecules, where a 19 kJ/mol energy is required to break a dipole bond between two water molecules. 
This bond is called a hydrogen bond; a hydrogen bond is formed as a result of the ability of a hydrogen 





oxygen and nitrogen, and that explains why water has a higher boiling point (100°C) in comparison with 
hydrogen chloride (-85 °C) (Manning, 2009). 
5.4 Overview of Hansen Solubility Parameters (HSP) and miscibility 
theory 
The first scientists who worked on the concept of development of a solubility parameter (δ) were 
Hildebrand and Scott, followed by Hansen who developed his theory in 1967. 
In 1950, Hildebrand and Scott proposed a theory stating that the chemical and physical interaction for 
every material is basically energy, which can be calculated in different ways, and is called cohesion 
energy. Dividing this cohesion energy by molar volume, (i.e. the volume occupied by one mole of 
substance at a given temperature and pressure, and the unit is m3/mol) for any material will yield a 
cohesion energy density, which can be represented by the solubility parameter (δ). Materials that have 
the same δ values would be miscible, according to the basic rule “like dissolves like” (Hildebrand and 
Scott, 1950). However, one of the most important limitations of the Hildebrand parameter was that it 
was based on a single parameter (i.e. total cohesive energy) whereas the Hansen solubility parameter 
(HSP), which was developed from the Hildebrand parameter, uses the individual components of the 
total cohesive energy. For example, epoxies are not soluble in nitromethane or butanol, although both 
have the same value (δ) Hildebrand parameters. A 50:50 blend of these two solvents, however, is a good 
solvent for epoxies and this is effortlessly clarified by Hansen parameters and is not explained with 
Hildebrand (Abbott, Hansen and Yamamoto, 2013) 
The Hansen solubility parameter (HSP) model consists of three important types of interaction, one at the 
atomic level and two at molecular levels. The atomic one is dispersion cohesive energy, (ED), like van der 
Waals interactions which are found in any molecule, as a molecule is built from atoms. The second type 





third important one, a hydrogen bonding cohesive energy (EH), is a type of polar force, and it is also 
referred to as an electron exchange parameter (Hansen, 1967). There are more types of energy such as 
ionic energy, or electrostatic interactions, that may play a role, but the three energies mentioned above 
are the major ones.  
There are a lot of applications for HSP in different fields like coating,  paints and plastics manufacturing 
(Krauskopf, 1999). Also, HSPs have been considered a vital criterion to check the miscibility of a drug 
with excipients and carriers in solid dispersions (Greenhalgh et al., 1999). Furthermore, HSPs have been 
broadly used to anticipate liquid-liquid miscibility, miscibility of polymer mixes, surface wettability, and 
the adsorption of colours to surfaces (Hansen, 2014). This study aims to predict the miscibility of 
different materials in artificial sebum according to their HSP values. 
 
5.4.1 Theory and miscibility models 
Thermodynamics can determine if a reaction is possible or not. For example, sodium chloride dissolves 
in water because the solvated sodium and chloride ions are thermodynamically more stable than 
crystalline form. Conversely, barium sulfate is insoluble in water because its crystals are 
thermodynamically more stable than the ionized form.  Kinetics describes how quickly the reaction 
proceeds if it is thermodynamically possible. The strength of HSPs is that they are based on 
thermodynamics. They are about whether reactions are fundamentally possible or not (Abbott, Hansen 
and Yamamoto, 2013). To consider whether a solute dissolves in a solvent, it is necessary to compare 
two energy losses with one energy gain, and in the case where the gained energy is greater than energy 
loss, then the solute will dissolve in a solvent. 
Some physicochemical properties of a material can be determined using the solubility parameter which 





point of a material (Hancock, York and Rowe, 1997). The cohesive energy is considered to be the sum of 
a number of forces holding the material together, as well as the energy required to break these forces 
within the atoms and molecules of a material, the main forces being van der Waals interactions, 
covalent bonds and hydrogen bonds (Hancock, York and Rowe, 1997). To calculate the solubility 
parameter (δ), the cohesive energy density (CED) which is the cohesive energy per unit volume is used; 
this is accomplished based on regular solution theory and can only be used in non-polar systems 
(equation 5.1),  (Mohammad, Alhalaweh and Velaga, 2011): 
δ = (CED)0.5 = ( 
∆EV
Vm
)0.5 Equation 5.1 
∆EV : Energy of vaporization 
 Vm : Molar volume 
 δ: Solubility parameter,  measured in units of (J/cm3)0.5, MPa0.5 or (cal/cm3)0.5 
1 (cal/cm3)0.5 = 2.0421 MPa0.5 or (J/cm3)0.5. 
One of the most important attempts made to develop the previous approach was to extend the 
approach to include polar systems and strongly interacting species using an HSP theory.  This theory 
proposes that the total force of the interactions can be split into partial solubility parameters 
representing the possibility of intermolecular interactions between similar or different molecules; these 
partial solubility parameters are: dispersion (δd), polar (δp) and hydrogen bonding (δh). The total 
solubility parameter (δt) which is also known as the three-dimensional solubility parameter, can be 
calculated using the following equation (equation 5.2): 
                       Δδt = (δd
2 + δP
2 + δh
2)0.5 Equation 5.2 
Multiple methods have been used to estimate the HSPs of materials using both theoretical approaches 





experimental approaches such as using inverse gas chromatography (IGC), solubility and miscibility with 
compounds with already known values of δ.   The most regularly used theoretical method is the group 
contribution method, and this merely requires knowledge of the compound’s chemical structure to 
calculate the HSP (Hansen, 2014; Subrahmanyam, Prakash, & Rao, 1996).  
According to the principle of ‘like dissolves like’, Van Krevelen and others had found compounds with 
similar δ values are likely to be miscible. Van Krevelen and Hoftyzer determined the miscibility of two 
compounds using the 

  factor, which can be calculated using equation 5.3: 
( ) ( ) ( )  5.0212212212 hhppdd  −+−+−=  Equation 5.3 
 
 Van Krevelen and Hoftyzer found that to accomplish good miscibility between liquids, the 

 should 
be less or equal 5 MPa0.5 (Van Krevelen, 1997; Güner, 2004). Subsequently, Bagley and co-workers found 
a volume-dependent solubility parameter (δv) which is described by equation 5.4  
( ) 5.022 pdv +=  Equation 5.4 
Because they found the effect of δd and δp are thermodynamically similar, therefore )(vaR  the miscibility 
of two compounds, can be calculated using the following (equation 5.5): 
Equation 5.5 
 
It can be plotted in two dimensions,  δv against δh (Breitkreutz, 1998). According to Albers, studies have 
suggested that if Ra(v) is less or equal to 5.6 MPa0.5  the two compounds will be miscible (Albers, 2008). 





Greenhalgh et al. (1999) also described another method to calculate miscibility depending on the 
differences between the total solubility parameters (Equation 5.6)   
 
∆δt = |δt1 − δt2| Equation 5.6 
Where t1 and t2 are solvent and drug, respectively. It was found that if ∆δt was less than 7 MPa
0.5 the 
two compounds would be miscible, and if it is greater, then they would not be miscible (Greenhalgh et 
al., 1999). 
In this study, HSPs of components of artificial sebum and antiseptic compounds were calculated by three 
different theoretical methods (the Van Krevelen–Hoftyzer method, Yamamoto-Molecular Break (Y-MB) 
using HSPiP software and using a multiple regression model), and then the miscibility was checked 
according to three scientific approaches (Van Krevelen–Hoftyzer, Bagley, and Greenhalgh). Finally, the 
miscibility was determined experimentally using HPLC to determine the amount of active in sebum.  
5.5 Methods to calculate Hansen solubility parameters (HSPs) 
Unfortunately, researchers have not yet developed a direct method to determine the value of the 
component of HSPs  δd, δp, δh, so the researchers endeavoured to calculate these values using 
complicated methods, some theoretical and other experimental methods. 
5.5.1 Theoretical methods in calculating HSPs 
The theoretical methods for calculating HSPs are based on the tables of group contributions which were 
found using the theory that states that large molecules with complicated compositions can be divided 
into smaller sections with known HSPs values and the HSPs for the whole material can, therefore, be 
calculated by adding these sections together (Scott, 1992). Consequently, it is only necessary to know 





be determined. As the chemical structure of most compounds is widely known it is therefore not 
difficult to determine HSPs using these methods.  
The values of the group contributions may vary between studies due to the use of different methods for 
calculation. Figure 5.3 shows some of the important group contributions as calculated by various 
researchers. 
 





5.5.1.1 Small method 
In 1953 a definition of molar attraction constant was proposed by Small which can be calculated using 
the following, (Equation 5.7). 
𝐹 = √(𝐸𝑐𝑜ℎ/𝑉(298 𝐾))   Equation 5.7 
 
5.5.1.2 Fedors method 
This method was published by Fedros in 1974, and the accuracy of this method was found to be lower 
than other methods. However, the advantage of it is that it included many functional groups (Hansen, 
2014). 
5.5.1.3 Hoftyzer- van Krevelen method 
Hoftyzer-van Krevelen based this method on the known values of polymers.  
In 1976 three relationships were established to calculate the partial HSPs;  δd, δp and δh using the group 





















































 Equation 5.10 







:  Group contributions to the dispersion forces 
 ip
F
: Group contributions to the polar forces  
 ih
E
: Group contributions to the hydrogen-bonding energy 
 i
V
 : Group contributions to the molar volume 
 
5.5.2 Experimental methods for calculating HSPs 
5.5.2.1 The heat of vaporisation method 
The heat of vaporisation of a material can be used to determine the total solubility parameters if the 
tested material is stable at a temperature higher than its boiling point. Therefore, the heat of 







  Equation 5.11 
However, this method can only be used for determining the total solubility parameters and cannot be 
used for pharmaceutical materials or excipients due to instability at high temperatures (Hancock, York 
and Rowe, 1997).  
5.5.2.2 Surface free energy 
Another method used to determine the solubility parameters of a material is to determine the 
material’s surface free energy as the surface free energy of material has been found to have a directly 







 Equation 5.12 





𝛾: surface free energy of the material 
n: constant relating to atom and molecule arrangement in space 
Therefore, using surface free energies, solubility parameters can directly be calculated. This method has 
been found to have a very good correlation with other approaches used to find solubility parameters 
and has consequently been commonly used for a broad number of pharmaceutical materials. Due to this 
direct relationship between a material’s surface free energy and its cohesive energy, it is, therefore, 
feasible to find a material’s solubility parameters through any approach that obtains the material’s 
surface energetic properties such as the contact angle analysis method (Hancock, York and Rowe, 1997). 
5.5.2.3 Inverse Gas chromatography 
The use of inverse gas chromatographic (IGC) is another method used to establish the solubility 
parameters for various liquids and solids. For this method, the retention times of gases of known 
cohesive energies are used. The solubility parameters for a large selection of pharmaceutical drugs and 
excipients have been calculated using this method (King, 1995). 
This method has been found to result in solubility parameters that are both precise and reproducible, 
however, it cannot be considered a true equilibrium method and a heterogeneous distribution of active 
sites on the stationary phase could influence the acquired results. It has also previously been suggested 
that the measured cohesive energy may be affected by the essential manipulation of the stationary 
phase and its extended exposure to carrier gases throughout the experiment. The infrequent differences 
that can be found between this IGC method and other more straightforward methods are most likely 
due to the higher sensitivity of this method to surface heterogeneities in comparison with methods 





5.5.2.4 Solubility and miscibility 
Another common method for finding the partial and total solubility parameters is through the 
determination of the miscibility and solubility of the materials in liquids; this is achieved using the 
known cohesive energies of these liquids. The liquid in which the tested material dissolves most 
completely and without involving heat or a change in temperature is obtained, and the solubility 
parameter of this liquid is accepted as the solubility parameter of the tested material. The directness 
and practicality of this method in addition to its possible application to gases, liquids and solids have led 
to this being a very common and well-known approach (Hancock, York and Rowe, 1997). This method 
has also been used for a few pharmaceutical film-coating polymers by Archer as the solubility 






5.6 Aim and objectives 
This chapter aims to predict the miscibility of the antiseptic nanoemulsion formulations with artificial 
sebum. As mentioned in the introduction, the hair follicle is considered one of the most important 
routes to deliver the drug within and through the skin and the presence of sebum may obstruct this 
route. Therefore, it is important to know the miscibility of the drug to find out whether the drug will 
reach the target site. To achieve this, HSPs were used as a tool to determine whether the antiseptic 
nanoemulsion formulation is miscible with sebum.  
The objectives of this chapter to accomplish the mentioned aim include: 
 
• To calculate the sebum’s HSPs using three different methods: 
a. Hoftyzer- Van Krevelen group contribution method 
b. Y-MB method using HIHSP software 
c. Using regression statistics to calculate HSPs of sebum from different chemical 
compounds with known HSP that are soluble within it 
 
• To calculate HSPs for triclosan and PCMX using two method methods; 
a.  Hoftyzer- Van Krevelen group contribution method 
b. Y-MB method using HIHSP software 
 






5.7 Results and Discussion 
5.7.1 Hansen Solubility Parameter calculations for antiseptic 
compounds and artificial sebum 
As mentioned in the introduction, targeting the HF is a promising potential pathway for dermal and 
transdermal delivery. However, one of the biggest obstacles restricting this route is the presence of 
sebum, the oily secretion from sebaceous glands that fills the hair follicle and can prevent particles 
reaching the target site in the hair follicle.  This study was carried out to investigate the miscibility of 
artificial sebum with antiseptic nanoemulsion formulations containing triclosan and PCMX. The HSPs for 
artificial sebum were calculated using three methods, and one of the methods was calculated using 
regression statistics via the solubility of different chemical structures known as δ in artificial sebum. The 
solubility of these chemical structures in artificial sebum was gathered from the literature (Valiveti & Lu, 
2007; Valiveti, & Lu, 2008)  and the HSPs were calculated. Table 5.1 shows the HSPs and solubility of 













water (µg/mL)  
Solubility in 
Sebum (µg/mL)  
Y-MB VKH 
ᵟD ᵟP ᵟH ᵟtol δD δP δH δTotal 
Ketoconazole 531.43 9111.28 22.17 201995.30 21.6 11.9 6.2 25.4 20.7 5.9 9.6 23.5 
Minoxidil 209.25 5.17 2483.87 12837.11 21.1 14.9 24.0 35.3 24.5 12.8 20.0 34.1 
Salicylic acid 138.12 3.17 6972.45 21613.29 19.6 8.3 15.1 26.1 20.6 6.2 16.8 27.2 
2,5-Dihydroxyl benzoic acid 154.12 2.11 23816.76 50251.76 20.6 9.5 18.8 29.4 20.6 7.1 20.7 30.1 
Lidocaine 234.34 192.43 23318.34 4487082.74 17.2 5.5 4.7 18.6 17.2 4.4 6.3 18.8 
Phenyl 4-hydroxybenzoate 214.22 91.93 23.19 2131.85 19.8 7.2 8.9 22.8 19.0 4.1 12.4 23.1 
4-Hydroxybenzoic acid 138.12 2.38 6531.03 15543.78 20.1 8.8 16.1 27.2 20.6 6.2 16.8 27.2 
Methyl 4-hydroxybenzoate 152.15 5.74 1641.05 9419.34 19.0 9.1 11.0 23.8 19.1 5.5 14.4 24.5 
Ethyl 4-hydrooxybenzoate 166.17 13.66 640.16 8743.76 18.6 8.5 10.0 22.8 18.8 4.9 13.6 23.7 
Propyl 4-hydroxybenzoate 180.20 51.96 245.65 12730.27 18.3 7.7 9.2 21.9 18.6 4.4 12.9 23.1 
Butyl 4-hydroxybenzoate 194.23 151.54 177.25 26852.88 18.2 7.3 8.1 21.2 18.5 4.0 12.3 22.5 
Amyl 4-hydroxybenzoate 208.25 471.18 103.16 48578.65 18.0 7.0 7.7 20.8 18.3 3.6 11.8 22.1 
Hexyl 4-hydroxybenzoate 222.20 1768.05 24.29 42945.93 17.9 6.5 7.3 20.4 18.2 3.4 11.3 21.7 
Heptyl 4-hydroxybenzoate 236.31 3818.15 11.45 43717.24 17.9 6.2 6.9 20 18.1 3.1 10.9 21.4 







5.7.1.1 Solubility parameters calculation of artificial sebum, 
antiseptics compounds using Hoftyzer –Van Krevelen group 
contributions 
Using the three equations of Hoftyzer –Van Krevelen (equations 5.8, 5.9, 5.10) to calculate the partial 
solubility parameters (δd, δp and δh) and Fedors table to determine the molar volumes, it was possible to 
determine HSPs for triclosan and the components of artificial sebum and the value of the group 
contributions according to Hoftyzer –Van Krevelen are shown in Figure 5.4. 
As mentioned in section 5.2, the triglycerides in human sebum were replaced with olive oil, cottonseed 
oil and coconut oil in artificial sebum and to calculate the HSPs for oils the composition of these oils 
should be determined Table 5.3 shows the composition of each oil.    
Table 5.2 and Figure 5.5 shows how HSPs were calculated for triclosan and for the components of 
artificial sebum (see appendix A). Table 5.3 shows the value of the HSPs for PCMX and all components of 















Figure 5.5 Chemical structure of triclosan 
 
 
Table 5.2 Calculation of HSPs and molar volume for triclosan according to the Hoftyzer-van Krevelen methods) 
 




= 5.20 MPa0.5 
 
 = 10.43 MPa0.5 
 
δt = (δD2 + δP2 + δH2)0.5 = 23.65 MPa0.5 











(o,m,p) phenylene 2 2540 24200 0 104.8 
ring 2 380 0 0 32 
-Cl 3 1350 907500 1200 72 
-OH 1 210 250000 20000 10 

























































Table 5.3 Calculated HSPs for PCMX and artificial sebum components according to Hoftyzer –Van Krevelen methods 
  
Oil composition VK-H 
Fatty acids percentage 
molecular 
Volume 
δD δP δH δtol 
PCMX   153.49 18.06 4.90 11.53 21.98 
Squalene     477.05 16.11 0.00 0.00 16.15 
Oleic acid     314.40 16.32 1.39 5.60 17.32 
Palmitic acid     287.40 16.54 1.59 5.92 17.54 
Palmitoleic acid     282.28 16.33 1.53 6.00 17.41 
Cholesterol oleate     675.14 17.01 0.74 3.25 17.44 
Cholesterol     381.22 17.75 1.32 7.26 19.16 
Coconut oil (C12–
16)(ZAMBIAZI, 2007)  
Lauric acid 45.46 223.04 16.37 1.88 6.70 17.78 
Myristic acid 18.82 255.25 16.42 1.65 6.26 17.65 
Palmitic acid 10.08 287.47 16.53 1.51 5.97 17.54 
Caprylic acid 6.38 158.65 16.20 2.65 7.94 18.24 
Capric Acid 5.56 190.87 16.30 2.20 7.24 17.97 
Stearic acid 4.31 319.68 16.53 1.33 5.63 17.53 
Arachidic acid 0.08 351.89 16.51 1.24 5.34 17.42 
Oleic acid 7.45 314.40 16.37 1.35 5.63 17.36 
Linoleic acid 1.80 309.24 16.14 1.36 5.69 17.16 
gadoleic acid 0.06 346.62 16.36 1.21 5.37 17.26 
Cotton seed oil 
(C16–C18)(Carlos 
Zambiazi et al., 2007)  
Palmitic acid 21.87 287.44 16.53 1.52 5.91 17.57 
Stearic acid 2.27 319.62 16.56 1.35 5.63 17.53 
Myristic acid 0.77 255.25 16.42 1.65 6.26 17.65 
behenic acid 0.36 384.03 16.54 1.10 5.10 17.31 
Arachidic acid 0.26 351.84 16.55 1.24 5.33 17.43 
Lignoceric acid 0.12 416.27 16.67 1.02 4.92 17.35 
Margaric acid 0.08 303.59 16.52 1.44 5.73 17.56 
Linoleic acid 56.35 309.22 16.14 1.36 5.69 17.16 
Oleic acid 16.61 314.49 16.33 1.31 5.65 17.38 
Palmitic acid 0.47 282.22 16.34 1.53 6.06 17.41 
Linolenic acid 0.33 304.09 15.95 1.38 5.74 17.01 
Nervonic acid 0.16 411.00 16.42 1.02 4.93 17.18 
gadoleic acid 0.14 346.66 16.36 1.21 5.37 17.26 
Myristoleic 
acid 
0.11 250.00 16.20 1.68 6.32 17.47 
eicosadienoic 
acid 
0.10 341.43 16.20 1.23 5.41 17.12 
Olive oil (C16–
18)(Carlos Zambiazi 
et al., 2007)  
Palmitic acid 10.84 287.44 16.52 1.5 5.92 17.55 
Stearic acid 3.59 319.65 16.54 1.3 5.63 17.57 
Arachidic acid 0.50 351.81 16.55 1.2 5.34 17.42 
behenic acid 0.15 384.03 16.57 1.1 5.15 17.37 
Margaric acid 0.14 303.55 16.57 1.4 5.72 17.52 
Lignoceric acid 0.12 416.23 16.62 1.0 4.96 17.37 
Oleic acid 75.55 314.46 16.35 1.3 5.62 17.31 
Linoleic acid 7.01 309.27 16.14 1.36 5.69 17.16 
Palmitic acid 0.92 282.24 16.35 1.5 6.03 17.48 
Linolenic acid 0.66 304.05 15.95 1.38 5.74 17.01 
gadoleic acid 0.32 346.62 16.36 1.21 5.37 17.26 
Myristoleic acid 0.21 250.00 16.20 1.68 6.32 17.47 
docosadienoic 
acid 





5.7.1.2 Calculation of artificial sebum and antiseptic solubility 
parameters using Y-MB methods 
To calculate an HSP for artificial sebum component and antiseptics according to Y-MB method, HSPiP 
(Hansen Solubility Parameters in Practice) software was used. The HSPiP was developed by Steven 
Abbott, Charles M. Hansen and Hiroshi Yamamoto. It has more than 10,000 chemical compounds in the 
dataset. To calculate a partial solubility parameter of any chemical compound, the structure is entered 
in SMILES format (e.g. www.chemspider.com). This method is fast and accurate. One of the limitations 
of this method however, is that it is not suitable for large molecules such as large polymers (more than 
120 atoms). The way that is used to overcome this limitation is to split the molecules to two regions 
(Abbott, Hansen and Yamamoto, 2013). Table 5.4 shows the HSPs for triclosan, PCMX and components 






Table 5.4 HSPs for Triclosan, PCMX and artificial sebum components according to Y-MB method. 
  
Oil composition Y-MB 
Fatty acids percentage δD δP δH δtol 
Triclosan   21.2 7.0 8.3 23.8 
PCMX   18.8 4.1 8.8 19.2 
Squalene     17.0 0.9 3.1 17.3 
Oleic acid     16.4 3.0 5.5 17.6 
Palmitic acid     16.2 3.3 5.8 17.5 
Palmitoleic acid     16.5 3.4 6.3 18.0 
Cholesterol oleate     17.2 1.0 1.7 17.3 
Cholesterol     17.2 2.1 3.9 17.7 
Coconut oil (C12–
16)(Carlos Zambiazi 
et al., 2007) 
Lauric acid 45.46 16.3 4.0 7.5 18.3 
Myristic acid 18.82 16.3 3.3 6.6 17.8 
Palmitic acid 10.08 16.2 3.3 5.8 17.5 
Caprylic acid 6.38 16.3 5.2 10.1 19.8 
Capric Acid 5.56 16.3 4.2 8.6 18.9 
Stearic acid 4.31 16.2 2.8 5.2 17.2 
Arachidic acid 0.08 16.1 2.7 4.7 17.0 
Oleic acid 7.45 16.4 3.0 5.5 17.6 
Linoleic acid 1.8 16.7 3.1 6.1 18.0 
gadoleic acid 0.06 16.4 2.9 5.1 17.4 
Cotton seed oil 
(C16–C18)(Carlos 
Zambiazi et al., 
2007) 
Palmitic acid 21.87 16.2 3.3 5.8 17.5 
Stearic acid 2.27 16.2 2.8 5.2 17.2 
Myristic acid 0.77 16.3 3.3 6.6 17.8 
behenic acid 0.36 16.2 2.3 4.3 16.9 
Arachidic acid 0.26 16.1 2.7 4.7 17.0 
Lignoceric acid 0.12 16.1 2.4 3.9 16.7 
Margaric acid 0.08 16.2 2.8 5.4 17.3 
Linoleic acid 56.35 16.7 3.1 6.1 18.0 
Oleic acid 16.61 16.4 3.0 5.5 17.6 
Palmitic acid 0.47 16.5 3.4 6.3 18.0 
Linolenic acid 0.33 16.9 3.3 5.8 18.2 
Nervonic acid 0.16 16.3 2.2 4.2 17.0 
Gadoleic acid 0.14 16.4 2.9 5.1 17.4 
Myristoleic acid 0.11 16.5 3.6 6.9 18.3 
eicosadienoic acid 0.1 16.6 2.8 5.3 17.6 
Olive oil (C16–
18)(Carlos Zambiazi 
et al., 2007) 
Palmitic acid 10.84 16.2 3.3 5.8 17.5 
Stearic acid 3.59 16.2 2.8 5.2 17.2 
Arachidic acid 0.5 16.1 2.7 4.7 17.0 
Behenic acid 0.15 16.2 2.3 4.3 16.9 
Margaric acid 0.14 16.2 2.8 5.4 17.3 
Lignoceric acid 0.12 16.1 2.4 3.9 16.7 
Oleic acid 75.55 16.4 3.0 5.5 17.6 
Linoleic acid 7.01 16.7 3.1 6.1 18.0 
Palmitic acid 0.92 16.5 3.4 6.3 18.0 
Linolenic acid 0.66 16.9 3.3 5.8 18.2 
gadoleic acid 0.32 16.4 2.9 5.1 17.4 
Myristoleic acid 0.21 16.5 3.6 6.9 18.3 





5.7.1.3 Calculation of artificial sebum using multiple regression 
model 
The HSPs of artificial sebum were calculated by using a multiple regression model, and an equation was 
used to predict the partition coefficient of a drug between two solvents (Equation 5.13) (Al balkhi et al., 











































































𝑊]𝑋2 + 𝐶 
 
Where 𝑉𝑚 is the molar volume, T is the temperature (in degrees Kelvin), R is the gas constant, and 
superscripts S, W, D indicate sebum, water, and the drug, respectively. Positive values of 𝑙𝑛𝐾𝑆𝑊 mean 
that the concentration of the drug in sebum is higher than in water; the higher the value, the higher the 
concentration of the drug in sebum compared to water.  
















for different chemical compounds 




δTotal(J/cm3) 0.5 Vm * δTotal δTotal(J/cm3) 0.5 Vm * δTotal 
Ketoconazole  9111.24 9.18 396.70 25.43 10076.18 23.55 8184.79 
Minoxidil 5.17 1.64 162.68 35.35 5739.78 34.16 3967.35 
Salicylic acid  3.14 1.13 106.64 26.16 2782.26 27.28 2912.99 
2,5-Dihydroxyl benzoic acid 2.11 0.75 108.12 29.43 3178.14 30.13 3513.06 
Lidocaine  192.43 5.26 231.99 18.66 4313.34 18.85 4839.54 
Phenyl 4-hydroxybenzoate  91.93 4.52 175.83 22.87 4008.24 23.17 4029.06 
4-Hydroxybenzoic acid  2.38 0.86 105.99 27.23 2880.48 27.29 2912.99 
Methyl 4-hydroxybenzoate  5.74 1.74 128.73 23.82 3063.06 24.52 3187.46 
Ethyl 4-hydrooxybenzoate  13.66 2.61 146.35 22.87 3335.64 23.74 3465.07 
Propyl 4-hydroxybenzoate  51.96 3.95 163.49 21.97 3578.46 23.17 3741.56 
Butyl 4-hydroxybenzoate  151.54 5.02 180.62 21.28 3828.72 22.54 4017.17 
Amyl 4-hydroxybenzoate  471.18 6.16 196.38 20.82 4083.04 22.13 4292.07 
Hexyl 4-hydroxybenzoate  1768.05 7.48 213.06 20.41 4345.26 21.72 4566.38 
Heptyl 4-hydroxybenzoate  3818.10 8.24 229.54 20.09 4590.08 21.48 4840.22 





𝑙𝑛𝐾𝑆𝑊   can be considered a dependent variable and 𝑉𝑚


















𝑊) according to each method ( Y-MB and VK-H) were 
determined as shown in Table 5.6, and according to Hansen, the solubility parameter for water is 
18.1,17.1,and 16.9 (δd), (δp) and (δh) respectively (Hansen, 2014). From Equation 5.2 the total solubility 






𝑤 = ((18.1)2 + (17.1)2 + (16.9)2)0.5 
δ𝑡
𝑤 = 30.09 MPa0.5 
Table 5.6 Output of Regression statistics 
Y-MB VK-H 
















-1.5917 0.068142895 -0.00151789 0.87 2.717264 0.11079928 -0.00443946 0.87 
 
For the Y-MB method, the value of the total solubility parameter of artificial sebum is: 
As shown in Equation 5.13 Ln ksebum is multiplied by RT so the value of the output of regression statistics 

























𝑆 = 27.1 
(2𝛿𝑡
𝑆 − 2𝛿𝑡
𝑊) =  −0.00151789 (8.314 ∗ 298.15 ) 
2𝛿𝑡
𝑆 = 2𝛿𝑡
𝑊 − 3.76258 
2𝛿𝑡
𝑆 = 56.4174 
𝛿𝑡
𝑆 = 28.2 
So, the values of both ways are close. 




















𝑆 = 25.1 
(2𝛿𝑡
𝑆 − 2𝛿𝑡
𝑊) =  −0.00443946 (8.314 ∗ 298.15 ) 
2𝛿𝑡
𝑆 = 2𝛿𝑡
𝑊 − 11.0046 
2𝛿𝑡
𝑆 = 49.17538 
𝛿𝑡
𝑆 = 24.6 
The total solubility parameters by using this method are 27.1, 28.2 for Y-MB method and 25.1, 24.6 for 
VK-H method, which shows a relatively similar value as the previous methods. And as R2 of regression 
statistics was 0.87 (table 5.6) that explain the difference value of 𝛿𝑡





5.7.2 Limitations in the calculation of HSPs for artificial sebum 
components 
One of the main challenges in this study was the calculation of HSPs for paraffin wax, and spermaceti 
wax (the wax esters in artificial sebum, see Figure 5.1). As these are natural products, their constitution 
tends to be complex and variable. Exact compositions have not been defined for either paraffin wax or 
spermaceti wax, except one paper which claimed that paraffin comprised 67 different compounds, but 
these were not identified (Levy, 1961). Determination of the composition of paraffin wax or spermaceti 
wax would require column chromatography to separate the components, then NMR spectroscopy to 
define the components, thereafter HPLC to know the percentage of each component, and this is beyond 
the scope of this project and the value is somewhat limited. Therefore, HSPs of paraffin wax and 
spermaceti wax were estimated using IGC (section 2.1.6 Inverse gas chromatography) (Adamska and 
Voelkel, 2005). Table 5.7 shows the HSPs of paraffin wax and spermaceti wax determined using IGC.  
 
Table 5.7 The HSPs of paraffin wax and spermaceti wax by using IGC method 
 δD δP δH δTotal 
Paraffin wax 55.78 18.80 4.08 59.01 
Spermaceti wax 47.58 9.82 6.80 49.05 
 
The calculation of HSPs is based on the experimental retention data of test solutes called probes and the 
targeted material. More specifically, measured retention volumes using IGC can be used to calculate 
Flory-Huggins interaction parameters (𝜒1,2
∞ ). Subsequently, the total solubility parameter (𝛿𝑇) and its 
components, dispersive (𝛿𝐷), polar (𝛿𝑃), and hydrogen bonding (𝛿𝐻) can be determined. The selection 
of test probes is crucial in measuring solubility parameters using IGC as each type of solvent represents a 





IGC was firstly reported by Price et al. (1986). Several researchers have reported solubility parameter 
calculations using IGC measurement data(Price, Guillet and Purnell, 1986; Voelkel and Fall, 1996; 
Adamska and Voelkel, 2005). 
𝜒1,2
∞  can be calculated using retention volume measured at infinite dilution after being transformed into 
a mass activity coefficient using equation 5.15: 








  Equation 5.15 
Where Ω∞ is the mass activity coefficient. Vr  is the retention volume, 𝑝1
0, V1, and M1 are saturation 
pressure, molecular mass, and molecular volume of the probe molecule. B11 is the second virial 
coefficient.  B11 value was calculated using Guggenheim and McGlashan approach (McGlashan and 
Wormald, 1964). Then 𝜒1,2
∞  can be calculated using the following equation 5.16: 
𝜒1,2
∞ = 𝑙𝑛 Ω∞ + 𝑙𝑛 (
𝜌1
𝜌2
) − (1 −
𝑉1
𝑉2
) Equation 5.16 
Where 𝜌1, and 𝜌2 are true densities of the probe and sample, respectively. 𝑉1 and 𝑉2 are the molecular 
volume of probe and sample, respectively. Finally, the calculation of solubility parameter was performed 



















) Equation 5.17 
Where 𝛿1, and 𝛿2 are solubility parameter of test probe, and sample, respectively. 𝜒1,2
∞  is Flory-Huggins 
parameter, 𝑉1 is the molecular volume of probe. 𝜒𝑠
∞, is the entropic contribution of the Flory-Huggins 





















  Equation5.18 
Whereas, aromatic hydrocarbons, ketones, or nitropropanes were selected for determination of the 




  Equation5.19 
 




  Equation5.20 








) vs. 𝛿1 from DiPaolo and Guillet 
equation calculated from retention volumes of n-alkanes, polar, and alcohol probes.  





5.7.3 Hansen Solubility Parameters of artificial sebum 
According to the composition of artificial sebum in Figure 5.1, HSPs of artificial sebum calculated using 
both VK-H and Y-MB methods are shown in Tables 5.8 and 5.9 respectively. These two methods show a 
similarity in partial solubility parameters, dispersion (δd), polar (δp) and hydrogen (δh). 
 
 
Table 5.8 HSPs of artificial sebum according to Hoftyzer –Van Krevelen method 





HSPs HSPs of artificial sebum 
δD δP δH δTotal δD δP δH δTotal 
Squalene 15 2.41 0 0 2.41 
24.94 4.21 4.91 26.13 
Oleic acid 1.4 0.22 0.01 0.07 0.24 
Palmitic acid 5 0.82 0.07 0.29 0.87 
Palmitoleic acid 5 0.81 0.07 0.29 0.86 
Cholesterol oleate 2.4 0.40 0.01 0.07 0.41 
Cholesterol 1.2 0.21 0.01 0.08 0.22 
Coconut oil (C12–16) 10 1.63 0.17 0.64 1.77 
Cotton seed oil (C16–C18) 25 4.06 0.34 1.43 4.32 
Olive oil (C16–18) 10 1.63 0.13 0.56 1.73 
Paraffin wax 10 5.57 1.88 0.41 5.90 




Table 5.9 HSPs of artificial sebum according to Yamamoto-Molecular Break method 





HSPs HSPs of artificial sebum 
δD δP δH δTotal δD δP δH δTotal 
Squalene 15 2.55 0.13 0.46 2.59 
25.08 4.57 5.31 26.32 
Oleic acid 1.4 0.22 0.04 0.07 0.24 
Palmitic acid 5 0.81 0.16 0.29 0.87 
Palmitoleic acid 5 0.82 0.17 0.31 0.90 
Cholesterol oleate 2.4 0.41 0.02 0.040 0.41 
Cholesterol 1.2 0.20 0.02 0.04 0.21 
Coconut oil (C12–16) 10 1.63 0.17 0.64 1.77 
Cotton seed oil (C16–C18) 25 4.06 0.34 1.43 4.32 
Olive oil (C16–18) 10 1.63 0.13 0.56 1.73 
Paraffin wax 10 5.57 1.88 0.40 5.90 







5.7.4 Miscibility of antiseptic with artificial sebum 
5.7.4.1 Theoretical miscibility of antiseptic with artificial sebum 
In this study, the miscibility of triclosan and PCMX with artificial sebum was calculated according to the 
Greenhalgh equation 5.6 with good miscibility having values of  ∆δt ≤ 7 MPa
0.5. Table 5.10 shows the 
miscibility results of triclosan and PCMX with artificial sebum and eucalyptol considering two 
methodologies VK-H and Y-MB. 
Table 5.10 the miscibility of triclosan and PCMX with artificial sebum considering two methodologies VK-H and Y-MB 
  Phase 1 Phase 2  
Miscibility 
tool 
  δd δp δh  δt δd δp δh  δt δtotal MPa0.5 
Triclosan_artificial 
sebum Y-MB 21.2 7.0 8.3 23.8 25.1 4.6 5.3 26.3 2.5 
Triclosan_artificial 
sebum VK-H 20.6 5.2 10.4 23.6 24.9 4.2 4.9 26.1 2.5 
Triclosan_ eucalyptol  
Y-MB 21.2 7.0 8.3 23.8 16.6 2.5 2.5 16.9 6.9 
Triclosan_eucalyptol  
VK-F 20.6 5.2 10.4 23.6 17.1 2.5 4.3 17.8 5.8 
PCMX_artificial sebum  
Y-MB 18.8 4.1 8.8 21.2 25.1 4.6 5.3 26.3 5.2 
PCMX_artificial sebum 
VK-H 18.1 4.9 11.5 22.0 24.9 4.2 4.9 26.1 4.2 
PCMX_ eucalylptol Y-MB 18.8 4.1 8.8 21.2 16.6 2.5 2.5 16.9 4.3 
PCMX_ eucalylptol VK-F 18.1 4.9 11.5 22.0 17.1 2.5 4.3 17.8 4.2 
 
 δtotal Using both methodologies VK-H and Y-MB, triclosan and PCMX are miscible with artificial sebum, 
being less than 7 MPa0.5 in all cases. The affinity of triclosan to be released from eucalyptol to artificial 
sebum higher than the affinity of PCMX as shown the value of δtotal for triclosan with artificial sebum is 
2.5 in both methods (VK-H and Y-MB) whereas the value δtotal for triclosan with eucalyptol is 6.9 and 
5.8 for VK-H and Y-MB respectively. This means triclosan will be released from nanoemulsion 
formulation (eucalyptol oil) into artificial sebum more easily than PCMX, although the affinity of both 





5.7.4.2 Experimental miscibility of antiseptic with artificial sebum 
The miscibility of triclosan and artificial sebum was determined experimentally.  Artificial sebum (14 mg) 
was combined with 1 ml of triclosan nanoemulsion in a vial. The vials were shaken for 15 h at 37 ºC, 
then centrifuged at 8000 rpm for 15 min, and the supernatant was analysed by HPLC. To measure how 
much of the amount of triclosan partitioned into artificial sebum, the amount of triclosan in the 
supernatant was subtracted from the amount in the initial triclosan nanoemulsion (Valiveti, Wesley and 
Lu, 2008). Two different formulations of triclosan nanoemulsion (Table 5.11) were studied, and the 
miscibility results are shown in Table 5.12.  
 
Table 5.11 Two formulations of triclosan nanoemulsion used in miscibility studies 
Formulation 
code 




F1-80 5 0.34% 1 94.16 
F3-80 5 5.00% 1 89.00 
   
 
 
Table 5.12 The results of miscibility of two triclosan formulations with artificial sebum 
  Triclosan concentration (µg/ml) 
 F1-80 7.47 
F1-80 + 14 mg artificial Sebum 0.72 
F3-80 12.94 
F3-80 + 14 mg artificial Sebum 3.31 
    
Table 5.12 confirmed the theory of the HSPs miscibility of triclosan and artificial sebum by moving the 
most amount of triclosan from nanoemulsion formulation to artificial sebum. In addition, it showed the 
formulation with a lower amount of surfactant (F1-80) was more miscible than the other formula (F3-
80). This can be attributed to the fact that increasing surfactant reduces miscibility, which may be 





was found in chapter 3 to be the optimum formulation. The same study was carried out using PCMX 
formulations to determine the miscibility of PCMX with artificial sebum. Table 5.13 shows the two 
different formulations of PCMX Nanoemulsions and table 5.14 shown the miscibility results   
Table 5.13 Two formulations of PCMX Nanoemulsion used in miscibility studies 
Formulation 
code 




C1/P061 5 0.4% 0.24 94.56 
C1/P060 5 2.0% 0.24 92.76 
 
Table 5.14 The results of miscibility of two PCMX formulations with artificial sebum 
  PCMX concentration (µg/ml) 
C1/P060 35.11 
C1/P060+ 14 mg artificial Sebum 2.81 
C1/P061 32.67 
C1/P061+ 14 mg artificial Sebum 2.58 
 
The difference in miscibility was not as clear as the in triclosan formulations as the difference in the 
amount of surfactant in PCMX formulations was lower than the triclosan formulations. However, there 
is a difference which that supports the theory that the multilayer of surfactant decreases the amount of 






To calculate the HSPs for the artificial sebum, the HSPs for its components were calculated, and to 
validate these results; three various methods were used; VK-H method using contribution group 
method, Y-MB using HSPiP software and the third method using regression statistics with different 
soluble chemical compounds in artificial sebum with known HSPs. 
In the first two methods, the components of HSPs δd, δp and δh were calculated. 
The results are 24.94, 4.21, 4.91, 25.08, 4.57, 5.31 MPa0.5 for the VK-H method and Y-MB method, 
respectively. 
In a third method, the total HSPs for the artificial sebum were calculated, this method showed similar 
results to the total HSPs found using the first two methods (26.13,26.32 VK-H method and Y-MB 
methods respectively).   
The miscibility of the antiseptic with the artificial sebum was then calculated in accordance to the 
Greenhalgh equation; the results showed the affinity of triclosan to be released from eucalyptol to 
artificial sebum, whereas the affinity of PCMX was less than that of triclosan. 
These results were confirmed experimentally and showed the miscibility between antiseptic compounds 
and artificial sebum.  






6 Chapter 6- General Conclusion and Future Work 
Infections resulting from surgery and other medical incisions of the skin generally known as healthcare-
associated infections (HAIs), these types of infections have detrimental effects on healthcare services 
and are extremely costly to these types of services as they result in patients requiring additional and 
more extensive care and longer occupancy within hospitals, these infections have also been found to be 
linked to increased morbidity rates. The burden these HAIs form means that effective antisepsis of the 
skin before any incision is made is crucial to avoid these unfavourable effects. Surgical site infections 
(SSIs) are believed to make up around 15% of all HAIs making them the most likely type of infection 
within patients undertaking surgery. The care given to patients after the surgery they undergo has been 
found to lead to a decrease in the number of infections, however this alone is not enough and efficient 
and adequate procedures prior to surgery is essential for the prevention of surgical related infections. 
(Vilela et al., 2007) (Stevens, 2009) 
The most frequent pathogens to be involved in SSIs are S. aureus and S. epidermidis, these 
microorganisms are often found in surgical sites, when incisions are performed on the skin, the tissue 
underneath the incision is exposed to the endogenous flora above which leads to a higher rate of SSIs 
(Piette and Verschraegen, 2009). The issue with these microorganisms is their ability to grow within the 
skin regardless of the use of antiseptic agents leading to further complicating these infections. Current 
recommendations state that 2% w/w CHG 70% (v/v) isopropyl alcohol (IPA) should be used as the ideal 
antisepsis before incisions are made to the skin. (Loveday et al., 2014) However, it is essential to note 
that prior to antisepsis of the skin, microorganisms have been found to linger in the skin, this in addition 
to inadequate penetration of most antiseptic agents are major contributing factors to SSIs. (Hendley and 





Therefore, it is essential to develop a carrier system which enhances the penetration of antimicrobial 
agents within the skin long-term, this would be applied to the skin prior to any surgical incisions to 
prevent the growth of bacteria in the surgical site and consequently limit infections of the skin.  
In this thesis, the efficiency of nanoemulsion NE was studied to improve the amount of antimicrobial 
agent penetrating to the target site within the skin. 
In chapter 3 of this thesis, two different techniques were used for the design and development of 
triclosan NE, the first technique was using a high-pressure homogeniser, as for the second technique it 
was using a high-shear homogeniser followed by ultrasonication. The design and development of 
triclosan NE was achieved successfully, and a study of various parameters of physiochemical 
characterisation of the formulation was performed including; MDS, PDI, ZP, pH and viscosity. In order to 
find the optimum formulation, the amount and type of surfactant were explored as well as the amount 
of oil. Different parameters for each of the two techniques were explored which included the effect of a 
number of cycles for the first technique and the sonication time for the second. A stability study was 
performed on all formulations in each of the techniques over a period of three months.  
The HLB for the eucalyptol was calculated and found to be 12.5. The best penetration and retainment 
within the skin was achieved by the formulation with the lowest amount of surfactant (0.34%w/w), 
T20/S20 ratio 1:1.  
As for chapter 4, high-shear homogenisation followed by ultrasonication was used and found to be a 
successful method for designed and developing PCMX NE. for this nanoemulsion the same 
physiochemical characterisations were explored as in the triclosan NE. Similarly to the triclosan NE, 
various types and amounts of surfactants were explored this was carried out to find the optimum 





time and speed of mixer in the high-shear homogeniser. Over three months, a long-term accelerated 
stability study was performed on all formulations. 
Results of this chapter indicated that the formulations with the least surfactant showed the best 
penetration and skin retention which was (0.4%w/w) and T80/S80 with a ratio of 3:1.  
The hair follicle HF is an essential drug delivery route within the skin, and through it, hair follicles also 
play a large role in leading to infections as they harbour microorganisms. Drug delivery is sometimes 
obstructed from reaching the target site within the HF, this obstruction may occur due to the presence 
of sebum. In order to prevent the sebum from obstructing drug delivery to target sites, Chapter 5 of this 
thesis focused on calculating HSPs of artificial sebum, this was tested to find the miscibility of antiseptic 
with artificial sebum.  
The HSPs for the different components of artificial sebum were calculated to find the overall HSP of the 
artificial sebum, these results were also validated, three different methods were used which are; VK-H 
method using contribution group method, Y-MB using HSPiP software and the third method using 
regression statistics with different soluble chemical compounds in artificial sebum with known HSPs. 
In the first two methods, the components of HSPs δd, δp and δh were calculated. 
The results are 24.94, 4.21, 4.91, 25.08, 4.57, 5.31 MPa0.5 for the VK-H method and Y-MB method 
respectively. 
In a third method, the total HSPs for the artificial sebum were calculated, this method showed similar 
results to the total HSPs found using the first two methods (26.13,26.32 VK-H method and Y-MB 
methods respectively).   
The Greenhalgh equation was then used to calculate the miscibility of the antiseptic with the artificial 
sebum, the affinity of triclosan was found to be released from eucalyptol to the artificial sebum, as for 





experimentally supported and demonstrated the miscibility between the antiseptic compounds and the 
artificial sebum.  
 
Future work 
• This study showed that the lower concentration of surfactant results in better penetration for 
triclosan and PCMX, to further investigate and support this finding, the same method could be 
applied to other nanoemulsion formulations. 
• Transmission electron microscopy TEM could be used to present the actual shape of the 
nanoemulsion droplet when surrounded by the surfactant to support the finding of the 
monolayer of the surfactant.  
• Micro CT scan was successfully used in this study to show the distribution of the nanoemulsion 
within the skin qualitatively, this could be applied to other nanoemulsion formulations to 
support this finding.  
• Atomic force microscopy could be used to study the changes occurring on the surface of the skin 
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These are the linearity test for five groups (A, B, C, D, and E), all groups have a high regression coefficient 
(R2) more than 0.99 
Group A 
This table shows the peak area for each concentration of Triclosan. 
Group A 
concentration of Triclosan( µg/ml) 
peak area of triclosan 
Run 1 Run 2 Average 
100 1446164 1448123 1447143.5 
50 723142 723558 723350 
20 311980 313153 312566.5 
10 151937 152746 152341.5 
5 72566 72513 72539.5 
1 18392 18082 18237 
 
This graph shows the linearity carve of group A 
 





























This table shows the ratio of peak area to each concentration of Triclosan. 
Group B 
Concentration of Triclosan (µg/ml) 
peak area of triclosan 
Run 1 Run 2 Average 
100 1665021 1664258 1664639.5 
50 799664 798692 799178 
20 323115 323367 323241 
10 184160 186416 185288 
5 88765 88966 88865.5 
1 22309 22037 22173 
 
This graph shows the linearity carve of group B 
 
 


























ratio of peak area







This table shows the ratio of peak area to each concentration of Triclosan. 
 
Group C 
concentration of Triclosan(µg/ml) 
peak area of Triclosan 
Run 1 Run 2 Average 
100 1663627 1662768 1663197.5 
50 798610 798971 798790.5 
20 323629 322736 323182.5 
10 184758 185397 185077.5 
5 88917 88659 88788 
1 22173 22014 22093.5 
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This table shows the ratio of peak area to each concentration of Triclosan. 
Group D 
concentration of Triclosan(µg/ml) 
peak area of triclosan 
Run 1 Run 2 Average 
100 1569013 1569088 1569050.5 
50 808935 808177 808556 
20 333507 333582 333544.5 
10 172550 171881 172215.5 
5 89710 89751 89730.5 
1 19010 19128 19069 
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This table shows the ratio of peak area to each concentration of Triclosan. 
Group E 
concentration of Triclosan(µg/ml) 
peak area of triclosan 
Run 1 Run 2 Average 
100 1566551 1566551 1566551 
50 808407 809022 808714.5 
20 332702 333217 332959.5 
10 172145 171817 171981 
5 89649 89933 89791 
1 19843 19121 19482 
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 This table shows the Relative standard Deviation (RSD) for intra-day precision  
 
 
This table shows the Relative Standard Deviation (RSD) for inter-day precision for the first day.  
First Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
peak area of Triclosan peak area of Triclosan peak area of Triclosan 
1 1289595 657496 83654 
2 1289054 657766 83854 
3 1289627 657626 83298 
4 1289465 656948 82987 
5 1289765 656606 83169 
Mean 1289501.2 657288.4 83392.4 
Standard Deviation 271.8054451 491.6083807 355.2031813 
Relative standard 
Deviation (RSD) 
0.02107834 0.074793406 0.42594191 
 
number of Run 
High (80  µg/ml ) Medium (40  µg/ml ) Low (4  µg/ml ) 
peak area of Triclosan peak area of Triclosan peak area of Triclosan 
1 1293147 658114 80667 
2 1292403 656896 80484 
3 1291875 655941 80893 
4 1292364 656542 80626 
5 1290910 657072 80733 
Mean 1292139.8 656913 80680.6 
Standard Deviation 824.0932593 798.4979649 149.7307584 
Relative standard 
Deviation (RSD) 





This table shows the Relative Standard Deviation (RSD) for inter-day precision for the second day.  
Second  Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
peak area of Triclosan peak area of Triclosan peak area of Triclosan 
1 1293147 658114 80667 
2 1292403 656896 80484 
3 1291875 655941 80893 
4 1292364 656542 80626 
5 1290910 657072 80733 
Mean 1292139.8 656913 80680.6 
Standard Deviation 824.0932593 798.4979649 149.7307584 
Relative standard 
Deviation (RSD) 
0.063777407 0.121553077 0.185584587 
 
This table shows the Relative Standard Deviation (RSD) for inter-day precision for the third day.  
Third-Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
peak area of Triclosan peak area of Triclosan peak area of Triclosan 
1 1304469 664987 83234 
2 1305671 664794 83853 
3 1305094 664209 83873 
4 1304840 664062 82926 
5 1305601 664686 83325 
Mean 1305135 664547.6 83442.2 
Standard Deviation 509.095767 394.7775323 411.6706208 
Relative standard 
Deviation (RSD) 






This table shows the Relative Standard Deviation (RSD) for inter-day precision for the fourth day.  
fourth Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
peak area of Triclosan peak area of Triclosan peak area of Triclosan 
1 1314925 672797 83490 
2 1313902 666843 82808 
3 1313706 672444 83050 
4 1304024 672665 83113 
5 1305098 671424 83720 
Mean 1310331 671234.6 83236.2 
Standard Deviation 5301.180057 2513.553719 364.5822267 
Relative standard 
Deviation (RSD) 
0.40456801 0.374467246 0.438009216 
 
This table shows the Relative Standard Deviation (RSD) for inter-day precision for the fifth day.  
Fifth  Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
peak area of Triclosan peak area of Triclosan peak area of Triclosan 
1 1314092 666534 83056 
2 1313934 666235 83258 
3 1313930 667342 83180 
4 1312818 666424 82893 
5 1313033 665428 83019 
Mean 1313561.4 666392.6 83081.2 
Standard Deviation 589.0847138 685.1334177 142.2522408 
Relative standard 
Deviation (RSD) 







These are the linearity test for five groups (A, B, C, D, and E), all groups have a high regression coefficient 
(R2) more than 0.99 
Group A 
This table shows the peak area for each concentration of Triclosan. 
Group A 
concentration of PCMX( µg/ml) 
Peak area of PCMX 
Run 1 Run 2 Average 
100 734949.2 734707.4 734993.8 
50 404944.5 404835.5 404741.2 
20 146449 146216.2 146329.9 
10 73227.2 73178.2 73305 
5 36688.4 36708.3 36767.3 
2 14749.5 14806.7 14708 
 
This graph shows the linearity carve of group A 
 
 



























This table shows the ratio of peak area to each concentration of Triclosan. 
Group B 
Concentration of PCMX (µg/ml) 
Peak area of PCMX 
Run 1 Run 2 Average 
100 734910.9 734710.6 734812.6 
50 404874.2 404982 405082.6 
20 146051.5 146458.3 146602.6 
10 73478.6 73460.8 73528.2 
5 36476.8 36717.7 36598.4 
2 14708 14846.6 14859.8 
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This table shows the ratio of peak area to each concentration of Triclosan. 
 
Group C 
concentration of PCMX(µg/ml) 
Peak area of PCMX 
Run 1 Run 2 Average 
100 741532.8 741485.5 740835.2 
50 407701.6 408114.5 408741.7 
20 147562 147402.5 147502 
10 74046.8 73699 73948.3 
5 36973.3 36976.9 37178.6 
2 15019.4 14917.1 14861.2 
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This table shows the ratio of peak area to each concentration of Triclosan. 
Group D 
concentration of PCMX (µg/ml) 
Peak area of PCMX 
Run 1 Run 2 Average 
100 801302.9 800532.4 800792.9 
50 394499.7 395023.8 395023.8 
20 160610.1 160607.8 160636.4 
10 80696.1 80646.6 80750.7 
5 40762.4 40913.8 40835.6 
2 16216.3 16083.1 15920 
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This table shows the ratio of peak area to each concentration of Triclosan. 
Group E 
concentration of PCMX (µg/ml) 
Peak area of PCMX 
Run 1 Run 2 Average 
100 800714 800846.8 800274.8 
50 394603.9 395058.6 395610.2 
20 160535.6 160486.5 160791.9 
10 80568.8 80662.9 80680.9 
5 40685.2 40797.7 40748.8 
2 15982.8 16006.3 16153.6 
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 This table shows the Relative standard Deviation (RSD) for intra-day precision  
 
 
This table shows the Relative Standard Deviation (RSD) for inter-day precision for the first day.  
First Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
Peak area of PCMX Peak area of PCMX Peak area of PCMX 
1 589091.4 296194.2 29473.8 
2 586285.8 296442.8 29672.2 
3 588219 296554.3 29419.8 
4 588674.7 296431.9 29254.6 
5 587630.8 296833.5 29254.6 
Mean 587980.34 296491.34 29415 
Standard Deviation 1091.695098 231.9584295 173.9889652 
Relative standard 
Deviation (RSD) 
0.18566864 0.07823447 0.591497417 
 
number of Run 
High (80  µg/ml ) Medium (40  µg/ml ) Low (4  µg/ml ) 
Peak area of PCMX Peak area of PCMX Peak area of PCMX 
1 593852.1 298126.7 29462.7 
2 593759.8 297765.6 29495.6 
3 593891.8 297839.3 29480.1 
4 593594.8 298251.8 29593.9 
5 593805.5 297558.4 29566.4 
Mean 593780.8 297908.36 29519.74 
Standard Deviation 115.1648601 279.8415141 57.19373217 
Relative standard 
Deviation (RSD) 





This table shows the Relative Standard Deviation (RSD) for inter-day precision for the second day.  
Second  Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
Peak area of PCMX Peak area of PCMX Peak area of PCMX 
1 588791.4 296192 29473.8 
2 585285.8 296217.4 29672.2 
3 589218 295374.4 29419.8 
4 588874.7 296404.7 29254.6 
5 589430.8 295453.1 29254.6 
Mean 588320.14 295928.32 29415 
Standard Deviation 1715.849661 477.6750224 173.9889652 
Relative standard 
Deviation (RSD) 
0.291652375 0.161415786 0.591497417 
 
This table shows the Relative Standard Deviation (RSD) for inter-day precision for the third day.  
Third-Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
Peak area of PCMX Peak area of PCMX Peak area of PCMX 
1 591999.7 297951.5 29473.8 
2 591521.5 297187.3 29672.2 
3 591015.6 297568.6 29419.8 
4 590192 296814.2 29254.6 
5 590477.5 297125.3 29254.6 
Mean 591041.26 297329.38 29415 
Standard Deviation 739.7573947 439.1768744 173.9889652 
Relative standard 
Deviation (RSD) 






This table shows the Relative Standard Deviation (RSD) for inter-day precision for the fourth day.  
fourth Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
Peak area of PCMX Peak area of PCMX Peak area of PCMX 
1 593852.1 298126.7 29462.7 
2 593759.8 297765.6 29495.6 
3 593891.8 297839.3 29480.1 
4 593594.8 298251.8 29593.9 
5 593805.5 297558.4 29566.4 
Mean 593780.8 297908.36 29519.74 
Standard Deviation 115.1648601 279.8415141 57.19373217 
Relative standard 
Deviation (RSD) 
0.019395181 0.093935435 0.193747412 
 
This table shows the Relative Standard Deviation (RSD) for inter-day precision for the fifth day.  
Fifth  Day 
number of Run 
High (80 µg) Medium (40 µg) Low (4 µg) 
Peak area of PCMX Peak area of PCMX Peak area of PCMX 
1 595840.9 298858.9 29735.8 
2 596057.6 299022 29468.5 
3 595817 299029.3 29582.7 
4 595879.8 299051.9 29655.7 
5 595984.2 299230.3 29588.2 
Mean 595915.9 299038.48 29606.18 
Standard Deviation 101.8002947 131.8899617 98.84830297 
Relative standard 
Deviation (RSD) 













Structural group Frequency Fdi  (J






-CH3 2 840 0 0 67 30.07 
(o,m,p) phenylene 1 1270 12100 0 52.4 75.09 
-Cl 1 450 302500 400 24 35.45 
-OH 1 210 250000 20000 10 17.01 
more planes of symmetry   calculated Molar Volume 153.4  
Σ=  2770 564600 20400  157.62 
δD = ΣFD / MV 18.06 
  
δP = (ΣFP
2)1/2 / MV 4.90 







Structural group Frequency Fdi  (J






-CH3 8 3360 0 0 268 120.28 
-CH2- 10 2700 0 0 161 140.27 
=CH- 6 1200 0 0 81 78.11 
=C< 6 420 0 0 -33 72.07 
more planes of symmetry   calculated Molar Volume 477  
Σ=  7680 0 0  410.73 
δD = ΣFD / MV 16.10 
  
δP = (ΣFP
2)1/2 / MV 0.00 
















Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 14 3780 0 0 225.4 196.38 
=CH- 2 400 0 0 27 26.04 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 314.4  
Σ=  5130 176400 10000  282.47 
δD = ΣFD / MV 16.32 
  
δP = (ΣFP
2)1/2 / MV 1.34 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 14 3780 0 0 225.4 196.38 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 287.4  
Σ=  4730 176400 10000  256.43 
δD = ΣFD / MV 16.46 
  
δP = (ΣFP
2)1/2 / MV 1.46 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 12 3240 0 0 193.2 168.33 
=CH- 2 400 0 0 27 26.04 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 282.2  
Σ=  4590 176400 10000  254.42 
δD = ΣFD / MV 16.27 
  
δP = (ΣFP
2)1/2 / MV 1.49 














Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COOH 1 530 176400 10000 28.5 45.02 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 106.9  
Σ=  2200 438500 30000  138.12 
δD = ΣFD / MV 20.58 
 
δP = (ΣFP
2)1/2 / MV 6.19 












Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 5 2100 0 0 167.5 75.18 
-CH2- 11 2970 0 0 177.1 154.30 
>CH- 7 560 0 0 -7 91.13 
>C< 2 -140 0 0 -38.4 24.02 
=CH- 1 200 0 0 13.5 13.02 
=C< 1 70 0 0 -5.5 12.01 
-OH 1 210 250000 20000 10 17.01 
ring 4 760 0 0 64 0.00 
more planes of symmetry   calculated Molar Volume 381.2  
Σ=  6730 250000 20000  386.67 
δD = ΣFD / MV 17.65 
  
δP = (ΣFP
2)1/2 / MV 1.31 














Structural group Frequency Fdi  (J






-CH3 6 2520 0 0 201 90.21 
-CH2- 25 6750 0 0 402.5 350.68 
>CH- 7 560 0 0 -7 91.13 
>C< 2 -140 0 0 -38.4 24.02 
=CH- 3 600 0 0 40.5 39.06 
=C< 1 70 0 0 -5.5 12.01 
-COO- 1 390 240100 7000 18 44.01 
ring 4 760 0 0 64 0.00 
more planes of symmetry   calculated Molar Volume 675.1  
Σ=  11510 240100 7000  651.12 
δD = ΣFD / MV 17.05 
 
δP = (ΣFP
2)1/2 / MV 0.73 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 7 1890 0 0 112.7 98.19 
>CH- 1 80 0 0 -1 13.02 
>C< 1 -70 0 0 -19.2 12.01 
=CH- 10 2000 0 0 135 130.19 
=C< 5 350 0 0 -27.5 60.06 
-Cl 2 900 605000 800 48 70.91 
-O- 3 300 480000 9000 11.4 48.00 
-CO- 1 290 592900 2000 10.8 28.01 
-N< 4 80 2560000 20000 -36 56.03 
ring 5 950 0 0 80 0.00 
more planes of symmetry   calculated Molar Volume 347.7  
Σ=  7190 4237900 31800  531.44 
δD = ΣFD / MV 20.68 
 
δP = (ΣFP
2)1/2 / MV 5.92 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH2- 5 1350 0 0 80.5 70.14 
=CH- 1 200 0 0 13.5 13.02 
=C< 3 210 0 0 -16.5 36.03 
-OH 1 210 250000 20000 10 17.01 
-NH2 1 280 0 8400 19.2 16.02 
-NH- 1 160 44100 3100 4.5 15.01 
-N< 3 60 1920000 15000 -27 42.02 
ring 2 380 0 0 32 0.00 
one plane of symmetry       
two planes of symmetry       
more planes of symmetry   calculated Molar Volume 116.2  
Σ=  2850 2214100 46500  209.25 
δD = ΣFD / MV 24.53 
  
δP = (ΣFP
2)1/2 / MV 12.81 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
(o,m,p) phenylene 1 1270 12100 0 52.4 75.09 
-OH 2 420 500000 40000 20 34.01 
-COOH 1 530 176400 10000 28.5 45.02 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 116.9  
Σ= 
 2410 688500 50000  154.12 
δD = ΣFD / MV 20.62 
 
δP = (ΣFP
2)1/2 / MV 7.10 













Structural group Frequency Fdi  (J






-CH3 5 2100 0 0 167.5 75.18 
-CH2- 3 810 0 0 48.3 42.08 
>C< 1 -70 0 0 -19.2 12.01 
=CH- 6 1200 0 0 81 78.11 
=C< 4 280 0 0 -22 48.04 
-COOH 1 530 176400 10000 28.5 45.02 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 300.1  
Σ=  5040 176400 10000  300.44 
δD = ΣFD / MV 16.79 
 
δP = (ΣFP
2)1/2 / MV 1.40 













Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 6 1620 0 0 96.6 84.16 
>CH- 3 240 0 0 -3 39.06 
>C< 1 -70 0 0 -19.2 12.01 
=CH- 9 1800 0 0 121.5 117.17 
=C< 7 490 0 0 -38.5 84.08 
-O- 1 100 160000 3000 3.8 16.00 
-COOH 1 530 176400 10000 28.5 45.02 
ring 6 1140 0 0 96 0.00 
more planes of symmetry   calculated Molar Volume 319.2  
Σ=  6270 336400 13000  412.53 
δD = ΣFD / MV 19.64 
 
δP = (ΣFP
2)1/2 / MV 1.82 












Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 3 1260 0 0 100.5 45.11 
-CH2- 1 270 0 0 16.1 14.03 
>CH- 3 240 0 0 -3 39.06 
>C< 2 -140 0 0 -38.4 24.02 
=CH- 3 600 0 0 40.5 39.06 
=C< 7 490 0 0 -38.5 84.08 
-OH 5 1050 1250000 100000 50 85.04 
-CO- 3 870 1778700 6000 32.4 84.03 
-NH2 1 280 0 8400 19.2 16.02 
-N< 1 20 640000 5000 -9 14.01 
ring 4 760 0 0 64 0.00 
more planes of symmetry   calculated Molar Volume 233.8  
Σ=  5700 3668700 119400  444.45 
δD = ΣFD / MV 24.38 
 
δP = (ΣFP
2)1/2 / MV 8.19 












ETHYL HEXYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 2 840 0 0 67 30.07 
-CH2- 5 1350 0 0 80.5 70.14 
>CH- 1 80 0 0 -1 13.02 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 242.9  
Σ=  4330 502200 27000  250.34 
δD = ΣFD / MV 17.83 
 
δP = (ΣFP
2)1/2 / MV 2.92 












PHENYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






=CH- 5 1000 0 0 67.5 65.10 
=C< 1 70 0 0 -5.5 12.01 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 2 380 0 0 32 0.00 
more planes of symmetry   calculated Molar Volume 174.4  
Σ= 
 3320 502200 27000  214.22 
δD = ΣFD / MV 19.04 
 
δP = (ΣFP
2)1/2 / MV 4.06 












4 HYDROXY BENZOIC ACID 
Structural group Frequency Fdi  (J






(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COOH 1 530 176400 10000 28.5 45.02 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 106.9  
Σ=  2200 438500 30000  138.12 
δD = ΣFD / MV 20.58 
 
δP = (ΣFP
2)1/2 / MV 6.19 












METHYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 129.9  
Σ=  2480 502200 27000  152.15 
δD = ΣFD / MV 19.09 
 
δP = (ΣFP
2)1/2 / MV 5.46 












ETHYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 1 270 0 0 16.1 14.03 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 146  
Σ= 
 2750 502200 27000  166.18 
δD = ΣFD / MV 18.84 
 
δP = (ΣFP
2)1/2 / MV 4.85 












PROPYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 2 540 0 0 32.2 28.05 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 162.1  
Σ= 
 3020 502200 27000  180.21 
δD = ΣFD / MV 18.63 
 
δP = (ΣFP
2)1/2 / MV 4.37 















BUTYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 3 810 0 0 48.3 42.08 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 178.2  
Σ=  3290 502200 27000  194.23 
δD = ΣFD / MV 18.46 
 
δP = (ΣFP
2)1/2 / MV 3.98 











AMYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 4 1080 0 0 64.4 56.11 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 194.3  
Σ=  3560 502200 27000  208.26 
δD = ΣFD / MV 18.32 
 
δP = (ΣFP
2)1/2 / MV 3.65 












METHYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 5 1350 0 0 80.5 70.14 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 210.4  
Σ=  3830 502200 27000  222.29 
δD = ΣFD / MV 18.20 
 
δP = (ΣFP
2)1/2 / MV 3.37 












HEPTYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 6 1620 0 0 96.6 84.16 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 226.5  
Σ=  4100 502200 27000  236.31 
δD = ΣFD / MV 18.10 
 
δP = (ΣFP
2)1/2 / MV 3.13 












OCTYL 4 HYDROXY BENZOATE 
Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 
-CH2- 7 1890 0 0 112.7 98.19 
(o,m,p) phenylene 1 1270 12100 0 52.4 76.10 
-OH 1 210 250000 20000 10 17.01 
-COO- 1 390 240100 7000 18 44.01 
ring 1 190 0 0 16 0.00 
more planes of symmetry   calculated Molar Volume 242.6  
Σ=  4370 502200 27000  250.34 
δD = ΣFD / MV 18.01 
 
δP = (ΣFP
2)1/2 / MV 2.92 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 16 4320 0 0 257.6 224.43 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 319.6  
Σ=  5270 176400 10000  284.49 
δD = ΣFD / MV 16.49 
 
δP = (ΣFP
2)1/2 / MV 1.31 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 18 4860 0 0 289.8 252.49 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 351.8  
Σ=  5810 176400 10000  312.54 
δD = ΣFD / MV 16.52 
 
δP = (ΣFP
2)1/2 / MV 1.19 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 22 5940 0 0 354.2 308.60 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 416.2  
Σ=  6890 176400 10000  368.65 
δD = ΣFD / MV 16.55 
 
δP = (ΣFP
2)1/2 / MV 1.01 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 20 5400 0 0 322 280.54 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 384  
Σ=  6350 176400 10000  340.59 
δD = ΣFD / MV 16.54 
 
δP = (ΣFP
2)1/2 / MV 1.09 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 15 4050 0 0 241.5 210.41 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 303.5  
Σ=  5000 176400 10000  270.46 
δD = ΣFD / MV 16.47 
 
δP = (ΣFP
2)1/2 / MV 1.38 













Structural group Frequency Fdi  (J






-CH3 1 420 0 0 33.5 15.04 







=CH- 4 800 0 0 54 52.08 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 309.2  
Σ=  4990 176400 10000  280.45 
δD = ΣFD / MV 16.14 
 
δP = (ΣFP
2)1/2 / MV 1.36 











Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 10 2700 0 0 161 140.27 
=CH- 6 1200 0 0 81 78.11 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 304  
Σ=  4850 176400 10000  278.44 
δD = ΣFD / MV 15.95 
 
δP = (ΣFP
2)1/2 / MV 1.38 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 8 2160 0 0 128.8 112.22 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 190.8  
Σ=  3110 176400 10000  172.27 
δD = ΣFD / MV 16.30 
 
δP = (ΣFP
2)1/2 / MV 2.20 












Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 16 4320 0 0 257.6 224.43 
=CH- 2 400 0 0 27 26.04 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 346.6  
Σ=  5670 176400 10000  310.52 
δD = ΣFD / MV 16.36 
 
δP = (ΣFP
2)1/2 / MV 1.21 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 10 2700 0 0 161 140.27 
=CH- 2 400 0 0 27 26.04 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 250  
Σ=  4050 176400 10000  226.36 
δD = ΣFD / MV 16.20 
 
δP = (ΣFP
2)1/2 / MV 1.68 





















-CH3 1 420 0 0 33.5 15.04 
-CH2- 16 4320 0 0 257.6 224.43 
=CH- 4 800 0 0 54 52.08 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 373.6  
Σ=  6070 176400 10000  336.56 
δD = ΣFD / MV 16.25 
 
δP = (ΣFP
2)1/2 / MV 1.12 























-CH3 1 420 0 0 33.5 15.04 
-CH2- 12 3240 0 0 193.2 168.33 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 255.2  
Σ=  4190 176400 10000  228.38 
δD = ΣFD / MV 16.42 
 
δP = (ΣFP
2)1/2 / MV 1.65 













Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 20 5400 0 0 322 280.54 
=CH- 2 400 0 0 27 26.04 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 411  
Σ=  6750 176400 10000  366.63 
δD = ΣFD / MV 16.42 
 
δP = (ΣFP
2)1/2 / MV 1.02 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 14 3780 0 0 225.4 196.38 
=CH- 4 800 0 0 54 52.08 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 341.4  
Σ=  5530 176400 10000  308.51 
δD = ΣFD / MV 16.20 
 
δP = (ΣFP
2)1/2 / MV 1.23 












Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 10 2700 0 0 161 140.27 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 223  
Σ=  3650 176400 10000  200.32 
δD = ΣFD / MV 16.37 
 
δP = (ΣFP
2)1/2 / MV 1.88 








Structural group Frequency Fdi  (J
1/2.cm3/2.mol-1) Fpi2 (J1/2.cm3/2.mol-1) Ehi (J/mol) V (cm3/mol) 
Molecular 
weight (g/mol) 
-CH3 1 420 0 0 33.5 15.04 
-CH2- 6 1620 0 0 96.6 84.16 
-COOH 1 530 176400 10000 28.5 45.02 
more planes of symmetry   calculated Molar Volume 158.6  
Σ=  2570 176400 10000  144.22 
δD = ΣFD / MV 16.20 
 
δP = (ΣFP
2)1/2 / MV 2.65 
δH = (ΣFH / MV)
1/2 7.94 
δ = (δD
2 + δP
2 + δH
2)1/2 18.24 
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